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Abstract
Mitochondria form an essential component of nearly all eukaryotic cells, are implicated in
numerous diseases and may play important roles in ageing. Mitochondrial populations are
dynamic, controlled and heterogeneous, with different types – both mutant and wildtype –
potentially coexisting in single cells. This thesis will study the dynamics of both mitochondria
and their genetic material (mtDNA) to improve our understanding of the role of these dynamics
in pathology and ageing.
This study suggests, as well as critically evaluates, reasons for the existence of complex continu-
ous mitochondrial networks using coarse-grained mathematical models, underlining a nonlinear
relation between functionality and network structure. Understanding the link between mor-
phology and function is important as disruption of the former is directly implicated in cellular
dysfunction. We perform experiments in which we measure the influence of mitochondrial
fusion and division events on integrated mitochondrial membrane potential, an indicator of
functionality, and find evidence for its conservation.
The cellular homeostatic control acting on a mitochondrial population is poorly understood;
to address this, we study the influence of general feedback control strategies on mutant and
wildtype mtDNA dynamics. We introduce a simple linear control mechanism that captures a
wide variety of biologically observed dynamics, and study optimal parameterisations through
the construction of an energy-based mitochondrial cost function. Not only cellular control, but
also gene-therapeutic control of mtDNA is studied, allowing us to investigate optimal treatment
strategies to reduce mutant loads.
The cellular proportion of mutant mtDNA molecules, known as heteroplasmy, is crucial in
mitochondrial disease and we study the influence of cellular mtDNA exchange on heteroplasmy
dynamics and mutant expansion during ageing. We find that this exchange of genetic material
can induce preferential mutant expansion during ageing (even in the face of selection against
mutants) through a stochastically driven increase in cellular mean heteroplasmy levels.
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Glossary
mtDNA Mitochondrial DNA
Carrying Capacity The steady state copy number of a given species when present
at homoplasmy in a single cell
Relaxed Replication The continuous turnover of mtDNA molecules even in the
absence of cellular turnover. The ‘relaxed replication model’
refers to a mathematical model of mtDNA dynamics [1, 2]
Clonal expansion The expansion of a specific (clonal) mtDNA species over time,
often referring to mutant mtDNA
Cellular mean heteroplasmy The average heteroplasmy value of a population of cells, i.e.
1
n
∑
i
mi
wi+mi
with n the number of cells in the population, and
mi and wi denoting mutant and wildtype mtDNA copy num-
bers in cell i, respectively
Homogenate heteroplasmy The level of heteroplasmy obtained when all mtDNAs of a
population of cells are combined together, i.e.
∑
imi∑
i(wi+mi)
with
mi and wi denoting mutant and wildtype mtDNA copy num-
bers in cell i, respectively
System Size Expansion A technique to approximate Master equations, whereby the
dynamics are split into a deterministic and a stochastic com-
ponent. The larger the system size, the smaller the stochastic
contributions to the dynamics
Linear Noise Approximation The leading order term in the System Size Expansion
Gillespie algorithm A stochastic modelling method using random numbers to sim-
ulate individual reaction events; it is often used in computa-
tional systems biology.
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1
Introduction
1.1 Mitochondria - the vital organelles
Mitochondria are double membrane-bound organelles present in nearly all eukaryotic cells.
Their acquisition occurred roughly 2 billion years ago perhaps when a bacterium was engulfed
by another cell as an endosymbiont [3]. The relationship between bacterium and cell turned out
to be a beneficial one, perhaps as the bacterium provided a new source of energy for the cell,
which in turn provided protection from the environment. Over millions of years of evolution,
the bacterium lost its independence and became an organelle of the cell: the mitochondrion.
Currently most cells in our body cannot survive without mitochondria which, besides being the
main energy producers in the cell, are involved in various other processes including intracellu-
lar calcium signalling, iron-sulfur cluster biogenesis, and cell death [4–6]. The importance of
studying and understanding mitochondria cannot be understated as they have been implicated
in numerous diseases including Parkinson’s [7], diabetes [8], cancer [9], and Alzheimer’s [10],
and are of central importance in various devastating mitochondrial diseases [8, 11, 12]. For
many years, mitochondria have been linked to ageing [13–24] (recent reviews are provided in
Refs. [23, 25–28]).
Because of the large number of different processes mitochondria are involved in, it is challeng-
ing to experimentally probe all of them which limits our ability to combat disease. Though
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new technologies increasingly reduce these difficulties, mathematical and in silico models of
mitochondria can provide useful additional insights and have been applied to many different
mitochondrial research fields including development [29–33], ageing [2, 34–39], and mitochon-
drial dynamics [40–44].
1.2 Mitochondrial structure and behaviour
In this thesis, we first introduce some of the major mitochondrial components and functions,
knowledge of which is required in the remainder of the thesis. Mitochondria have an outer and
inner membrane, the latter containing many invaginations, called cristae, increasing surface
area to accommodate a large number of proteins. The inner membrane is split between the
inner boundary membrane and the crista membrane which, though connected, are populated
by different proteins [45, 46]. Cristae have connections with the inner boundary membrane
through tubules called crista junctions (Figure 1.1). A recent review on mitochondrial cristae
structure is provided in Ref. [47]. An important feature of mitochondria is that they retain their
own genetic material, mitochondrial DNA (mtDNA), which is discussed in detail in Section 1.3.
In many cells, mitochondria are the main producers of ATP, the energy currency of the cell,
whose synthesis is driven by an electrochemical potential gradient across the inner membrane.
This gradient is maintained by pumping protons, H+, from the matrix into the intracristal and
intermembrane spaces (Figure 1.1), a process carried out by a set of large protein complexes.
Ideas about the organization of these complexes have changed over time and it is now clear
that they assemble into various supercomplexes [48] (e.g. Figure 1.1). They transfer electrons
from donors to acceptors via reduction and oxidation reactions, and are therefore often referred
to as the electron transport chain. Protons are allowed to flow down their gradient back into
the matrix via the enzyme ATP synthase, thereby releasing their potential energy which is
used to phosphorylate ADP to ATP (Figure 1.1). The entire process is known as oxidative
phosphorylation because the final electron acceptor is oxygen.
Sometimes protons may leak across the inner membrane without being coupled to ATP pro-
duction, thereby generating heat; this process is known as uncoupling. Uncoupling provides
a mechanism of increasing an organism’s temperature, used by e.g. hibernating animals [49].
However, it can also be the result of damage to the mitochondrial membrane caused by e.g.
Reactive Oxygen Species (ROS), a source of mitochondrial damage induced by leakage of elec-
trons from the electron transport chain. Damaged mitochondria may be removed by the cell
through a process called mitophagy [50–53], though controversy exists over its ability to se-
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lectively target damaged mitochondria [27, 54–56]. A recent study suggests that selectivity is
relatively limited in physiological settings but can be greatly enhanced experimentally [57].
Mitochondria are heavily involved in programmed cell death, known as apoptosis. Apoptosis
can be triggered by the release of an enzyme, called cytochrome c, in the cytoplasm. Normally,
cytochrome c resides in the cristae with limited diffusion to the intermembrane space (for a
review see Ref. [58]), but widening of the crista junctions enables cytochrome c to diffuse into
the cytoplasm.
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Figure 1.1: Mitochondrial structure. A simplified cartoon illustrating several main mitochondrial components.
Left: mitochondrial membrane structure and compartmentalization. A fission event is illustrated. Right: respiratory
chain complexes embedded in the mitochondrial inner membrane. As an example, the respirasome supercomplex is
shown together with complex II (which is mainly found in free-floating form) and complex V (ATP synthase).
1.2.1 Mitochondrial fusion and fission dynamics
Mitochondria are highly dynamic organelles and they are observed to undergo fusion and fission
events continuously (Figure 1.1), leading to a diverse range of mitochondrial morphologies, from
fragmented states to continuous networks. Images of mitochondrial networks are provided in
Chapters 2 and 3. Fusion events are known to be selective, and only involve mitochondria with
a sufficiently high membrane potential [59]. This selectivity of fusion events will turn out to
play an important role in the beneficial effects of highly fused states (Chapter 2). Cristae are
also capable of undergoing fission and fusion events, thereby changing the morphology of the
cristae-network inside the mitochondrion [60].
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The morphological state of the network is itself directly implicated in a variety of diseases [61],
and inhibiting fission or fusion can lead to severe cellular dysfunctions [62, 63]. Understanding
why a network remodels itself and how exactly its structure impacts its function is of great
importance but still unclear; we discuss this topic in detail in Chapter 2.
Mitochondrial fusion/fission dynamics do not merely change the shape of the network, they
are able to isolate certain mitochondrial fragments which are then – due to their small size –
susceptible to degradation. Because fusion with the network is selective, fragments containing
mutant mitochondrial DNA may be less likely to join than others. Experimentally, disrupting
the balance between fusion and fission has been shown to lead to loss of mtDNA [64], and
increased mitochondrial fission is associated with reductions in lifespan [65–67]. Interestingly,
a recent study showed that transient increases in fission in midlife can increase lifespan [68].
These findings indicate a close linking between mitochondrial fusion/fission dynamics, ageing,
and mtDNA dynamics, the three main topics of this thesis.
1.3 Mitochondrial DNA, heteroplasmy and pathology
MtDNA is tiny compared to nuclear DNA and in humans comprises 16,569 base pairs, encoding
only 37 genes. In healthy cells, the levels of mtDNA are controlled and remain fairly constant
over time as we age [69], though there are indications that copy numbers drop with age in
skeletal muscle [70–72] which is likely to be linked to muscle deterioration. The number of
mtDNA molecules per cell ranges from about 100 to 105 and depends heavily on the type of
cell, reflecting different cellular functions (e.g. mtDNA levels per cell have been measured to
be 3650 ± 620 in skeletal muscle, 6970 ± 920 in heart [69], all the way up to 105 in mature
human oocytes [73]). Note that due to the high mtDNA copy numbers, the total amount of
mtDNA can comprise a macroscopic fraction of total cellular DNA (mtDNA and nuclear DNA
combined). MtDNA molecules are packaged into protein structures called nucleoids which each
contain ∼ 1− 2 mtDNAs [74].
Replication of mtDNA is linked to the cell cycle [75], as copy numbers must approximately
double before a new cell division occurs. However, mtDNA turnover is still present in post-
mitotic cells and is thus capable of occurring in the absence of cellular turnover [76]. Mutations
in mtDNA can occur, and though it was previously thought that ROS damage was the main
cause of mutations, it has now become clear they are mostly generated through errors during
replication [77] (reviewed in Ref. [27]). Though machinery to repair mtDNA exists [78, 79], this
machinery is possibly less efficient than nuclear DNA repair. Continuous mtDNA turnover in
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post-mitotic cells is therefore desirable as otherwise mutations would accumulate without the
possibility of their removal. However, mtDNA turnover, though it may be capable of eliminating
mutations from the population, can itself lead to expansions of mutants as discussed in Chapters
4 and 5.
When mutations occur, they often coexist with wildtype mtDNA molecules, a situation which
is called heteroplasmy. Denoting the number of wildtype and mutant mtDNA molecules in a
cell by w and m respectively, the level of heteroplasmy is defined as
h =
m
w +m
(1.1)
and can vary between cells in the same tissue, between different tissues, and between individuals.
A state in which only a single type of mtDNA is present is known as homoplasmy.
Because of the large number of mtDNAs in a cell, the presence of a few mutants does not im-
mediately cause major problems. The heteroplasmy value has to exceed a critical heteroplasmy
threshold, typically 60-90%, before biochemical defects are observed [21, 80–85]. As mean het-
eroplasmy values do not completely specify threshold crossing probabilities, it is vital to have
knowledge of how the heteroplasmy distribution changes over time. This requires stochastic
treatments as opposed to deterministic ones which typically only describe mean behaviour.
When mutation loads are sufficiently high they can have detrimental consequences, as is the
case in mitochondrial diseases which affect ∼1 in 4300 of the adult human population (including
mutations of both mtDNA and nuclear DNA) [86]. This again underlines the importance of
studying mitochondrial behaviour.
Interestingly, the same pathogenic mutations that cause mtDNA diseases, are also found in
healthy individuals but at much lower levels [87, 88]. These low-level mutations, both patho-
logical and non-pathological, accumulate with age [27] and are typically seen in post-mitotic
tissues (e.g. skeletal muscle, myocardium and brain). Often a cell contains very high fractions
of a single mutation [89], which is said to have clonally expanded. Clonally expanded muta-
tions are often deletion mutations which lack parts of the mtDNA (rendering them shorter)
though point mutations can also expand [90, 91]. Mutation load only reaches high levels in a
small fraction of cells, giving rise to a mosaic structure with patches of high-heteroplasmy cells
distributed among low-heteroplasmy cells (e.g. [85, 92]).
How does this process of clonal expansion occur? Can we delay, or even prevent it? Despite
ongoing active research, the answers to these questions are as yet unknown. Many hypotheses
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on this topic involve a selection advantage for the mutant species such as: a shorter replication
time for deletion mutants due to their smaller genomes [93, 94]; a lower degradation rate for
certain mutants due to their reduced release of damaging superoxide molecules [95]; or, faster
mutant replication which is stimulated by their microenvironment [96, 97]. Even though all of
these hypotheses have some attractive features, they are not fully supported by data or only
concern certain types of mutants [98, 99].
Rapid progress is being made, however, and various mathematical models incorporating these
hypotheses and others are discussed in Section 1.4.2. The power of mathematical modelling
becomes apparent when considering their useful insights and findings such as i) the discovery
that many expanded mutants in aged individuals are likely to have occurred early in life [17, 20,
34], ii) two competing species cannot coexist indefinitely and one species will always outcompete
the other [100], iii) before homoplasmy is reached the variance of at least one mtDNA species
in a heteroplasmy cell always increases with time [101, 102]. We will adopt similar modelling
approaches to add to this collection of interesting findings.
1.4 Modelling mitochondria
This thesis uses mathematical modelling as a tool to gain insights into mitochondrial biology and
mitochondrial roles in ageing, disease, and cellular function. Therefore, having introduced vari-
ous essential mitochondrial components in previous sections, we here turn towards summarising
mathematical models currently existing in the literature, mainly focussing on stochastic models
of ageing and mitochondrial dynamics as these topics are the main focus of this thesis.
We stress the crucial role of mathematical models in mitochondrial research. For example, they
can generate new insights, lead to experimental suggestions, integrate and combine knowledge of
different fields, enable sensitivity analyses, and deepen understanding. For a general discussion
of the relevance of modelling in biology, we refer to Ref. [103]. Mitochondria and their mtDNAs
form a stochastic system (e.g. the occurrence of mutations is random), the dynamics of which
are hard to track experimentally without damaging the cell. Mathematically, one can readily
simulate large populations of cells and, importantly, perform simulations over long timescales.
Experimentally probing mtDNA dynamics over a lifetime will literally take a lifetime, whereas
computer simulations can generate statistics within hours; modelling is thus a highly relevant
tool in studying clonal expansion during ageing.
6
Examples of models describing mitochondrial and/or mtDNAs dynamics are illustrated in Fig-
ure 1.2. As mtDNA molecules replicate and degrade continuously, a mathematical approach
known as a birth-death model [100] provides a natural way of describing their dynamics. In
this class of models there are only two types of events: each individual of the population has
a probability per unit time of increasing (birth) or decreasing (death) its copy number by one.
In general, the birth and death rates may differ between mutant and wildtype and may depend
on time or copy number (Figure 1.2(i)). These intracellular dynamics can be combined with
any of the others shown in the figure.
One particular model to which we will often refer is the well-known ‘relaxed replication model’
which assumes continuous turnover of mtDNA in post-mitotic cells [1, 2]. Degradation rates are
assumed to be constant, and replication rates are allowed to depend on wildtype and mutant
copy numbers. The aim of the model was to see how the presence of mutant molecules affects
the overall dynamics, and how heteroplasmy varies over time. A heteroplasmy threshold was
predicted by assuming that wildtype copy numbers are being controlled towards a specific
‘optimal’ value. The model has since been used in a variety of other models [34, 36] and has
obtained experimental support [104].
We split this section into four parts, each discussing mathematical models of different mito-
chondrial aspects: i) mitochondria during development, ii) mutant accumulation during ageing,
iii) mitochondrial fusion/fission dynamics, and iv) a specific feedback control model we will use
throughout this thesis.
1.4.1 Models of mitochondria during development
Unfertilised human eggs contain ∼ 105 mtDNAs, some of which may be mutated. After fertilisa-
tion, the egg starts dividing, and with each division the mtDNAs are stochastically partitioned
between the daughter cells. By chance, some daughter cells will inherit more mutants than
others, introducing a variance in heteroplasmy across the population of cells (see e.g. [105]).
A drastic drop in mtDNA copy number per cell in early development, known as the bottleneck,
further increases stochasticity. There is evidence suggesting that different mtDNA mutations
lead to different genetic bottlenecks which induces a variety of inheritance patterns [106].
The exact mechanism by which heteroplasmy variance increases through development is highly
debated. It may be the result of a combination of random mtDNA copy number drift in
between cell divisions and stochastic partitioning at cell divisions [101, 107–112], or additional
mechanisms may be required such as restricting the ability to replicate to only a subpopulation
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Figure 1.2: Mitochondrial modelling. Various kinds of mitochondrial models have been developed, focussing
on different aspects. Four examples of the main ingredients often included in mitochondrial modelling are shown:
i) mtDNA turnover within cells (with possible mutation events), ii) mitochondrial fusion/fission dynamics, which
may or may not be selective processes (instead of redistribution of mtDNAs, more abstract ‘health units’ are often
considered [40–42]), iii) cellular turnover with stochastic partitioning of mitochondria, and iv) intercellular mtDNA
or mitochondrial exchange. Extension, variations and combinations of any of these basic models are possible.
of mtDNAs [113], or clustering of mtDNAs during cell divisions [114]. Recently, a general
model was developed which was able to reproduce all of these mechanisms and, importantly,
provides a statistical framework to compare them given experimental observations [32]. Using
Approximate Bayesian Computation [115, 116] it was found that most support is found for a
mechanism involving a combination of random mtDNA turnover and binomial partitioning at
cell division [32].
Analytical treatments of heteroplasmy dynamics through development use results from popula-
tion genetics such as the Wright formula [30] (providing information on heteroplasmy mean and
variance) and the Kimura distribution [29] (allowing for descriptions of the entire heteroplasmy
8
probability distribution after any number of cell divisions). Recently, a model was developed
that includes mtDNA dynamics in-between cell divisions [31, 32], suggesting a modification to
the Wright formula [101].
Cellular turnover during development clearly plays a role in mtDNA and heteroplasmy dynam-
ics, yet few models exist combining embryonic phases with post-natal mtDNA turnover during
ageing [108]. This is likely due to an uncertainty in the contribution of embryonic mutations to
end-of-life mutation levels, especially in long-lived organisms. Stochastic modelling suggested
that inclusion of embryonic turnover in wildtype mice had little influence on mean mutant
loads at older ages, but did increase heteroplasmy variance and led to long-tailed heteroplasmy
distributions [108].
1.4.2 Models of mutant accumulation during ageing
Mutant accumulation during ageing can be modelled by assuming a certain mtDNA mutation
rate. As most mutations occur during replication [117] a probability of mutation upon repli-
cation, Pmut, is often used [34, 36–38]. The aim is to construct a model that can explain the
experimentally observed levels of clonal expansion in aged individuals, thereby generating an
understanding of both the mechanisms behind the expansion and ways in which to reduce its
rate.
Stochastic simulations were used to model whether shorter deletion mutant replication times
– due to their smaller genome – could account for observed levels of clonal expansion in aged
mammals [37, 118]. If the mtDNA population can be considered well-mixed, then predictions
of this survival-of-the-tiny hypothesis agree with experimental data, but only under the as-
sumption that mutation rate increases with heteroplasmy [118]. A more recent study by the
same authors argues against the hypothesis in the context of short-lived mammals such as mice
and rats [37]. Their results, however, seem to suggest that survival-of-the-tiny can account
for clonal expansion in short-lived animals under the assumption that mtDNA half-lives are
∼ 2− 4 days. Though studies in mice and rats suggest half-lives on the order of ∼ 1− 3 weeks
[119–121], these studies are both sparse and old [37]. Shorter replication times in deletion mu-
tations may therefore, according to their treatment, still contribute to their expansion, though
cannot explain expansion of point mutations.
A deterministic model employing slower mutant degradation and replication, correctly predicted
a faster mutant accumulation rate in post-mitotic cells compared to dividing cells [99]. Recent
evidence, however, suggests that mutants are degraded faster, rather than slower [59, 122]. A
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recently proposed model, involving faster mutant replication due to altered transcription rates,
is able to explain data in both short- and long-lived species [38]. However, the high level of
positive mutant selection used (a 50% increase in replication rate) is likely to lead to much
higher mutant levels – and therefore better agreement with data of short-lived species – in any
model, without requiring the specific interpretation referring to transcription rates. Also, the
model assumes a constant total population size which is unrealistic and misses out on implicit
selection effects that become apparent when population size varies (Chapter 5).
Besides these selective models, various neutral models, without explicit mutant selection, were
proposed to account for the observed data [34, 36, 123–125]. Mutants may generate more
ROS, leading to even more mutants thereby creating a vicious cycle [123–125]. The vicious-
cycle-hypothesis, however, predicts a plethora of distinct mutants, contrasting experiments.
Moreover, it has become clear that ROS is not responsible for most mtDNA mutations [27, 77].
An alternative view is that, in theory, stochastic drift of mtDNA molecules over time can
lead to a mutant taking over the entire mtDNA populations purely by chance because of
the stochasticity of mtDNA replication and degradation, as well as cell divisions. Through
stochastic simulations, using the relaxed replication model, it was found that no positive mutant
selection is required to account for the observed levels of clonal expansion in aged humans [34].
However, a neutral model could not account for heteroplasmy data in short-lived mammals
[36], which is due to a high level of Pmut being required to match the relatively high mutant
levels in post-mitotic tissue of aged rodents. Any mutation event that occurs is assumed to
generate a distinct type of mutant, and a high Pmut predicted a large number of such distinct
mutants towards the end of life, disagreeing with experimental observations. These findings
seem to suggest that neutral models cannot account for clonal expansion, though we revisit
this question in Chapter 5.
1.4.3 Models of mitochondrial fusion/fission dynamics
Fusion and fission events can alter the rate of mutant mtDNA accumulation, and may thus
be important processes to consider in modelling ageing. In many mathematical models the
mtDNA molecules are assumed to be physically well-mixed and each mtDNA has a given
probability per unit time of being replicated and degraded. However, through fusion and
fission events, certain mitochondrial fragments may become separated from the network and
can subsequently be degraded through mitophagy. The occurrence of mitophagy events, events
involving the degradation of a whole mitochondrion, means that all the mtDNA molecules
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within are simultaneously degraded. In this case, it becomes important to know which mtDNA
resides in which mitochondrion. Moreover, mitochondria can only fuse with others when they
are sufficiently close, meaning that spatial positions start to play a role in mtDNA dynamics.
Different kinds of models of fusion and fission dynamics exist, some of which focus on their
role on heteroplasmy and clonal expansion [43, 44] whereas others focus not on mtDNA but
rather the fusion and fission events themselves and how they affect the health of the overall
mitochondrial population [40–42]. One model focussed on the different morphological structures
of mitochondrial networks which arise from changing the relative rates of fusion and fission; it
was suggested that the network contains a percolating phase transition [126].
Through stochastic Gillespie simulations [127] it was shown that slower mtDNA mixing in-
creases the heteroplasmy variance between cells [43], which is only beneficial when mitophagy
and fusion are sufficiently selective [44]. It was therefore suggested that the expansion of mu-
tant mtDNA likely involves a decline in the selectivity of mitochondrial degradation and fusion
with age [44]. Higher rates of fusion and fission tend to lead to more healthy mitochondria
[40–42], though this may not be true if a damaged mitochondrion spreads this damage when
fusing with others [42].
1.4.4 A linear model of mitochondrial feedback control
Having provided an overview of models in the literature on various mitochondrial aspects, we
here focus on a specific model of mtDNA dynamics which will be used extensively throughout
this thesis. This model, like many others discussed above, assumes that the mitochondrial
population is under homeostatic control. Indeed, there is evidence of communication between
the nucleus and mitochondria, known as retrograde signalling (mitochondrial signals to the
nucleus) and anterograde signalling (nuclear signals to the mitochondria), which is used to
regulate mtDNA content [128]. Different mutants accumulate preferentially in different tissues
[129], again suggesting involvement of the cellular environment and the nucleus.
Our model belongs to the class of birth-death models, in which control can be incorporated by
letting the mtDNA birth and death rates be functions of mutant and wildtype copy numbers
themselves. We will mainly focus on a simple type of birth-death model, namely one in which
the death rate is constant and the birth rate is a linear function of w and m. More precisely,
referring to Figure 1.2(i), we assume a constant death rate µw = µm ≡ µ and a birth rate
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λw = λm ≡ λ(w,m) of the form
λ(w,m) = c0 − c1(w + δm) (1.2)
where c0, c1 > 0 and δ are constants. We will occasionally include a small mutation rate.
We note that our model is neutral, a choice made due to the uncertainties surrounding the
physiological relevance of possible selection mechanisms. We would argue that a neutral model
forms an appropriate null model and can itself, remarkably, lead to selection effects (Chapter
5). A linear birth rate may seem limiting but it represents a first order approximation to many
non-linear models, and can give rise to a surprisingly rich set of dynamics as shown in Chapters
4 and 5.
In steady state λ(w,m) = µ, meaning we can rewrite the above equation into the more easily
interpretable form
λ(w,m) = µ+ c1(Nss − (w + δm)) (1.3)
where Nss denotes the steady state value towards which the effective population, here defined
as w + δm, is controlled. This equation states that replication rate will increase or decrease
as the effective mtDNA population is decreased or increased with respect to its desired value,
respectively. We note that assuming the existence of Nss does not imply a control based on copy
number; other quantities related to mitochondria (e.g. total ATP production, mtDNA mass
or concentrations of specific mitochondrial proteins or transcripts) may be controlled instead,
their desired values being reached at an effective population size of Nss.
The parameter δ allows for differential feedback contributions of mutant and wildtype species,
and the magnitude of c1 determines how tightly the population is controlled. The deterministic
steady state solution of Equation (1.3) is given by (wss + δmss) = Nss and represents a straight
line in (w,m) space (Figure 1.3), whose slope depends on the value of δ. Similar lines of steady
states are present in the relaxed replication model [1, 2]. Stochastic dynamics will fluctuate
along this steady state line until fixation of either species has occurred.
For later convenience, we note that a population homoplasmic in wildtype or mutant has steady
state wss = Nss and mss = Nss/δ, respectively. This difference in steady state copy numbers
will lead to stochastic selection effects (Chapter 5).
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Figure 1.3: A linear feedback control has straight steady state lines. The deterministic steady state lines
of the feedback control given in Equation 1.3 are shown in (w,m) space for various values of δ (grey lines show
particular examples of ranges of δ). Constant heteroplasmy lines form straight lines through the origin.
1.5 Challenges and Outline
After decades of mitochondrial research, many challenges still exist. Here, we review some of
the major outstanding challenges in mitochondrial research, before elaborating further on those
challenges which we address in this thesis.
One major challenge is to understand the role of mitochondria in ageing. How and why do
mutant mtDNA molecules accumulate during ageing? Why are the vast majority of clonally ex-
panded mutations in aged individuals deletions, rather than point mutations? No consensus on
these questions has been reached. Is there a causal link between mtDNA mutations and ageing?
A homozygous ‘mutator mouse’, engineered to have two defective copies of the enzyme synthe-
sising mtDNA (POLG), accumulates high levels of mtDNA mutations (∼ 2500-fold higher than
wildtype mice [130]) and shows premature ageing phenotypes [24, 131]. However, a heterozy-
gous mutator mouse, showing mutation levels ∼ 500 times higher compared to wildtype mice,
has a normal lifespan [130]. Another type of transgenic mouse, which accumulates deletion
mutations in skeletal muscle and brain, also lacked premature ageing phenotypes (though mu-
tations levels were relatively low) [132]. As of yet the existence of a causal link in physiological
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conditions, though compelling, has not been proven (reviewed in Ref. [27]). If the accumula-
tion of deletion mutations does cause ageing, can the removal of these mutations in middle-aged
individuals reverse ageing phenotypes, or is the metabolic state of the cell irreversibly damaged
by that point? Another point of discussion is the extent to which clonally expanded mutants
are the result of somatic de novo mutations or mutations inherited at birth [17, 23, 133], as
discussed in more detail in Chapter 5.
Another major challenge is to successfully treat patients with mtDNA diseases. No cure cur-
rently exists and treatment is often limited to treating or preventing the dysfunctions caused
by the mutations (e.g. diabetes, myopathy and epilepsy) [134]. Mitochondrial disorders present
themselves with large phenotypic heterogeneity, making it challenging to obtain correct diag-
noses or predict disease progression. The same mtDNA mutation can affect different organs in
different patients, the reason of which is currently unclear and a lack of animal models replicat-
ing human disease phenotypes means it is hard to make progress in this area [134]. Improved
sequencing techniques have enabled better characterization of mtDNA diseases and the proteins
and genes involved in mitochondrial function (e.g. Ref. [135]), and may provide answers to
some of the currently open questions.
Mitochondria are maternally inherited and it was estimated that, on average, there are ∼ 150
births per year in the United Kingdom among women at risk of transmitting mtDNA diseases
[86]. Women carrying mtDNA mutations currently have several options including mitochondrial
replacement therapy (MRT), in which nuclear DNA from an oocyte of the affected woman is
transferred into enucleated donor oocytes containing healthy mitochondria [136, 137]. The
method, however, raises ethical concerns and the long-term safety of the approach is yet to
be established, as some mutated mtDNAs may be transferred together with the parent donor
nucleus, possibly leading to complications arising from non-compatibility between nuclear and
mitochondrial DNA as well as mitochondrial-mitochondrial DNA [138–141].
Fast progress is being made on designing methods to specifically cleave mutant molecules,
thereby reducing heteroplasmy, using mitochondrially targeted nucleases [142–146]. However,
these therapies are just beginning to develop and face many challenges themselves, e.g. high
levels of off-target cleavage [142]. Designer nucleases are promising tools to treat patients using
gene therapy, though the large size of some of these nuclease constructs may make it hard to
package them into many vector systems [147]. Shorter nucleases were developed but showed
lowered efficiency [147]. As of now, these therapies are designed to cleave specific mutant
sequences. Though this may be suited for treating patients with a single type of deletion or
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point mutation, it is less efficient for patients heteroplasmic in multiple pathogenic mutations
or for combating ageing (which involves a wide variety of different mutations). Therefore,
an interesting challenge is to design constructs that target short genomes, regardless of their
sequence, to selectively degrade all deletion mutations at once.
Mitochondrial networks also impose challenges. The presence of large connected mitochondrial
networks is associated with improved functionality (e.g. [148–151]). Many of the advantages of
mitochondrial dynamics (such as sharing of components [83, 152]), however, could be obtained
through frequent fusion/fission events, without requiring a large connected component. Are
there beneficial effects associated with large continuous mitochondrial structures, which cannot
be attained through small-scaled fusion/fission dynamics? Mitochondria tend to become more
fragmented with age [153], and increased fission or fusion is associated with a decrease or
increase in life-span, respectively [65, 66, 154]. How these effects are established, and whether
mitochondrial fusion/fission dynamics play a causal role in ageing, remains unclear.
This thesis is centered on the theme ‘mitochondrial dynamics’ which refers both to fusion/fission
dynamics as well as mtDNA dynamics. As discussed before, these two types of dynamics are
closely linked (Sections 1.2.1 and 1.4.3). We use mathematical tools to address various specific
challenges, as outlined below.
In Chapter 2, we address questions surrounding the advantages of large fused mitochondrial
components (see above) by presenting an overview of existing hypotheses in the literature, as
well as presenting some of our own, on this precise topic. We critically investigate each of
these, provide coarse-grained mathematical models to probe their plausibility, and generate
predictions and experimental tests for further validation. Overall, we find that large fused
components can have a variety of advantages whose effect sizes depend nonlinearly on network
state, being low or absent in relatively fragmented states and only becoming apparent in highly
fused states. These insights stress the importance of fusion and may provide useful intuition on
the consequences of impaired fusion. This chapter has appeared as a publication in Bioessays
[155].
Chapter 3 forms a brief auxiliary chapter in which we perform one of the experimental tests
suggested in Chapter 2. Specifically, we measure mitochondrial membrane potentials during
fusion and fission events to test whether these events conserve total mitochondrial membrane
potential (as defined in the chapter). We find evidence that this is indeed the case, which
provides support for a novel mathematical model, presented in Chapter 2, relating fusion/fission
events and ATP production rate.
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In Chapter 4, we explore the role of nuclear control in mtDNA and heteroplasmy dynamics by
considering a variety of control mechanisms to identify important aspects and general conse-
quences of different strategies. Because it is unknown how the cell truly controls its mtDNA,
this exercise provides useful insights and intuition (see also Ref. [101]). We continue by in-
troducing a mitochondrial energy-based cost function enabling us to explore optimal control
mechanisms. To our knowledge, no computational approaches have yet been considered for
describing recently developed mitochondrial disease therapies. We provide such an approach
by constructing a mathematical model of nuclease treatment using recent experimental data,
allowing us to explore optimal treatment strategies. Some of our findings are: i) long, weak
treatments are more efficient than short, strong treatments, and ii) heteroplasmy distribution
(not mean alone) is crucial for the success of gene therapies. Chapter 4 corresponds to a pre-
print (Ref. [156]) which has been submitted to Cell Systems and been through one round of
peer review; it is currently in preparation for resubmission.
Finally, in Chapter 5 we describe in detail the heteroplasmy dynamics resulting from the linear
feedback model introduced in Section 1.4.4. We construct a model which includes intercellular
mtDNA exchange, an approach which has not been considered before in the context of mtDNA
dynamics. This novel approach leads to several interesting insights such as: i) the possibility of
preferential mutant expansion without any selection advantage, and ii) a possible explanation as
to why only certain types of mutants expand and why these often occur at high copy numbers.
Finally, we provide new estimations of mutant loads in aged individuals which appear to be
much lower than often assumed. The main finding of this chapter is that random drift models,
in which all types of mtDNA have identical replication and degradation rates, can still give
rise to stochastic selection effects. This means that experimental observations such as increases
in mean heteroplasmy or faster mutant proliferation rates do not necessarily imply a mutant
selection advantage. As such, we stress that random drift may play a larger role in ageing than
previously assumed and can lead to non-intuitive behaviours.
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What is the function of
mitochondrial networks?
Summary
The cellular advantages underlying large mitochondrial fused networks are still incompletely
understood. In this chapter, we describe and compare hypotheses as to the function of mi-
tochondrial networks, we use mathematical and physical tools both to investigate existing
hypotheses and to generate new ones, and we suggest experimental and modelling strategies.
Among the novel insights we underline from this work are the possible functions that: selective
mitophagy is not required for quality control because selective fusion is sufficient; increased
connectivity may have nonlinear effects on the diffusion rate of proteins; and fused networks
can act to dampen biochemical fluctuations. We hope to convey that quantitative approaches
can drive advances in the understanding of the physiological advantage of these morphological
changes.
2.1 Introduction
As mentioned in the thesis introduction, mitochondrial fusion/fission dynamics are directly
implicated in a variety of diseases [61]. Understanding the benefits of adopting a certain
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network morphology will help elucidate the consequences of disruption of this morphology. This
illustrates the importance of studying mitochondrial dynamics and elucidating the functions
that motivate form.
Various effects of fused mitochondrial states have been suggested, including an increase in ATP
production [148, 149, 151, 157, 158], protection against apoptotic stresses [149, 159–162], an
increase in cell proliferation ([163] and references therein), and regulation of various signalling
pathways [164–167]. How exactly these effects are established through increased mitochondrial
connectedness remains unclear. We try to provide more clarity by using physical reasoning to
explore the mechanistic advantages of mitochondrial networks including increases in controlla-
bility, efficiency, robustness of mitochondria with respect to perturbations, and increases in the
capacity to consume oxygen. To complement the mainly qualitative discussions that exist in
the literature, we here use mathematical and physical arguments to probe the properties and
bioenergetics of mitochondrial network formation, with the aim of gaining biological insights
and suggesting research strategies.
In this chapter we discuss the function of mitochondrial networks, by which we mean large
connected pieces of fused mitochondrial material. In the right-hand panel of Figure 2.1A, several
of these functions are proposed. Some of them are novel; others have been suggested based on
experimental results, and discussed qualitatively, largely in the absence of mathematical models
to test them. We hope to show that quantitative approaches to the question of mitochondrial
network formation can serve as a tool to critically analyse old hypotheses and motivate new
ones.
2.2 The main players involved in mitochondrial dynamics
Though the focus of this chapter is not on the proteins involved in mitochondrial dynamics,
we occasionally refer to them and therefore provide a brief overview. The three main proteins
involved in the fusion of mammalian mitochondria are the enzymes Optic Atrophy 1 (Opa1) and
the two mitofusins, Mfn1 and Mfn2. Opa1 is involved in inner membrane fusion, while Mfn1
and Mfn2 regulate fusion of the outer membrane [168]. The central protein in mitochondrial
division is the highly conserved Dynamin-Related Protein 1 (Drp1), which can be recruited to
mitochondria by the outer mitochondrial membrane protein Mff (mitochondrial fission factor).
All these proteins are involved in other processes besides mitochondrial fusion and fission, some
of which are summarised in Table A.5. Reviews on the proteins involved in mitochondrial
dynamics and their role in disease are provided in Refs. [169–171].
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Sharing of matrix and membrane 
components
Degradation of dysfunctional parts
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Increased ATP synthesis rate?
Increased control through 
calcium signalling?
Faster complementation?
Creation of genetic reservoir?
As-yet unknown function?
Improved quality control? MesofusionMicrofusion
Static hyperfusionDynamic hyperfusion
A) B)
Figure 2.1: Potential causes and types of mitochondrial network formation. A) There are clear benefits of
small scaled fusion events (microfusion) such as membrane- and matrix protein complementation (and possibly
mtDNA complementation) and degradation of dysfunctional fragments (e.g. [59, 83]). However, to appreciate
these advantages one does not require the formation of large extended networks, the functions of which remains
to be elucidated. In this chapter we discuss the functions proposed on the right panel. B) The quantity p, defined
as
γfus
γfis+γfus
, gives the probability that any two neighbouring mitochondrial units are fused. Note that different
rates of fusion and fission can lead to the same connectivity of the network, as long as the ratio
γfus
γfis+γfus
remains
constant. In a static hyperfused state, virtually no fission events occur and therefore no quality control is possible.
However, in a dynamic hyperfused state the fission rate is non-zero (γfis > 0) and quality control is present. The
red arrows represent fusion or fission events and are absent in the static hyperfused state.
2.3 Quantitative definitions of micro, meso- and hyperfusion
In this section, we provide quantitative definitions of different mitochondrial morphologies.
This approach facilitates further mathematical treatment and allows us to refer to the different
morphologies in a clear and precise manner; the terms introduced in this section are used
throughout the rest of the chapter.
We assume that there exists a smallest mitochondrial ‘unit’. These units may be fused (when
they are part of a lumenally continuous filament) or fragmented. This assumption is a mathe-
matical convenience and does not affect our later findings or represent our belief in a quantised
set of mitochondrial sizes. We define a fission rate γfis and a fusion rate γfus, which are con-
sidered to be the same for each mitochondrial unit∗. The quantity p ≡ γfus
γfis+γfus
then gives
the probability that a continuous link exists between any two neighbouring mitochondrial units
(i.e. the probability that two neighbouring units are fused).
Percolation theory [172] suggests that as p increases, at some value of p a percolating path will
exist (a chain of fused mitochondria extending from one end of the cell to the other, in the
∗This automatically makes the total fission and fusion rates larger in a long mitochondrial filament compared
to a small one because the larger filament consists of more units, each with fission rate γfis and fusion rate
γfus.
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limit of very large cells). This situation merits some special consideration in the context of
several hypotheses, and so we refer to this percolating value as pc. Roughly, at and above this
critical value a mitochondrion at one extreme end of the network is expected to be continuously
connected to a mitochondrion at the other end. We note that though simple percolation
theory is of relatively limited use in describing mitochondria (which are dynamic, unlikely to
lie on a lattice, and have connectivity properties dependent on membrane potential), it still
provides a framework that can be used to gain intuition. The possibility of a phase-transition
in mitochondrial network structure was raised previously in Ref. [126].
The different morphological states we introduce are: fragmented (p = 0; no fusion); microfused
(p ≈ 0; rare fusion); mesofused (0 < p < pc; fission dominated); dynamic hyperfused (pc < p <
1; fusion dominated); and static hyperfused (p ≈ 1; rare fission). These states are illustrated in
Fig. 2.1B.
A high value of p means that the mitochondrial population is in a highly fused state, which can
be the result of a high fusion rate, low fission rate, or both. The distinction between dynamic
hyperfusion and static hyperfusion is important. For both hyperfused states a percolating
continuous path exists (p > pc). The difference is that in dynamic hyperfused states there
can still be an appreciable rate of fission (e.g. if fusion proteins are overexpressed), whereas in
static hyperfused states there are (almost) no fission events (e.g. if fission proteins are knocked
out or heavily downregulated). Enforcing mitochondrial elongation leads to oxidative damage
and decreased respiration [59], increased cell death [150], mtDNA loss [64] and chromosomal
instability [173]. In many of these studies, the hyperfused state is induced by knockout of
fission proteins, which creates a static hyperfused state. However, if physiological hyperfusion
involves dynamic rather than static hyperfusion, fission events do occur and the afore-mentioned
negative consequences may not be manifest.
We appreciate that our assumption of equal rates of fission and fusion for all mitochondrial
units represents an oversimplification. In reality, fusion rate depends on membrane potential
[59, 174, 175] and fission and fusion events are not independent [59, 176]. We nonetheless
believe that using a simplified approach can help make testable predictions and it provides
a framework for more sophisticated models. We note that there is a disconnect between an
idealised mathematical description of network structure and experimental measurements that
are currently possible (including average mitochondrial length and form factors), although
new approaches are narrowing this gap [177, 178]. Useful insights may still be gained by
considering these mathematical abstractions. The exact value of the parameter pc depends on
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the underlying network structure, and it is not easy to find this value for real mitochondrial
networks. Similarly, it is hard to say how connected the network is for a given value of p,
without knowing the network structure.
Physiological circumstances in which meso- and hyperfusion occur, as well as the ‘typical’
morphological state of mitochondria, are summarised in Tables A.1 and A.2 in the appendix: it
is unclear whether meso- and hyperfusion are a widespread cellular phenomenon or restricted
to certain cell types and situations.
2.4 Hypothesised reasons for mitochondrial meso- and hyperfusion
In this section we list existing hypotheses as to the function of mitochondrial meso- and hy-
perfusion. Besides the hypotheses discussed here, additional ones are summarised in Section
A.2 of the appendix. These are: meso- and hyperfusion i) create a genetic reservoir [179]; ii)
increase ATP synthesis through a range of mechanisms in addition to the one described in
this chapter; iii) enable faster energy transmission along mitochondrial cables [180–183]; and,
iv) have no function. We note that the ‘cabling hypothesis’ (appendix Section A.2.3), which
is illustrated in Figure 2.6B, has obtained some recent support in skeletal muscle fibres and
cardiomyocytes [184–186]. All hypotheses, including the ones discussed in the appendix, are
summarised in Table 2.1; critiques of each hypothesis are included in this table. In Table 2.2
we provide experimental tests and further modelling suggestions for all hypotheses discussed in
this chapter.
One immediate consequence of a mathematical perspective on mitochondrial fusion is the ob-
servation that, for fused states to be physiologically beneficial, a nonlinear relationship between
a mitochondrial property and cellular functionality must be involved. In other words, a fused
mitochondrion must be of more use to the cell than the sum of the individual pre-fused mi-
tochondria. Suppose x denotes some property of a mitochondrion (for example its membrane
potential) and f(x) describes how useful this mitochondrion is to the cell. Then, if there is
another mitochondrion with property y and ‘usefulness’ f(y), we expect:
f(x+ y)︸ ︷︷ ︸
‘usefulness’ of the fused mitochondrion
> f(x) + f(y).︸ ︷︷ ︸
sum of ‘usefulness’ of the individual mitochondria
In other words, the function f(x), relating some aspect of mitochondrial size to ‘usefulness’,
must be nonlinear. Somehow fusion into networks must create ‘extra usefulness’ to the cell;
the network structure must allow for, or give rise to, options that were not available before.
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In some of the hypotheses discussed each individual fusion event benefits the cell, in others, a
benefit only arises once sufficiently many mitochondria have fused to form an interconnected
network.
Hypothesis & references Limitations/Criticism
Increased selection bias in quality con-
trol. ∗
The results of the model that is used depend on the rate of autophagy. If no
autophagy is present, one needs to create additional assumptions to obtain
the same results. If mitophagy is sufficiently functionally selective (meaning
dysfunctional mitochondria are more likely to be degraded) then an increase in
selection bias may be counteracted by a protection of dysfunctional fragments
from degradation.
Faster or more effective complementa-
tion [187–192].
Matrix protein complementation through small fusion events is efficient [192],
cells with low fusion levels show no major dysfunctions [62], and ongoing
fission and fusion events can, according to one estimate, lead to better mixing
after two hours than stress induced hyperfusion [190].
Increases in ATP production caused
by:
i) Changes in inner membrane shape
(discussed in Section A.2.2.1) [45, 46,
193–196].
i) There is no obvious reason why cristal shape should be determined by
overall state of mitochondrial organisation.
ii) Decreases in proton leak (discussed
in Section A.2.2.2) [197].
ii) This may only be relevant in brown adipose tissue (because proton leak
has a more important role in this tissue) it may not explain hyperfusion in
other tissues.
iii) Decreases in mitophagy levels (dis-
cussed in Section A.2.2.3) [148, 158].
iii) The cell may keep total mitochondrial mass (or mitochondrial volume) at
the same level; an absence of mitophagy may have other undesirable cellular
consequences.
iv) nonlinear response of ATP synthe-
sis rate to membrane potential. ∗
iv) The model discussed considers the role of ∆ψ in producing ATP, whereas
actually the electrochemical potential ∆µH+ drives ATP synthesis: exten-
sions to the electrochemical potential are desirable.
Improved bioenergetic control and en-
ergy production through Ca2+ sig-
nalling [198–201].
Various studies suggest that calcium has no significant influence on rate of
ATP synthesis in vivo [202]. Other modes of calcium uptake besides the
mitochondrial uniporter that are more rapid exist [203].
Increased buffering against perturba-
tions. ∗
It might seem just as natural that in a fragmented state the isolation of
the different mitochondria is a form of robustness. Fluctuations in larger
mitochondria will occur more frequently because of the larger surface area.
Enables energy transmission (power
cabling) along mitochondria (discussed
in Section A.2.3) [181–186].
Though experimental support for this hypothesis was found in skeletal muscle
and heart tissue [184–186], it does not account for hyperfusion in tissues that
are less dependent on oxygen and have lower ATP demand.
Creating a genetic reservoir (discussed
in Section A.2.1) [179]. ∗
It is not clear whether large-scale fusion is necessary to maintain a genetic
reservoir; modulating biogenesis and mitophagy might be sufficient. Some
mitochondria with harmful mtDNA mutations may not be able to fuse, and
are likely to be degraded regardless of increased fusion rates. If mtDNA
mutations are not harmful, increased fusion is not required per se to create
new mutations.
No function (discussed in Section
A.2.4).
It seems coincidental that different kinds of stress lead to increases in fusion
or decreases in fission activity with a hyperfused state as a result. Addition-
ally, the main argument to support this hypothesis (many shaping proteins
are involved in other processes) is also an argument for the importance of
mitochondrial dynamics.
Table 2.1: An overview of hypotheses on the function of mitochondrial fusion discussed in this chapter
including criticism. Asterisks denote hypotheses that, to our knowledge, have not been previously proposed.
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Hypothesis Further modelling Experimental tests
Increased selection bias
in quality control.
The ordinary differential equation
model we describe in Section A.1.1
is deterministic and neglects the pro-
nounced stochastic influences likely to
affect mitochondrial quality control.
More powerful models could be con-
structed by including these stochas-
tic influences and relaxing some of the
simplifying assumptions of our model.
One of the assumptions of our model is that only
small mitochondrial fragments are degraded. It
can be measured whether there exists a thresh-
old size above which a mitochondrial filament is
not degraded by mitophagy. Alternatively, con-
struct two populations of cells, one wild-type and
one with increased fusion rates. The rate of au-
tophagy should be the same in both populations.
Measure the average ∆ψ in cells from both popu-
lations. Our model predicts that the distribution
of averages is more centered towards low values of
∆ψ in the wild-type population.
Faster or more effective
complementation.
Mitochondria do not lie on a square
lattice, so a better model can use ran-
domly distributed nodes or use the
microtubule network. A model that
does not explicitly position nodes in
space has been developed [126], but it
does not consider diffusion on the net-
work. This model of the mitochon-
drial network also shows percolation
phenomena, and future work can ex-
tend the model by introducing a diffus-
ing particle on the network and prefer-
ably introducing heterogeneity in fu-
sion rates to represent heterogeneity in
membrane potentials.
This hypothesis suggests that the root mean
squared distance travelled by mitochondrial pro-
teins depends nonlinearly on the connectedness of
the network (network connectedness can e.g. be
estimated by measuring the average length of a mi-
tochondrial fragmented). Calculate the diffusion
coefficient of proteins and the root mean squared
distance travelled by these proteins while slowly
changing fission or fusion rate.
Increased ATP produc-
tion caused by nonlin-
ear response of ATP
synthesis rate to mem-
brane potential.
Numerous biophysical models of the
respiratory chain in mitochondria have
been developed (e.g. [204–206]). Us-
ing this class of models to study res-
piratory chain and TCA cycle kinetics
during fusion of two mitochondria can
help in finding the existence and cause
of increased ATP synthesis rate upon
fusion.
Measure ∆ψ (and preferably simultaneously ∆pH)
of mitochondria before, during and after fusion
events. Measurements of ∆ψ during and after fis-
sion (but not fusion) events have been done before
[59, 207], and an asymmetry in potential is seen
after fissioning [59]. It would be interesting to see
whether this asymmetry is simply a reversion to
a pre-existing asymmetry in potential before the
preceding fusion event (fusion events are usually
followed quite soon by fission events [59]). We
perform experiments along this line ourselves in
the next chapter (Chapter 3). Alternatively, take
snapshots of cells and quantify the amount of mi-
tochondrial mass that is fused (by e.g. measuring
the average mitochondrial size, which on average
will be proportional to the level of connectivity in
the cell) while also measuring [ATP]. Do this for
many cells in order to search for a potential corre-
lation between the amount of fused mitochondria
and cellular [ATP]. Such correlations have been
found before [148, 149, 151, 157] but not without
perturbing the cell. We propose to take advantage
of natural fluctuations in connectedness. Alterna-
tively, look at passive fluctuations in network size
of mitochondria in single cells, while reading out
[ATP]. Alternatively, induce fragmentation while
monitoring [ATP] and membrane potential during
treatment.
Table 2.2 continued on next page
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Table continued from previous page
Improved bioenergetic
control and energy pro-
duction through Ca2+
signalling.
Metabolic Control Analysis (MCA)
can be used to predict how sensitive
ATP production is to changes in activ-
ities of mitochondrial enzymes (caused
by changes in [Ca2+]). MCA has been
used to study OXPHOS and glycoly-
sis [208–212] and the TCA cycle [213].
It was shown that α-ketoglutarate de-
hydrogenase and and isocitrate dehy-
drogenase (both stimulated by Ca2+)
had 70% and 23% control over res-
piration respectively [213]. This re-
sult, however, is only true for spe-
cific conditions. To make physiologi-
cally relevant predictions, these mod-
els can be integrated into biophysical
models of the TCA cycle and respira-
tory chain. Ordinary differential equa-
tion based biophysical models linking
calcium and mitochondrial physiology
can also be probed to explore this re-
lationship [202].
Prepare two populations of cells, one wild-type
and one with more fused mitochondria. Then
stimulate [Ca2+]cytoplasm while also measuring
oxygen consumption of the populations. Com-
pare the change in oxygen consumption induced
by increased [Ca2+]cytoplasm between the two
populations of cells, to find a relationship be-
tween connectedness of the mitochondrial network
and calcium-stimulated respiration. Alternatively,
look at the distribution of [Ca2+]matrix in sin-
gle cells of both populations after stimulation of
[Ca2+]cytoplasm , to check whether this distribu-
tion is more homogeneous in cells with more fused
mitochondria (see Figure 2.5).
Increased buffering
against perturbations.
Biophysical models of the mitochon-
drion that already exist (many exist,
e.g. [214–216]) can be used to check
whether an increase in size indeed
dampens fluctuations in membrane po-
tential. However, one must be careful
to use models that define the flux of
ions into the mitochondrion to be pro-
portional to surface area. The model
presented in Ref. [204], for example,
defines flux to be proportional to mito-
chondrial volume, and this model thus
can not be used to check the hypothe-
sis discussed here.
While looking at (and quantifying) natural fluc-
tuations in the size of a mitochondrial filament,
measure fluctuations in membrane potential (and
preferably also fluctuations in ∆pH) of this fil-
ament to check whether larger filaments have
smaller fluctuations. Alternatively, increase the
permeability of the mitochondrial inner membrane
in cells with fused mitochondria, and cells with
fragmented mitochondria. Then measure the ef-
fect of this change in permeability on ∆ψ and ∆pH
in both situations.
Table 2.2: Suggestions for future modelling and experiments for further analyses of the hypotheses
on the function of mitochondrial fusion. For each hypothesis discussed in the main text, we suggest further
modelling approaches and experiments that will help test the hypotheses. Most of the experimental tests sug-
gested will be possible with the tools available today. We mentioned several hypotheses for an increase in [ATP]
in highly fused mitochondrial states; in this table we only discuss hypothesis (iv): the others are discussed in Sec-
tions A.2.2.1 - A.2.2.3
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2.4.1 Selective fusion creates the possibility of quality control without
needing selective mitophagy
Summary. Mitochondrial quality control is the process that maintains a healthy mitochon-
drial population by identifying and degrading dysfunctional mitochondria [59, 217], degrading
damaged mitochondrial components [218], and transporting damaged components out of the
mitochondrion [219, 220]. Three mechanisms contributing to this control are fusion, fission and
mitophagy. To ensure that a degradation bias is present, whereby dysfunctional mitochondria
are more likely to be degraded than healthy mitochondria, selection occurring in one of these
mechanisms is sufficient.
As mentioned in the thesis introduction, though mitophagy has been shown to be selective under
various experimental perturbations [52, 53], it is currently still debated whether selection effects
are significant in physiological settings [27, 54]. We argue that selective fusion combined with
non-selective fission and non-selective mitophagy leads to the desired biased degradation and
that in fact there are two levels of quality control: i) control on the level of the mitochondrial
network (non-selective fission and selective fusion) that does not require mitophagy and which
we call ‘blind surveillance’, and ii) control on the level of the cell using non-selective mitophagy.
In this section, our terms ‘selective’ and ‘non-selective’ refer to selection based on mitochondrial
function; we assume that mitophagy always selects on mitochondrial size [148, 158] (i.e. only
small mitochondrial fragments are targeted for mitophagy). Size-dependent mitophagy is the
source of nonlinearity in this model.
Blind surveillance consists of two parts. The first part involves random (blind) fission events.
By random we mean that they are not selective, and therefore a functional mitochondrion is
just as likely to become fragmented as a dysfunctional one. The second part is the surveil-
lance, which involved selective fusion events: a functional mitochondrion is more likely to fuse
[59]. As a consequence, a functional mitochondrion will, on average, stay fragmented for a
shorter period of time than a dysfunctional mitochondrion. With blind surveillance present,
mitophagy does not need to be selective because any isolated mitochondrion is more likely to
be dysfunctional than healthy and therefore even if mitophagy is non-selective, a bias towards
degrading dysfunctional mitochondria is automatically established. The strength of this effect
is exacerbated the more fused the mitochondria are (as shown below).
Having dysfunctional mitochondria being separated from the fused network is an advantage
on its own because a dysfunctional mitochondrion fusing with an already fused and functional
network may have negative effects that are not present if the mitochondrion in question remains
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isolated. Blind surveillance thus forms a first level of quality control (it separates dysfunctional
mitochondria from the network by using non-selective fission and selective fusion), and mi-
tophagy forms the second level by eliminating fragmented mitochondria (which are more likely
to be dysfunctional).
Experimental support. Selection on the level of fusion (mitochondria with low ∆ψ are less
likely to fuse [59, 174, 175]) has been discussed in the literature. Possible mechanisms for selec-
tive fusion are the increased processing of Opa1 by Oma1 [221, 222] or increased ubiquitination
of Mfn1,2 by Parkin [223, 224] when ∆ψ is low, which then results in a lower fusion probabil-
ity. Selective elimination of damaged mitochondria has been observed [50, 225–229], although
the precise mechanisms are still incompletely understood [230] and, as mentioned before, the
efficiency of selective mitophagy in physiological settings may be limited [57].
Coarse-grained quantitative model. Mathematical models of mitochondrial quality control
have been constructed previously [40–42] and show that fission, selective fusion and selective
autophagy together increase mitochondrial functionality. We here focus on the specific role of
the network state itself, assuming non-selective mitophagy and varying fusion and fission rates.
We construct a simple model of ordinary differential equations involving the following four
mitochondrial populations: i) healthy fused, ii) healthy fragmented, iii) unhealthy fused, and
iv) unhealthy fragmented. The concentrations of these populations are denoted by chf , chs, cuf
and cus, respectively (the subscripts ‘hf ’ and ‘us’ stand for ‘healthy fused’ and ‘unhealthy sin-
gleton’, where ‘singleton’ refers to a fragmented mitochondrion). In this context, mitochondria
are considered unhealthy if they have decreased fusion probabilities caused by e.g. lowered
membrane potential or mutant mtDNAs.
We denote the fusion rate of healthy and unhealthy mitochondria by γhf and γuf , respectively,
where we encode selective fusion by assuming γhf > γuf . The rate of fission is set to be the
same for all mitochondria and is denoted by γf . Mitochondria are created through biogenesis
(occurring at a constant rate B) and removed through mitophagy (occurring at rate M). We
assume that only fragmented mitochondria can be eliminated through mitophagy (as elongated
mitochondria are protected from degradation [148, 158]). We also assume that a mitochondrion
cannot change its status from healthy to dysfunctional or vice versa (this assumption is further
discussed in Section A.1.1). Finally, as we solely focus on the role of network state, we impose a
constraint to maintain constant total copy number, i.e. B ·(chf +cuf +chs+cus) = M ·(chs+cus).
The dynamics of this system, after eliminatingM using the constraint, are given by the following
equations (see Section A.1.1):
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c˙hs = −chs
(
γhf +B
chf + cuf
chs + cus
)
+ γfchf
c˙us = −cus
(
γuf +B
chf + cuf
chs + cus
)
+ γfcuf
c˙hf = chf (B − γf ) + γhfchs
c˙uf = cuf (B − γf ) + γufcus (2.1)
A) B)
Figure 2.2: Selective fusion on its own leads to a healthier mitochondrial population. A) The trajectories
of chf , cuf , chs and cus (all initialised at 1.0) are shown as a function of time. For long times, despite mitophagy
being equal for healthy and unhealthy mitochondria, only healthy ones survive because of the combination of se-
lective fusion and size-selective mitophagy. This behaviour does not depend on the initial conditions of the system.
Parameters used are γf = 0.8, γhf = 2, γuf = 1.3 and B = 0.3. B) Here we observe the rate of decay of the
unhealthy population (cuf + cus) for the following parameter settings: i) our ‘default’ parameters as used in figure
(A) (solid), ii) setting γf → 2 γf (dashed), iii) setting γhf → 2 γhf and γuf → 2 γuf (dash-dot), and iv) decreas-
ing fission such that the total fraction of fused mitochondria is similar to case (iii) (which results in γf = 0.55, as
shown in Section A.1.1).
Solving Equations (2.1) numerically, we find that the population of dysfunctional mitochondria
tends towards zero without selective mitophagy, due to the presence of selective fusion (Figure
2.2A). This dysfunctional population decreases faster when fusion rate is increased (keeping
the ratio γhf/γuf constant) and slower when fission rate is increased (Figure 2.2B). We also
decreased fission rate to obtain a level of connectedness similar to the setting with increased
fusion; this reduced the rate of decay of dysfunctional mitochondria† (Figure 2.2B). The total
number of healthy mitochondria that are degraded, however, is largest in the case of increased
fusion (as shown in Section A.1.1).
†Selective fusion is the factor in our model that drives dysfunctional mitochondria towards extinction, and
increasing its rate increases this drive. Decreasing fission does not strengthen the selective drive and only slows
down the rates of degradation as less mitochondria are fragmented.
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In conclusion, an increased network connectivity can decrease the number of dysfunctional
mitochondria solely through selective fusion. This decrease is faster at high levels of fusion, but
not at low levels of fission (which has the effect of keeping dysfunctional mitochondria in the
total population for a longer time). More details of the model are provided in Section A.1.1.
Limitations/Critique. Autophagy is required for this mechanism to function, although this
assumption also underlies other quality control mechanisms. Our model makes several assump-
tions (mentioned above), which may be relaxed in future work. Though we observe an increase
in the rate of removal of dysfunctional mitochondria at higher fusion levels, the effect size is
small. Also, our deterministic model merely forms an approximation to the actual stochastic
dynamics. It will be interesting to evaluate our model in a stochastic setting while investigating
in more detail the size of the selection effect as a function of parameter values.
In our model we used non-selective mitophagy, an assumption which, as discussed in the thesis
introduction, is controversial. However, we stress that the aim of the model is to illustrate
that selective mitophagy is not required per se; as such, we do not claim it is not present at
all. When mitophagy is selective, increased fusion will still contribute to a biased removal of
dysfunctional mitochondria, but this beneficial effect is counteracted by the effect of protecting
dysfunctional mitochondria from their selective degradation. A more detailed analysis is then
required to establish whether increased connectedness still has an overall beneficial effect, and
there will likely be a trade-off between the degree of functional selectivity of mitophagy and
fusion.
2.4.2 Small changes in fusion state can cause large changes in complementa-
tion rate
Summary. Large-scale fusion facilitates sharing of mitochondrial machinery, as this machinery
moves through the mitochondrial network. Increased sharing may equilibrate concentrations of
nuclear encoded proteins to enable better control over mitochondria [188], promote co-ordinated
behaviour between mitochondria to synchronise gene expression [61, 231], or improve the health
of the mitochondrial population by allowing mitochondria to complement each other’s deficien-
cies [83, 152] (functional complementation).
The effect of increased fusion (or decreased fission) on diffusion rate is most important for fast-
diffusing species because they will have their diffusion rate capped by fission and fusion rates.
By diffusion rate we mean the effective rate of diffusion through the mitochondrial network,
which will depend on fission and fusion rates. As the network becomes more interconnected,
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a fast-diffusing species will rapidly explore the new available spaces. Small increases in p (i.e.
small increases in network connectivity, where these increases can be caused by an increase
in fusion rate, a decrease in fission rate, or both) may lead to large, nonlinear, increases in
diffusion rate. This is especially the case near the percolating value pc, because when p > pc
it suddenly becomes possible to diffuse from one extreme end of the network to the other end,
whereas when p < pc the distance that can be travelled is much more restricted. A ‘switch-like’
response is thus present for fast-diffusing species. Slow-diffusing species will experience the
network as being rapidly fluctuating, and their diffusion rate is likely to increase linearly with
fusion level, lacking a ‘switch-like’ response.
Experimental support. Functional complementation through fusion has been observed in
numerous experimental studies [83, 152, 189], indicating that fused mitochondria do exchange
contents. As mentioned before, the effect of increased connectedness of mitochondria is likely
to be largest for fast-diffusing species. We therefore compare diffusion constants of several
mitochondrial proteins (and mtDNA) in Table S3. These diffusion coefficients are also used in
Chapter 5, in which we consider mtDNA diffusion along skeletal muscle fibres.
Coarse-grained quantitative model. We can study the diffusion of species along mito-
chondrial networks by simulations in which the network is represented by a 2D or 3D lattice.
Mitochondria are represented by nodes in the network, and can be connected through edges.
The edges can flicker ‘on’ and ‘off’, representing fusion and fission events, respectively, with
rates γfus and γfis. In this model, each mitochondrion has the potential to fuse with any of
its direct neighbours independently, and does so with rate γfus (similarly for fission). The
previously-defined value p determines how likely it is that an edge is ‘on’. Given a hopping rate
for molecules moving between adjacent points on the network, assuming particles are restricted
to move only along ‘on’ edges, the average time it takes a particle to diffuse across a certain
distance can be calculated in dynamic hyperfused (pc < p < 1), mesofused (0 < p < pc) and
microfused (p ≈ 0) states (see Section A.1.2). Our coarse-grained model makes several assump-
tions, including constant mitochondrial mass (corresponding to short timescales), an absence of
mitophagy, and a lattice topology. Ref. [126] provides an alternative approach in which spatial
structure is ignored but more realistic network morphologies are allowed; the authors do not
consider diffusion on the network.
Figure 2.3A shows how the apparent diffusion coefficient varies with p for different values of τ ,
where τ is the relaxation time of the fluctuating bonds [232, 233] and is defined as τ = 1
γfis+γfus
(a lower τ means that bonds flicker more frequently between the states ‘on’ and ‘off’). This
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Figure 2.3: Apparent diffusion coefficient depends nonlinearly on degree of fusion. An abrupt change in
diffusion rate can occur with only small changes in fusion rate. A) This figure shows the diffusion constant
of a particle diffusing on a 2D fluctuating lattice as a function of p (the fraction of present bonds) and τ (the re-
laxation time of the fluctuating bonds). If τ = ∞, bonds are static and in the limit of very fast fluctuating bonds,
τ = 0. B) We show the trajectory of a diffusing particle (left) and a lattice snapshot for p = 0.6 and τ = 100
(right). The red dot marks the starting point of the particle. Existing bonds in the lattice snapshot are shown in
red. C) Trajectory and lattice snapshot for p = 0.4 and τ = 100. Figures B and C show that (for τ = 100) in-
creasing the value of p from 0.4 to 0.6, results in a more connected network and less restricted diffusion, as is also
suggested in Figure A which indicates a rather abrupt increase in effective diffusion rate around p = 0.5.
figure is based on a mean field approximation, and similar results are produced by our stochastic
model. In static percolation (τ =∞), an abrupt change in diffusion rate is present at p = 0.5
(in 2D, assuming a square lattice), but when bonds fluctuate in time, the diffusion rate changes
less abruptly. For a given p, faster fluctuation has the effect of increasing diffusion rate; this
effect is largest around p = 0.5. The simple model shows that a microfused state results in a
smaller diffusion rate than a hyperfused state, even if the microfused state has very frequent
fusion and fission events. Even slowly-varying hyperfused networks thus afford more facility to
spread elements throughout the cell, confirming that a hyperfused morphology confers a mixing
advantage for proteins.
Limitations/Critique. Complementation may be sufficiently achieved without a need for
large-scale fusion: short ‘kiss and run’ events are claimed to be responsible for most mixing
because of their high frequency [192]. In the spirit of ‘back-of-the-envelope’ calculations in
biology [116], we use rough estimates to assess the feasibility of equilibration. The duration of
association of these fusion events after exchange of content ranges from 4 s to 5 min, with a
mean of 45 s [192]. The diffusion coefficient of Green Fluorescent Protein was measured to be
20-30 µm2/s [234, 235], meaning that in 45 seconds a distance of about x ≈ √2Dt ≈ 40-50 µm
can be travelled by a small protein, which is more than enough to accomplish equilibration.
Even though complementation of matrix components is feasible, kiss and run events are likely
to be too short to allow for sharing of membrane proteins and nucleoids.
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2.4.3 Fusion increases ATP synthesis
Summary. Mitochondrial fusion may increase ATP production, through one or more of several
possible mechanisms. We suggest the following mechanisms of particular interest: higher ATP
production is caused by (i) fusion-induced changes in inner membrane shape; (ii) fusion-induced
decreases in proton leak; (iii) fusion-induced decreases in mitochondrial degradation; (iv) a
nonlinear response of ATP synthesis rate to membrane potential. (i)-(iii) are discussed in more
detail in the appendix. We note that it is not entirely clear whether mitochondrial fusion is
the cause of an observed increase in ATP production, or whether hyperfusion and high ATP
production rates have a common cause, e.g. a recent study suggested that an increase in ATP
production may precede mitochondrial fusion [236].
Experimental support. Several studies suggest that hyperfusion increases ATP levels and
mitochondrial respiratory capacity [148, 149, 151, 157]. In nutrient-rich environments mito-
chondria tend to be fragmented, whereas under starvation they are observed to form elongated
networks [148, 158], which can be interpreted as an attempt to enhance energy production in
challenging environments. Hyperfusion is also observed at the G1/S transition, before energet-
ically costly DNA replication [151]. It is worth noting that in hyperfused states, concentrations
of cellular ATP – not just the rate of ATP production – were measured to be higher [149].
These increased concentrations suggest a physiological role for fusion beyond that of meeting
extra ATP demand. This role could be to act as a cellular ‘accelerator pedal’, because an
increase in ATP/ADP ratio in the cell has the consequence that many reactions will go faster
[237, 238]. Further support for specific hypotheses is described in Sections A.2.2.1 - A.2.2.3.
Coarse-grained quantitative model. We focus mathematically on hypothesis (iv) which
we have not seen discussed elsewhere. We first consider how the membrane potentials of two
equally sized individual mitochondria ∆ψ1, ∆ψ2 are related to the overall membrane potential
of their fused product, ∆ψ1+2. A simple model is that the fused product inherits the arithmetic
average of the two individuals, i.e. ∆ψ1+2 =
1
2
(∆ψ1 + ∆ψ2)
‡. We will show that this simple
averaging of potentials can lead to increases of total ATP synthesis rates due to a sigmoidal
dependence of ATP synthesis rate (rATP ) on ∆ψ [239, 240] (Figure 2.4). We note that care
must be taken in interpreting measured sigmoidal relations between ∆ψ and ATP synthesis
rate [239]. The saturating behaviour observed at high ∆ψ may be an experimental artefact
caused by the saturating relation between the ratio of ion concentrations at either side of the
‡Calculations based on considering charged capacitors show that it is possible that ∆ψ1+2 > 12 (∆ψ1 + ∆ψ2)
(Section A.1.3), though this capacitor model does not necessarily capture the behaviour of mitochondria fusing
in chains. A simple averaging is the most natural null model to consider.
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inner mitochondrial membrane and ∆ψ itself, as predicted by the Nernst equation. In the
analysis below we assume the saturating relation depicted in Figure 2.4 exists and investigate
the consequences of this relation.
Fusion causes net 
decrease in rATP 
Fusion causes net
increase in rATP 
ATP
synthesis 
rate  
A
B
DC
Figure 2.4: The effect of fusion on rate of ATP synthesis depends on the magnitude of the potentials of
the pre-fusing mitochondria. In this figure, ri denotes the ATP synthesis rate (rATP ) per unit of mitochondrial
size for mitochondrion i and ri+j denotes the rate per unit size for the fused product of mitochondria i and j (a
definition of mitochondrial size is provided in the next chapter). For simplicity we assume all pre-fusion mitochon-
dria to have unit size; our results still hold when this assumption is relaxed. Because of the nonlinear dependence
of rATP on ∆ψ, if two mitochondria in the exponential regime fuse (i.e. mitochondria A and B), then averaging
their potentials upon fusion causes the net ATP synthesis rate to decrease. This is because 2rA+B < rA + rB
(the fused mitochondrion is twice as large as the pre-fused mitochondria and the net post-fusion synthesis rate is
therefore 2rA+B). In the plateau region, rATP does not depend on ∆ψ so there will most likely be no ∆ψ-induced
change in rATP if two mitochondria in this regime fuse (e.g. mitochondria C and D). Fusion of mitochondria in
the saturating region (e.g. mitochondria B and C), induces net rATP increases because 2rB+C > rB + rC .
To explain this, consider Figure 2.4. As illustrated, fusion of mitochondria (B) and (C), while
averaging their potentials, results in a net increase in ATP production rate. This is because
the segment of the sigmoid connecting these two mitochondria is saturating§. Fusion of mito-
chondria (A) and (B), however, decreases net ATP production rates due to the strictly convex
curve connecting them. Because fusion only occurs at sufficiently high membrane potential
[59, 174, 175], we may expect events involving A-type mitochondria to be less common. Fusion
then more often increases than decreases rATP , leading to an overall increase in cellular ATP
production rates.
§A function f(x) whose slope decreases with increasing x satisfies f( 12 (x1 + x2)) >
1
2 (f(x1) + f(x2)) where
x1, x2 are any two points on the function. Similarly a decreasing slope with increasing x leads to f(
1
2 (x1 +x2)) <
1
2 (f(x1) + f(x2)), a situation which occurs when fusing mitochondria (A) and (B) in Figure 2.4.
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In the above, we assumed equally sized pre-fusion mitochondria and considered an averaging of
potentials. This is equivalent to assuming a size-weighted averaging of potentials when fusion
occurs between differently-sized mitochondria; the same argument as outlined above still hold.
In the next chapter, we find some evidence for size-weighted averaging upon mitochondrial
fusion/fission dynamics.
Limitations/Critique. The causal relationship between higher ATP levels and mitochondrial
fusion is incompletely understood, and it may be possible that fusion is the effect of high [ATP]
instead of the cause. A recent study showed that the rate of inner membrane fusion was
closely correlated with oxygen consumption, and increased during OXPHOS stimulation as the
result of increased Opa1 cleavage by Yme1l [236]. Also, in the model discussed above we have
considered the role of ∆ψ in ATP synthesis rate, whereas actually the proton motive force
(defined as ∆p = |∆ψ|+2.3RT
F
∆pH) drives ATP production [239, 240]. The region of the ATP
synthesis sigmoid at which mitochondria lie is not yet experimentally clear. Further critique of
specific hypotheses is described in Sections A.2.2.1 - A.2.2.3.
2.4.4 Fusion affects bioenergetic control and total energy production through
calcium signalling
Summary. Fusion averages out calcium concentrations across the mitochondrial network, giv-
ing rise to two advantages: 1) calcium concentrations are placed in an intermediate regime where
small changes have pronounced effects on enzymatic rates, and thus tight bioenergetic control
of the mitochondrial population is facilitated, and 2) the amount of mitochondrial volume that
experiences a rise in [Ca2+]matrix is increased, hence boosting total energy production.
Calcium is known to stimulate certain enzymes of the citric acid cycle (TCA cycle) [241–243],
which in turn influences rates of ATP production. The dependence of TCA cycle activity
on calcium is sigmoidal [244], meaning that the cell has maximal control over this activity
when [Ca2+]matrix is in the steeply rising part of the sigmoid, as indicated in Figure 2.5A.
If [Ca2+]matrix is high enough to reach the plateau region of the sigmoid, the enzymes are
saturated. Only mitochondria located near microdomains of high [Ca2+] (e.g. calcium channels
in the endoplasmic reticulum (ER)) are thought to take up calcium efficiently [245, 246]. The
calcium concentration in these mitochondria rises significantly during ER depletion or calcium
entry into the cell. This rise in [Ca2+]matrix can be such that the saturation level is reached,
and increasing [Ca2+]matrix further has no effect on enzyme activity. Because fusion averages
out concentrations inside the matrix, fusing a calcium-saturated mitochondrion with one with
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Figure 2.5: Fusion may increase controllability of TCA cycle activity and total energy production. A) If
only mitochondria in contact with the ER easily take up calcium, then in a fragmented state only few mitochondria
will have high (saturated) [Ca2+]matrix and most will have low [Ca
2+]matrix. The bottom figure indicates the posi-
tion of the mitochondria on the sigmoid describing enzyme activity. If mitochondria fuse, [Ca2+]matrix averages out,
which moves the previously saturated mitochondria down the sigmoid and also moves the mitochondria which pre-
viously had very low [Ca2+]matrix up the sigmoid with the result of increasing total enzyme stimulation. When even
more mitochondria fuse, total enzyme stimulation will drop again because the mitochondria moved too far down
the sigmoid. B) As the number of mitochondria fused to a mitochondrion close to the ER increases, total energy
output will first increase and then decrease again because [Ca2+]matrix is now so diluted as to reach the low enzyme
activity regime. This plot is merely meant as a proof of principle, details are given in Section A.1.4.
low [Ca2+]matrix has the effect of shifting [Ca
2+]matrix towards the more controllable region.
Mitochondria far from high [Ca2+] microdomains with lower [Ca2+]matrix increase stimulation
of their TCA cycles by fusing with a mitochondrion with high [Ca2+]matrix. Fusion therefore
increases the amount of mitochondrial volume affected by a calcium signal, which subsequently
increases total energy production.
Experimental support. The idea that fusion increases the number of mitochondria that
experiences a given calcium signal in the cell has been suggested before in Refs. [245, 247].
The existence of high [Ca2+] microdomains was suggested in Refs. [245, 246, 248], and it was
found that only a small fraction of mitochondria were in close contact with the ER in various
cell types [248].
Coarse-grained quantitative model. We focus on the uptake of calcium from the ER as
the most important influence on mitochondrial calcium levels, assuming that without fusion,
the mitochondria near ER calcium channels have saturated calcium-dependent TCA cycle en-
zymes, and the mitochondria far from the ER or plasma membrane have low [Ca2+]matrix (as in
Figure 2.5A). The first few fusion events will increase total enzyme stimulation (and therefore
ATP production) because the mitochondria fusing to the calcium saturated ones experience a
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significant increases in [Ca2+]matrix and enzyme activation, whereas the saturated mitochondria
experience little change in enzyme activation, despite their drop in [Ca2+]matrix (because of the
sigmoidal dependence of enzyme activity on [Ca2+]). Adding more and more mitochondria to
the fused chain will ultimately lead to a decrease in enzyme stimulation (because [Ca2+]matrix
will reach the lower part of the sigmoid), meaning that there exists a certain number of fused
mitochondria that leads to maximal enzyme activation. This number depends on the amount
of calcium released by the ER, the number of mitochondria near the ER, the basal [Ca2+]matrix
present in mitochondria far from the ER, the exact shape of the sigmoid, and, furthermore,
relies on the assumption that when many mitochondria are fused, [Ca2+]matrix becomes so di-
luted as to reach the low enzyme activity regime. There will of course be many other factors
that influence this ‘optimal number of fused mitochondria’ (e.g. the ratio of phosphate-bound
calcium to free calcium): we merely present the basic idea, which is also shown in Figure 2.5B
(for details see Section A.1.4).
Limitations/Critique. This hypothesis is based on several assumptions that are debated in
the literature. While various studies show that higher calcium concentrations lead to increases
in NADH production and oxygen consumption [213, 249, 250], mathematical modelling [202]
and uniporter studies [251] suggest that calcium perturbations may have little effect on res-
piration. Other studies observed calcium modulation only with elevated glucose [252] or only
on a single TCA enzyme [244]. Which mechanisms of calcium uptake are mainly used, the
dependence of these mechanisms on calcium concentrations, and the number of sites close to
sources of calcium are also debated [245, 253] (for details, see Section A.1.5). Mitochondria have
been observed to experience calcium transients, meaning that they extrude calcium quite after
having absorbed it [199] and the simple model we discuss in Section A.1.4 may therefore only
be valid on short timescales. Finally, calcium signalling linked to mitochondrial ultrastructure
is by no means the only, or simplest, way in which the cell regulates its energy status.
2.4.5 Fusion provokes state changes protective against perturbations
Summary. By changing their morphological state, mitochondria can make themselves less
susceptible to perturbations (for example, fluctuations in electrochemical membrane poten-
tial). The fused neighbours of a mitochondrial element can act as a buffer for biochemical or
physical fluctuations. If failure of individual mitochondria has severe consequences for the cell,
this increased robustness through fusion will be beneficial when mitochondria are subject to
perturbations.
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Experimental support. There are experimental indications that fused mitochondria are
better protected against stress [254]. This hypothesis could account for why hyperfusion occurs
during stress [149], and may explain why fusion protects the cell against apoptosis [149, 159–
162] (or delays apoptosis [255]), because prior to cytochrome c release (which induces apoptosis)
remodelling of cristae structure has been seen as a cause of changes in membrane potential
[256]. If a larger network protects against fluctuations in membrane potential, it may be able
to prevent cristae remodelling, thereby potentially delaying or preventing apoptosis.
In stressful conditions it may thus be disadvantageous for the cell to have its mitochondria
fragmented because all of them are vulnerable to e.g. membrane potential fluctuations. If the
cell fuses its mitochondria, they become more robust to the fluctuations, which may prevent
the failure of many individual mitochondria, and subsequent cell death.
Coarse-grained quantitative model. A biophysical calculation considering the change in
membrane potential upon changes in permeability of the inner mitochondrial membrane (see
Section A.1.6.1) suggests d∆ψ
dt
∝ ry where r is the radius of the mitochondrion and y ∈ (−1, 0)
depends on the structure of the membrane (the more invaginated the membrane, the larger y).
This result suggests that for large mitochondria, fluctuations of ∆ψ will be of smaller magnitude.
Fusing mitochondria thus protects them from perturbations, as illustrated in Figure 2.6A. This
particular model assumes spherical mitochondrial geometry (as outlined in Section A.1.6.1).
Small fragmented mitochondria are often seen to have a spherical shape and the fusion of
two small spherical mitochondria may produce a mitochondrion that itself has an approximate
spherical shape. The model discussed here may therefore be applied to fusion events involving
small mitochondrial fragments.
We provide an alternative model that is independent of volume and surface area scaling and
involves picturing mitochondria as individual agents coupled with spin-like interactions [257].
This model, in which a mitochondrion prefers to be in a similar state as its neighbours, shows
that groups of mitochondria are less likely to undergo a catastrophic loss of function than
individuals (see Section A.1.6.2).
Limitations/Critique. Even though fluctuations in larger mitochondria (fused mitochon-
dria) may be of relatively smaller magnitude, they will occur more frequently because of the
larger surface area which increases the probability that, for example, a pore opens or an ETC
component fails. Stress does not always lead to a fused mitochondrial state, but can also lead
to mitochondrial fragmentation [258, 259]. It can be that the level of stress is important, and
that too much stress leads to fragmentation and subsequent apoptosis.
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Figure 2.6: A) Mitochondrial fusion buffers fluctuations in membrane potential. Opening of the mitochon-
drial permeability transition pore or changes in leak can lead to depolarizations of mitochondria. These perturba-
tions to the membrane potential will have less effect when mitochondria are fused because their bigger size makes
them more robust. B) The ‘cable hypothesis’: a mechanism of mitochondrial power cabling. Oxygen con-
centrations are higher at the periphery of the cell and mitochondria positioned here are able to pump protons out
of the matrix. If ATP is required in central regions of the cell, protons will flow into the matrix through ATP syn-
thase. An electrochemical gradient establishes itself along the mitochondrial cable. Protons as well as K+ and Na+
cations (which can be exchanged for protons through Na+/H+ and K+/H+ antiporters) diffuse along the cable
thereby transmitting electrochemical potential. This is the main idea of mitochondrial power cabling and it re-
places diffusion of ATP or oxygen through the cytoplasm by cation movement along mitochondrial filaments, which
may result in an increased speed of energy transmission.
2.5 Discussion
The function of mitochondrial networks is currently unclear, suggesting that new research
strategies may be of use. We have shown that ideas from physics and mathematics provide a
framework to suggest and critically evaluate hypothesised functions. Among the insights we
underline from this work are the possibilities that ‘blind surveillance’ through selective fusion
alone leads to an increase in mitochondrial quality control; that increased fusion may have
nonlinear effects on the diffusion rate of proteins; that the effect on membrane potential of
fusion may be more complicated than a simple averaging; and that fusion can act to dampen
biochemical fluctuations. We note that selective fusion, being a key element of the hypotheses
discussed in Section 2.4.1 and Section 2.4.3, is likely to be an important factor contributing to
the benefits of fused networks. We stress again the observation that with increased fusion, ATP
concentration, rather than merely the rate of production and consumption of ATP, changes.
This implies an acceleration of cellular processes and suggests that fusion serves as a cellular
accelerator pedal.
Which hypothesis is most likely to be true? Three hypotheses that we find attractive are
(i) increased robustness; (ii) blind surveillance; and (iii) increased ATP production through
nonlinear dependence of ATP flux on the properties of fusing mitochondria. Hypothesis (i)
suggests a reason why mitochondrial morphology is dependent on cellular stress, which seems
to be the main regulator of mitochondrial morphology. Hypothesis (ii) also links fusion with
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oxidative stress, because in stress conditions improved quality control is beneficial. Hypothesis
(iii) provides intuitive mechanisms by which fusion may improve the energetic status of the
cell, compatible with a large amount of evidence that mitochondrial structure is correlated with
bioenergetic capabilities of the cell. We cannot exclude the possibility that the central ‘purpose’
of network formation is not one of the currently considered hypotheses; but we anticipate
that quantitative modelling approaches will also be powerful tools in analysing any future
hypotheses.
As mentioned before, the ‘cable hypothesis’ (discussed in more detail in Section A.2.3 and
summarised in Figure 2.6B) has obtained recent support in skeletal muscle and heart cells
[184–186]. These cells have high energy requirements and mitochondrial movement is relatively
limited [260, 261], meaning faster energy distribution through cabling may provide a significant
advantage. However, as noted in Table 2.1, this hypothesis does not necessarily explain meso-
and hyperfusion in other cell types.
We suggested experimental tests to further probe the hypotheses discussed in this chapter
(Table 2.2), one of which (related to Section 2.4.3) we perform ourselves in the next chapter.
Besides the future modelling strategies outlined in Table 2.2, which specifically address each of
the discussed hypotheses, we stress that modelling the network dynamics themselves and their
influence on mtDNA and heteroplasmy dynamics is of great interest. Network dynamics can
be incorporated in the stochastic models of mtDNA dynamics introduced in Chapters 4 and 5;
work along these lines is currently performed in our research group.
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3
Experimental exploration of
mitochondrial dynamics and
membrane potential
Summary
Changes in mitochondrial membrane potential ∆ψ upon mitochondrial fusion and fission play
an important role in determining how the state of the mitochondrial network influences cellular
ATP production rates. We previously showed a mechanism by which a size-weighted averaging
of membrane potentials during fusion can cause increased ATP synthesis rates in highly fused
mitochondrial networks. In this chapter, we use confocal microscopy to track membrane po-
tential during fusion and fission events in human primary fibroblasts. We find evidence that
the pre-fission potential forms a size-weighted average of post-fission potentials, suggesting that
total size-integrated mitochondrial potential is invariant under mitochondrial fusion/fission dy-
namics. This result, combined with i) a sigmoidal relation between ∆ψ and ATP synthesis
and ii) ∆ψ-dependent fusion, may form a potential explanation of observed increases in ATP
production in highly fused networks.
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3.1 Introduction
One of the hypotheses discussed in the previous chapter (Section 2.4.3) states that a highly
connected mitochondrial network produces ATP at a faster rate than a fragmented network.
The postulated underlying mechanism is that most fusion events cause a slight increase in ATP
production rate, where we assumed the post-fusion membrane potential to form a weighted
average (weighted by mitochondrial size) of the pre-fusion potentials (Figure 2.6). In this
auxiliary chapter, we investigate whether this rule holds in human primary fibroblasts.
Several studies have experimentally measured changes in ∆ψ during mitochondrial dynamics
by tracking mitochondrial network structure and membrane potential over time [59, 207, 262].
These studies mainly focus on the state of post-fission mitochondria, i.e. whether they are
hyperpolarised or depolarised relative to the pre-fission mitochondrion. It was found that in
85% of 48 fission events studied, one daughter became hyperpolarised (by a maximal amplitude
of −6.5 ± 3.8 mV) while the other became depolarised (by a maximal amplitude of 5.9 ± 3.7
mV) [59]; in 11% of cases no change was observed in potentials [59]. It was further found that
the average difference in ∆ψ between two fusing mitochondria is 6.2± 4.3 and 7.2± 4.1 mV in
INS1 and primary β cells, respectively [262].
However, from the existing studies it is unclear what the effect of a fusion or fission event is
on ‘cellular mitochondrial potential’, a measure of the overall functionality of all mitochondria
combined. This quantity cannot simply be defined as the mean value of ∆ψ (averaged over all
mitochondrial fragments) as this does not distinguish between a single (small) mitochondrion
with a certain potential or hundreds of mitochondria with the same potential. Obviously, a
notion of size is required; no information on mitochondrial size was provided in the studies
discussed above. If a large number of fission events were followed by a similar number fusion
events to recover the initial network state, has there been a net change in overall mitochondrial
potential?
In this chapter, we explore this question by performing similar experiments to those in Ref.
[59] (i.e. we track mitochondrial membrane potential during fission events) with the addition
of using data on mitochondrial size to test whether size-weighted average membrane potential
is conserved during fusion and fission events. We find evidence that this is indeed the case,
supporting the hypothesis discussed in the previous chapter stating that highly connected
networks are associated with higher ATP production rates. Finally, we discuss limitations of
our experiments and possible improvements for further research.
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3.2 Results
3.2.1 Hypotheses regarding changes in membrane potential during network
events
To test whether size-weighted averaging of potentials takes place, we first require a definition of
mitochondrial ‘size’. A natural candidate is the inner membrane area, as this is the site where
the respiratory complexes and ATP synthases are situated, and therefore the site of ∆ψ gen-
eration; however, this quantity is hard to measure experimentally. The most straightforward
measure of size is cross-sectional area (CSA), which we define as the area observed when cutting
a mitochondrion longitudinally. Assuming mitochondrial width and thickness are roughly con-
stant, a doubling of length corresponds to a doubling of both CSA and inner membrane length;
this means that, under these assumptions, CSA provides a suitable measure of mitochondrial
size.
We can now write down a definition of overall ‘cellular mitochondrial potential’, ∆ψT , namely
∆ψT =
∑
iAi∆ψi, where i labels all mitochondrial fragments, and Ai and ∆ψi are the CSA and
membrane potential of mitochondrion i, respectively. Our hypothesis is that ∆ψT , a notion of
overall mitochondrial functionality, is invariant under mitochondrial fusion and fission events.
Note that, under the assumption that no mitochondrial mass is lost or gained during fusion or
fission events, this statement corresponds to a conservation of integrated membrane potential.
We stress that we investigate the effect on ∆ψT purely due to the fusion and fission events
themselves. There will be many other processes (e.g. changes in proton leak or reverse ATP
synthase activity) that influence ∆ψT .
Specifically, we test the following identity:
∆ψ1+2 =
1
A1 + A2
(A1∆ψ1 + A2∆ψ2) (Model 1) (3.1)
where ∆ψ1+2 denotes the potential of the fused product which has a CSA of (A1 +A2) (Figure
3.1). We test this model against an alternative model given by
∆ψ1+2 =
1
2
(∆ψ1 + ∆ψ2) (Model 2) (3.2)
Here, potential is simply averaged regardless of mitochondrial size and ∆ψT is not conserved.
We will compute likelihoods for both models to test whether there is evidence to reject the
simple averaging model in favour of the weighted average model.
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Figure 3.1: A size-weighted averaging model for changes in ∆ψ during mitochondrial dynamics. This
cartoon illustrates the hypothesis we aim to test experimentally, namely that ∆ψ of the pre-fission (or post-fusion)
mitochondrion forms the size-weighted average of the post-fission (or pre-fusion) potentials.
3.2.2 Visualising and defining mitochondria
We labelled mitochondria in intact human primary fibroblasts with two fluorescent dyes, en-
abling us to obtain qualitative information on changes in mitochondrial membrane potential
while the mitochondria move around and undergo fusion and fission events. The two dyes used
are the cationic dye Tetramethylrhodamine Methyl Ester (TMRM) and MitoTracker Green
(MTG). Changes in the ratio of the fluorescent intensities of these dyes reflect changes in
∆ψ (see Materials and Methods) [59, 207]. Using the Nernstian fashion in which these dyes
accumulate inside the negatively charged mitochondrial matrix (see Materials and Methods),
information on changes in ∆ψ can be extracted and monitored over time.
To measure the membrane potential of a mitochondrion, we require a definition of its bound-
aries. Identifying the boundaries of a continuous fragment is complicated in itself and requires
the use of photoactivatable fluorescent proteins. If activated, these proteins become fluorescent
and spread throughout any mitochondrial sections continuously connected to the activated re-
gion, allowing for the boundaries to be easily visualised [207]. Because we had no access to such
proteins, we identified boundaries by thresholding TMRM images (see Materials and Methods).
Because of the uncertainty on whether a seemingly continuous mitochondrial fragment is ac-
tually fused, as well as uncertainty on the exact moment of fusion, we chose to focus solely on
fission events which are more easily distinguishable.
To minimise misidentifications, we focussed our analysis on mitochondria physically separated
from the bulk of the network (which usually surrounds the nucleus); these isolated mitochondria
were assumed not to be connected to others elsewhere in the cell. Furthermore, we only analysed
fission events which showed a clear physical separation of the two post-fission mitochondria.
These kinds of events are likely to only represent a small fraction of all fission events, as many
can occur without any physical separation [185, 207, 263]. Even with these precautions taken,
we cannot be completely certain of whether our pre-fission mitochondrion is actually continuous,
or whether any of our analysed mitochondria are connected to larger networks elsewhere in the
cell; limitations of our analysis, together with suggestions for improvements, are discussed in
Section 3.2.4.
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3.2.3 Data analysis shows support for a model of weighted averaging
Figure 3.2A shows an example of a mitochondrial network labelled by TMRM and MTG ob-
tained through confocal microscopy; merged and ratio images are also shown. A fission event
occurred in this network involving the mitochondrion at the bottom of the image, as shown
more clearly in Figure 3.2B. TMRM images were thresholded (Figure 3.2B) and subsequently
used to identify mitochondrial outlines using the image processing program ImageJ (Figure
3.2C, Materials and Methods). These outlines were used as masks and applied to ratio images
to obtain mean fluorescent intensities of individual mitochondria; changes in mean intensities
of the TMRM-to-MTG ratio reflect changes in membrane potential (Materials and Methods).
Data was collected for ∼ 50 cells, though only 11 cells showed the particular type of fission
event we focussed on (as discussed above). Time series data of changes in ∆ψ during 12 fission
events (one cell showed 2 events) are shown in Figure 3.3. Each value of ∆ψ in this figure
is calculated relative to the value in the very first frame of the series (using Equation 3.6),
which is arbitrarily set to zero. Measurements of CSA of each mitochondrion are also shown
and obtained from the number of pixels in the identified outlines (Figure 3.2C). Fluctuations
in potential can be large (Figure 3.3), though this may reflect actual fluctuations in potential
rather than large measurement errors.
Though we have several minutes’ worth of data for each fission event (Figure 3.3), we chose to
test our hypothesis using values of ∆ψ only at time points directly before and after fission∗.
The reasons for this are the following: i) we are interested in the immediate change in potential
caused by the actual events themselves and try to avoid any compensations made by the
mitochondria in response, and ii) we expect membrane potential values at later time points to
be unphysiological (as explained below), and including this data will only introduce extra noise.
The time interval between two consecutive frames in our experiments is usually ∼ 3 seconds,
which we assume is larger than the response time of TMRM to changes in ∆ψ. We do use
all available data on mitochondrial size and define the CSA of a single mitochondrion as the
time-averaged number of pixels contained in the outline defining the mitochondrion in question.
Assuming that the ‘true’ mitochondrial area remains constant in the short time window of our
experiment, using time-averaged values increases the accuracy of our estimations.
∗This means we used only three data points of ∆ψ in each fission event, one before and two after the event.
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A)
B) C)
TMRM MTG
Merged Ratio
Figure 3.2: Example images of mitochondrial networks and fission events. A) A mitochondrial network
is shown labelled by TMRM (red) and MTG (green). The merged and ratio images (TMRM-to-MTG) are also
shown. Scale bar indicates 2µm. B) A mitochondrion undergoes fission at the location indicated by the white
arrow. The black and white images are binary images obtained from thresholding the TMRM channel; identified
objects have value ‘1’ (white) while unidentified objects have value ‘0’ (black). Because we use a local thresholding
method, local fluorescent intensity maxima in the cytosol show up as white, but due to the often much higher
mitochondrial intensity a black band appears around the mitochondria making them easily distinguishable from
the cytosolic ‘objects’. Scale bar indicates 2µm. C) Outlines of mitochondria identified in Figure (B) are obtained
from the thresholded images, and are used as a mask to calculate statistics of the ratio image shown in Figure (A).
The number of pixels in these outlines was used to define mitochondrial CSA.
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Figure 3.3: Membrane potential and area analysis. Here we show the results obtained from analysing the
changes in membrane potential, using Equation (3.6); ∆ψ in every frame was calculate relative to the first frame,
with cytosolic intensities assumed to be constant. Solid lines show ∆ψ for the pre-fission (blue) and post-fission
(red and green) mitochondria, whereas dashed lines show the areas measured in number of pixels. Areas were nor-
malised to the area of the pre-fission mitochondrion directly before fission. Error bars indicate standard deviations.
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To test which of the two models defined in Equations (3.1) and (3.2) better accounts for the
data, we compare the following quantities: i) experimentally measured values of ∆ψ1+2 directly
before fission, and ii) values of ∆ψ1+2 as predicted by the models given experimentally measured
values of ∆ψ1 and ∆ψ2 (directly after fission) as well as A¯1 and A¯2 (CSA averaged over time);
correlations between these measured and predicted values are shown in Figure 3.4A. We then
compute the likelihoods of both models using a Gaussian error model (Materials and Methods).
The log-likelihoods of models 1 and 2 given our data are L1 ≈ −20 and L2 ≈ −37.0, respec-
tively (Section 3.2.5), confirming our prediction that the weighted average model is the one
most likely to account for the data. Because the poorer fit of model 2 may be due to a few
outliers (considering the small number of data points available), we used bootstrapping to ob-
tain distributions of log-likelihoods. These distributions were then used to calculate differences
in the Akaike information criterion (AIC), an estimator of the quality of a model relative to
other models (Section 3.2.5). The model with the lowest AIC, which was found to be model
1 in 99.9% of our bootstrap samples, is the most likely to explain the data (Figure 3.4B).
When model 1 was more likely, the relative likelihood of model 2 was less than 0.01 in 95% of
cases (Section 3.2.5, Figure 3.4C). Therefore, our experiments provide evidence for conserva-
tion of cellular mitochondrial potential upon fission events. Does a similar result hold for fusion
events? Though not proven, it seems plausible assuming that the same physical rules apply to
both division and fusion. If so, then the nonlinear relation between ATP synthesis rate and
∆ψ as defined in Section 2.4.3 of Chapter 2, combined with selective fusion, means that fused
mitochondrial networks produce ATP at a faster rate than fragmented networks.
One of the main limitations of our experiments is that the mitochondria we imaged showed signs
of phototoxicity after ∼ 10 minutes and sometimes even after < 5 minutes, as evidenced by
their change in shape and fluorescent intensity (Figure 3.5A). Unfortunately, this introduces the
possibility that effects due to cellular phototoxicity may influence our observations. However,
we would argue that this has little influence on our conclusion because one might expect changes
in ∆ψ to be governed by physics rather than physiology. Also, we only used potential values on
a very short time-scale and all of our analysed events occurred within 3 minutes of starting the
laser irradiation, at which point mitochondrial damage (if any) was limited. We thus argue that
our results justify further testing of our hypothesis with more data and in a more physiological
setting (as further discussed in the Discussion).
We briefly comment on other interesting behaviours that were observed. We found evidence for
spontaneous transient mitochondrial depolarization events, which have been widely reported
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in a variety of cell types [264–270]. On a time-scale of seconds, mitochondria can show a drop
and subsequent recovery in TMRM fluorescence (Figure 3.5B). It was suggested that the mi-
tochondrial permeability transition pore plays an important role in this phenomenon because
opening of the pore, potentially a response to increased stress, can cause rapid depolarizations
[269, 271, 272]. We observed transient depolarization events both at the start of experiments
(without obvious signs of phototoxicity) as well as the end. We also observed that, unsurpris-
ingly, mitochondrial CSA is well conserved.
A) B) C)
Figure 3.4: A weighted average model is better able to predict measured pre-fission potentials. A)
Here we show the relation between the actual measured pre-fission potentials ∆ψ1+2, and the predicted values
1
A¯1+A¯2
(A¯1∆ψ
0
1 + A¯2∆ψ
0
2) (Model 1) and
1
2 (∆ψ
0
1 + ∆ψ
0
2) (Model 2). Only potential values directly before and
after the events are used. Through likelihood comparison (Equation 3.9), Model 1 is found to be more likely to
account for the data. The straight line denotes identity. B) The distribution of the difference in AIC values be-
tween the two models is shown using bootstrapping (Materials and Methods, Equation (3.11)). At each bootstrap
iteration (5 × 105 iterations were used), 12 data points are sampled with replacement from the set of all 12 data
points. In 99.9% of cases, the AIC of model 1 (AIC1) is lower than that of model 2 (AIC2), meaning model 1 is
more likely to explain the data. C) This figure denotes the relative likelihood of model 2 in the case that AIC1 <
AIC2 (Equation (3.12)). For example, if this relatively likelihood is 0.01, then model 2 is 0.01 times as probable as
model 1 to explain the data (Materials and Methods).
47
t = 0s t = 3.6s t = 7.2s
t = 0m t = 5m
A)
B)
t = 0s t = 3.6s t = 7.2s
Figure 3.5: A) Phototoxic damage occurred during cell imaging. Here we show a fragment of a cell which
appears healthy at the start of imaging, but shows damaged mitochondria at < 5 minutes. This high level of laser-
induced damage made it nearly impossible to track mitochondria for more than a few minutes. Scale bars indicate
2µm. Transient mitochondrial depolarization events were observed in single mitochondria. B) Depolariza-
tion event, lasting only a few seconds, were not uncommon; two examples are shown. Scale bar indicates 2µm.
48
3.2.4 Discussion
As discussed in Section 2.4.3 of the previous chapter, changes in mitochondrial membrane
potential upon fusion and fission have important consequences for cellular ATP production
rates. We tracked mitochondrial membrane potential and cross sectional area over time, and
found evidence for conservation of total cellular mitochondrial potential ∆ψT during fission.
If this conservation rule extends to fusion events, then highly connected mitochondrial states
are expected to show increased rates of ATP synthesis as hypothesised in the previous chapter.
We focussed our analysis entirely on fission, rather than fusion, events due to the difficulty in
identifying the latter without photoactivatable fluorescent proteins. When such proteins are
available, our analyses may be extended.
We note that our results imply that an asymmetry in potentials after fission, as observed in
most events studied in Ref. [59], is not surprising if the two post-fission mitochondria are of
different size (which is likely to be true in most cases). For example, a mitochondrial fragment
may have a region with deficient ETC components or a damaged mitochondrial membrane,
which causes this region to slightly lower the membrane potential of the entire segment. When
fissioned off, the fragment containing the deficient region likely shows a lowered ∆ψ, whereas
the other post-fission fragment is likely to experience an increase; the larger the differences
in size between the post-fission mitochondria, the larger the asymmetry in potentials can be.
A mechanism like this was recently observed in cardiomyocytes [185]. The authors observed
that local damage (due to experimental uncoupling) caused depolarization of an electrically
continuous mitochondrial segment, after which electrical decoupling between different regions
within the segment was seen. Following this decoupling was a physical separation of the different
regions where the damaged region remained depolarised whereas the other region recovered its
potential.
We will now discuss various limitations of our experiments and suggest improvements for future
research. First, the mitochondria we imaged showed clear signs of phototoxicity, often at a
timescale of ∼ 5 minutes. This made it impossible to track mitochondria for longer periods
of time and, more importantly, means that our results cannot be considered to be valid for
healthy cells. A careful analysis of the time and intensity limits of laser exposure which induce
mitochondrial damage is therefore required. However, while phototoxicity limits the validity
of our results, changes in ∆ψ, as mentioned before, are likely to be governed by physics rather
than physiology. Therefore, the preliminary results we present form important ground-work
and, because of the positive evidence we found for our hypothesis, further testing is justified.
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As mentioned before, we cannot be completely sure whether a fragment classified as a ‘single
mitochondrion’ is actually continuous, or whether two seemingly fragmented mitochondria are
still electrically coupled. The post-fission mitochondria in the event illustrated in the lower
right corner of Figure 3.3 show a large degree of correlation, raising the possibility of an unob-
served connection. Alternatively, the consistent large up and down fluctuations in ∆ψ observed
throughout the imaging may indicate some external effect that dominates any natural fluctua-
tions.
In calculating changes in ∆ψ, we have implicitly assumed constant cytosolic dye concentrations
throughout the experiments. Though this assumption may be reasonable in stable healthy cells,
it may not be valid in our cells which increasingly accumulate irradiation damage. However,
any changes in cytosolic concentrations are expected to be small in the very brief time interval
of our analysed fission events.
There are various subtleties regarding the fluorescent dyes we used in our experiments. Be-
fore the cationic dyes accumulate inside the negatively charged mitochondrial matrix, they
accumulate inside the cells themselves due to their negative charge relative to the surrounding
medium. Changes in the potential across the plasma membrane of a cell (∆ψP ) will in turn
affect concentrations of TMRM in the cytoplasm. A change in TMRM fluorescence may there-
fore be caused by a change in ∆ψP rather than an actual change in mitochondrial potential
∆ψ [273]. Damages due to high phototoxicity may cause a drop in ∆ψP , causing changes in
TMRM fluorescent intensity to be unreliable predictors of ∆ψ. Simultaneous measurements of
∆ψ and ∆ψP have been performed before [274, 275] and provide a more accurate estimate of
∆ψ. Again, because we only use membrane potential data on a very short time interval, any
changes in ∆ψP are expected to be small.
The fluorescent intensity of TMRM can only be used as a measure for membrane potential in
a non-quench condition. At high dye concentrations, TMRM can form aggregates which do
not fluoresce. This means that further increases in concentration do not lead to increases in
fluorescent intensity, a phenomenon known as quenching. Therefore, dye concentrations must
be sufficiently low to prevent this behaviour. The quench-limit of TMRM was estimated previ-
ously [274] and it was found that concentrations below ∼ 10-20nM cause very little quenching;
concentrations of 50nM, however, which were used in these preliminary experiments, do cause
quenching. Therefore, high values of ∆ψ may not have been picked up in our experiments;
lower TMRM concentrations in any further experiment can prevent this problem. Absorption
spectra are often skewed towards shorter wavelengths, while emission spectra tend to be skewed
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towards longer wavelengths; it is therefore possible that emission from the green fluorophore
MTG is detected through red emission filters. We measured levels of cross-talk between the
dyes before starting our experiments; very little cross-talk was observed, making it unlikely to
have caused any artificial changes in ∆ψ.
To probe the influence on our results of the details of our thresholding method, we repeated
our analyses using different parameters in the Niblack thresholding algorithm that was used
(Materials and Methods). Often no large changes were seen but occasionally the exact moment
of fission was altered, i.e. a physical separation of mitochondria was seen a few frames later or
earlier†. This uncertainty in the exact moment of fission will affect predictions of changes in ∆ψ.
Ensuring full equilibration of both dyes across the mitochondrial inner membrane, subtracting
cytosolic intensities, and carefully checking by hand threshold images may minimise, though
not completely eliminate, this issue.
To summarise, we are of the opinion that this work presents useful insights and provides prelim-
inary evidence for a model of weighted averaging of ∆ψ during fission. We suggest the following
steps to be taken to continue this line of work with a similar but improved approach. Firstly,
more data needs to be collected, while ensuring low phototoxicity by lowering laser power and
checking whether cells still have a healthy mitochondrial network after ∼ 30 minutes; this time
window should be long enough to ensure healthy mitochondria during an entire fission event,
and to be able to perform imaging for longer periods of time (thereby increasing the chance of
observing fission or fusion events). Secondly, a lower concentration of TMRM should be used
to avoid dye quenching. The combination of these two points will lead to a lower mitochon-
drial signal and some trial-and-error will be required to obtain data from healthy cells whose
mitochondria are still distinguishable from background noise. If possible, fluorescent proteins
may be used to allow for the study of fusion events. Though simultaneous measurements of
both mitochondrial and plasma membrane potentials are desirable, this increases the complex-
ity of the experiment and, given the short time-span between the data points actually used for
analysis, may not yield significantly improved results.
†For example, consider a particular setting in which the mitochondria are, after thresholding, considered to
be separated for the first time at time t (meaning that at this time, a set of pixels in between the mitochondria
are below threshold). A different parameter setting which tends to reduce threshold values might still consider
these pixels to be above threshold, meaning that the mitochondria will separate at a time t′ > t.
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3.2.5 Materials and Methods
Cell culture. Human primary fibroblasts were cultured in DMEM, high glucose, glutamine,
pyruvate with phenol red; Gibco Catalog number:11995-073. For imaging, we used the following
recording medium: DMEM A14430 with 1g/L glucose, 2 mM glutamine, 1 mM pyruvate, 10
mM HEPES, pH 7.4; no serum, no phenol red. Cells were stored at 37◦C and 5% CO2.
Mitochondrial membrane potential analysis. The fluorescent intensity of the cationic dye Tetram-
ethylrhodamine Methyl Ester (TMRM) can be directly related (in a nonlinear fashion [275])
to the potential ∆ψ across the mitochondrial inner membrane; a loss of ∆ψ results in TMRM
leakage from the mitochondria into the cytoplasm. Changes in fluorescent intensity of TMRM
can occur because of changes in ∆ψ but also because of movement of a mitochondrion in and out
of the focal plane. To correct for such movements, fluorescent intensity of the dye MitoTracker
Green (MTG) was measured simultaneously. MTG is a dye that accumulates in mitochon-
dria according to their membrane potential, but subsequently binds to mitochondrial proteins
meaning that it is not released when mitochondria depolarise. The ratio of TMRM-to-MTG
fluorescence is largely independent of mitochondrial movement (since intensity of both probes
would decrease during an out-of-focus movement), and therefore reflects actual changes in ∆ψ
[59, 207].
The membrane potential can be calculated by using the Nernst equation, which calculates the
potential across a membrane due to a concentration difference of an ion of charge z and is given
by
E =
RT
zF
ln
(
Ci
Co
)
(3.3)
where R, T and F denote the ideal gas law constant, temperature and Faraday’s constant,
respectively, and Ci and Co denote the ion concentrations on the inside and outside of the
mitochondrion, respectively. It was shown previously that the fluorescent intensity of TMRM,
here denoted by F T , accumulates in a Nernstian fashion [264]. We thus obtain
∆ψ = −RT
zF
ln
(
F Ti
F To
)
(3.4)
where the minus sign appears due to the fact that mitochondrial potential is defined with
respect to the cytosol (leading to a negative mitochondrial potential). The difference in ∆ψ
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between two time points t and t′ > t is given by
∆ψt′ −∆ψt = RT
zF
[
− ln
(
F Ti,t′
F To,t′
)
+ ln
(
F Ti,t
F To,t
)]
=
RT
zF
ln
(
F Ti,t
F To,t
· F
T
o,t′
F Ti,t′
)
≈ RT
zF
ln
(
F Ti,t
F Ti,t′
)
(3.5)
where in the last step it was assumed that the cytosolic TMRM concentration is constant
between the two consecutive time points. We now adjust this equation to involve the ratio
TMRM-to-MTG intensity, rather than TMRM alone, giving
∆ψt′ −∆ψt ≈ RT
zF
ln
(
F Ti,t
F Ti,t′
FMi,t′
FMi,t
)
=
RT
zF
ln
(
F Ti,t
F Ti,t′
)
− RT
zF
ln
(
FMi,t
FMi,t′
)
(3.6)
where FMi,t refers to the MTG fluorescent intensities inside the mitochondrion at time t. The
correction term subtracts any contributions to ∆ψ caused by changes in MTG fluorescence due
to out-of-focus movements. In an ideal situation, with no change in MTG fluorescence (and
therefore TMRM fluorescence), this correction term is zero. Using T = 37◦C (though a recent
study suggests mitochondria might be maintained at nearly 50◦C [276]) and z = 1 [207], the
proportionality constant has a value ∼ 26.7 with ∆ψ measured in mV.
Loading with TMRM and MTG. Using a similar approach as in Ref. [59], mitochondria were
labelled with both TMRM and MTG, and the fluorescent intensities of both dyes were measured.
TMRM is a fluorescent indicator that accumulates in the negatively charged mitochondrial
matrix. Before imaging, TMRM was freshly prepared at a concentration of 50 nM by diluting
a stock of 50 µM which was stored at -20◦C. MTG was prepared in the same way and used at
the same concentration.
To prepare for imaging, 500 µL of recording media (defined under ‘Cell culture’) with both
TMRM and MTG was added to cells and incubated for 20 minutes at 37◦C. After incubation,
the solution was removed and TMRM was added, removed (to wash out any remaining MTG),
and added again. The final solution now contains recording media and TMRM (to keep its
concentration equilibrated across the mitochondrial and plasma membrane), but not MTG (we
want to prevent any additional uptake of MTG during the experiment).
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Confocal microscopy. During imaging, live cells were maintained at 37◦C. Cells were plated on
glass coverslips an hour before imaging. Confocal microscopy was performed with a Zeiss LSM
880 with Airyscan using a ×63 oil immersion objective. TMRM was detected with excitation
at 561 nm, and MTG with excitation at 488 nm. Each frame was scanned line by line and each
line was scanned twice, first to detect TMRM emission and then MTG emission. Autofocus
was used to prevent cells from drifting out of focus. A section of the cell not densely packed
with mitochondria (for reasons discussed in Section 3.2.4) was chosen and was typically imaged
for ∼5 minutes. In total, ∼ 50 cells were imaged.
Image analysis and processing. Image processing was performed with ImageJ. First, a ratio
image (TMRM-to-MTG) was created. In previous analyses we subtracted background inten-
sities for both channels using a rolling ball algorithm, but for the final results presented here
no background subtraction was used in creating the ratio image. The reasons for this are i)
the background subtraction itself induced noise and the ratio image contained very high pixel
values due to very low values in the MTG image (these high pixel values then increased mean
intensity values in the ratio image. A threshold value could have been used to exclude certain
pixel values but this introduces another parameter); ii) the results without background sub-
traction were less noisy, and iii) part of our analysis assumes constant background intensities
(Equation (3.5)) and therefore subtracting a different background value for each pixel (due to
the local rolling ball algorithm) seemed inappropriate. Background subtraction was used to
create threshold images (to be used as masks) using a rolling ball algorithm, as the increased
contrast between mitochondria and background rendered the thresholding more accurate.
The ∆ψ-independent channel identifies all mitochondria and this channel is usually used for
image thresholding (see e.g. [207]). However, in our experiments the MTG channel showed a
high level of noise which made thresholding based on this channel challenging, and thresholding
was therefore performed using the TMRM channel; this may exclude depolarised mitochondria
but for our purposes it suffices (in a few cases with less noisy MTG signals we compared results
based on thresholding for either channel and no notable difference were found). Nine different
local thresholding algorithms were compared and, after checking by hand the resulting images
for a few different cells, the Niblack thresholding algorithm proved to be most accurate and
was used for all further analyses [277]. All frames in the time series were checked by hand for
correct identification of mitochondria. Finally, the thresholded image was used as a mask to
obtain statistics of the ratio image.
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Hypothesis testing. Let ∆ψf1+2, ∆ψ
0
1 and ∆ψ
0
2 denote membrane potentials of the pre-fission
mitochondrion directly before, and the post-fission mitochondria directly after fission, respec-
tively. For a perfect model, the difference between measured and predicted pre-fission potentials
can be modelled by a random noise term with zero mean, where the noise is caused by a com-
bination of e.g. measurement noise, natural mitochondrial fluctuations in ∆ψ, and the discrete
time lattice used to store information (which means our first measurement after fission may be
several seconds after its actual occurrence). We use a Gaussian error model, giving
Model 1: ∆ψf1+2 =
1
A¯1 + A¯2
(A¯1∆ψ
0
1 + A¯2∆ψ
0
2) +N(0, σ
2
1) (3.7)
Model 2: ∆ψf1+2 =
1
2
(∆ψ01 + ∆ψ
0
2) +N(0, σ
2
2) (3.8)
where the bars indicate areas averaged over time, and N(0, σ21) and N(0, σ
2
2) denote normally
distributed noise terms with zero mean. The variance of the noise term is the only free parameter
used in both models.
To compare the two proposed models (Equations (3.7) and (3.8)) we evaluate their likelihoods,
i.e. the probability of observing the data given the model parameters. Denoting the measured
values of ∆ψf1+2 by (y1, y2, · · · yn), and introducing X1 = 1A¯1+A¯2 (A¯1∆ψ01 + A¯2∆ψ02) and X2 =
1
2
(∆ψ01 + ∆ψ
0
2), the log-likelihoods of models 1 and 2 are given by
L1 = log
(
n∏
i=1
(
1√
2piσˆ21
e−(yi−x1,i)
2/2σˆ21
))
= −n
2
log(2piσˆ21)−
1
2σˆ21
n∑
i=1
(yi − x1,i)2 (3.9)
L2 = −n
2
log(2piσˆ22)−
1
2σˆ22
n∑
i=1
(yi − x2,i)2 (3.10)
where n denotes the number of data points (corresponding to the number of events analysed),
σˆ21 =
1
n
∑n
i=1(yi − x1,i)2 denotes the maximum likelihood estimate of the noise variance (and
similar for σˆ22), and x1,i ∈ X1 and x2,i ∈ X2 denote the predictions of the two models.
The Akaike information criterion (AIC) is an estimator of the quality of a model relative to
other models and is defined as
AICi = 2ki − 2Li (3.11)
where ki and Li denote the number of parameters and maximum log-likelihood of model i,
respectively. In our models, k1 = k2 = 1 and Li is given by equations (3.9) and (3.10). The
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AIC provides a means of model selection and estimates the information lost when using a given
model to represent the actual process generating the data. The model with the lowest AIC is
most likely to minimize information loss (a low AIC corresponds to a large likelihood and a
small number of parameters). The quantity
e(AICmin−AICi)/2 (3.12)
denotes the relative likelihood of the ith model, with ATCmin denoting the minimum of all AIC
values. For example, if AIC1 = 50 and AIC2 = 52, the second model is e
(50−52)/2 ≈ 0.37 times
as likely as the first model to minimize information loss. We used equation (3.12) with i = 2
to calculate the relative likelihood of model 2 when model 1 is more likely (Figure 3.4C). To
create Figures 3.4B, C we used bootstrapping, i.e. we resampled with replacement the 12 data
points shown in Figure 3.4A and calculated the log-likelihoods of both models for each of these
resampled data sets. After 5 × 105 bootstrap iterations, the distributions of log-likelihoods
obtained were used to calculate the distributions shown in Figures 3.4B, C.
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4
Control and energetic costs of
stochastic mtDNA populations
Summary
The cellular proportion of mutant mtDNA molecules is crucial in mitochondrial disease; un-
derstanding the dynamics of mtDNA populations inside cells and the way in which mutants
accumulate over time is vital to understand these diseases. The mitochondrial population is
under homeostatic control, but the details of the control mechanisms involved remain elusive.
Here, we use stochastic modelling to derive general results for the impact of cellular control on
mtDNA populations, the cost to the cell of different mtDNA states, and the optimisation of
artifical, therapeutic control of mtDNA populations. We illustrate that an increasing mtDNA
variance can increase the energetic cost of maintaining a tissue, that intermediate levels of
heteroplasmy can be more detrimental than homoplasmy even for a dysfunctional mutant, that
heteroplasmy distribution (not mean alone) is crucial for the success of gene therapies, and
that long-term rather than short intense gene therapies are more likely to beneficially impact
mtDNA populations.
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4.1 Introduction
Mitochondrial biogenesis and maintenance require cellular resources, and mitochondria are key
sources of ATP and play other important metabolic roles: a tradeoff of bioenergetic costs and
benefits is thus involved in the interaction between the cell and its mitochondria. The particular
‘effective cost’ that cellular control acts to minimise remains poorly understood: for example,
both decreases [104] and increases [104, 278] in wildtype copy numbers have been observed for
different mutations as the mutant load increases. Some studies suggest that mtDNA density is
controlled [279–281], others that total mtDNA mass [282, 283], or mtDNA transcription rate
[38] is controlled. Understanding the dynamics of mtDNA populations inside cells, and how
these populations react to clinical interventions, is crucial in understanding genetic diseases
[141, 284]. However, experimental tracking of mtDNA populations over time is challenging,
necessitating predictive mathematical modelling to provide a quantitative understanding of
these systems.
In parallel with efforts to elucidate cell physiological control, protein engineering methods to
control mtDNA heteroplasmy are making fast progress. Two recently developed methods for
cleaving DNA at specific sites involve zinc finger nucleases (ZFNs) and Transcription Activator-
like Effector Nucleases (TALENs) [285–291], which have been re-engineered to specifically cleave
mutant mtDNA [142, 144, 145, 292, 293]. MitoTALENs have been successfully used to reduce
mutant loads in cells containing disease-related mutations, but elimination of the target mutant
mtDNA was not complete [144, 147]. Similarly, treating cells multiple times with mtZFNs
led to near-complete elimination of mutant mtDNAs [142, 293]. As mentioned in the thesis
introduction, quantitative theory for these promising therapeutic technologies has not yet been
developed, leaving open questions about how these tools can be optimally deployed.
In this chapter, we develop theory from bottom-up bioenergetic principles which allows us to
study the effects of distinct cellular mtDNA control strategies (Section 4.2.1), to analyse the
bioenergetic cost of different mtDNA states (Section 4.2.2), and to combine mtDNA control and
energy-based cost (Section 4.2.3.1) to identify optimal control strategies for the cell. Finally, we
construct a model for artificial mtDNA control using recent experimental data [142] to propose
optimised treatment strategies while highlighting challenges linked to heteroplasmy variance
(Section 4.2.3.2).
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Key results presented in this chapter.
I If only one mtDNA species is controlled the variance of the controlled species reaches a constant
value. When both species are controlled with equal strength their variances increase at identical
rates, and, in general, the more tightly controlled species has a more slowly increasing variance
(Figure 4.1, Section 4.2.1).
II The mean energetic cost of maintaining a tissue can increase over time due to the nonlinear influence
of mtDNA variance, even if the energetic demand on the tissue stays the same and mean levels of
mtDNA are constant (Section 4.4, Eq. 4.6).
III A control lacking any mutant contribution shows an exponentially increasing cost, and the effects
of particular cellular control strategies are more pronounced in low copy number cells (Section
4.2.3.1, Figure 4.3A, B).
IV Control strategies based on the energy status of the cell will often outperform control based on
mtDNA copy number or sensing mtDNA mass (which would work well for deficient deletion mu-
tants, but would be suboptimal for deficient point mutations) (Section 4.2.3.1, Figure 4.3C).
V Even for pathological mutants, reduction of mutant mtDNA alone is not always the optimal control
strategy for a cell to adopt (Section 4.2.3.1, Figure 4.4).
VI Tissues with high mean heteroplasmy levels will generally be harder to treat with mitochondrially
targeted endonucleases if the heteroplasmy variance is high, especially if this high mean level is
caused by a small percentage of cells (Section 4.2.3.2, Figure 4.5D).
VII Weak long-term rather than short intense endonuclease treatments are more likely to beneficially
impact mtDNA populations (Section 4.2.3.2, Figure 4.5G, H).
Table 4.1: Key results. Here we present key results of this chapter, which hold under the assumptions used in
our models. We model mtDNA dynamics using stochastic birth-death simulations and assume: cells are hetero-
plasmic (containing both wildtype and mutant mtDNA molecules); birth and death rates are identical for wildtype
and mutant species; the mtDNA dynamics are subject to cellular feedback control. We introduce a mitochondrial
energy-based cost function; results referring to optimal controls and costs depend on the structure of this cost
function which is discussed in Section 4.4 and Section B.3.
4.2 Results
4.2.1 Control: general insights on the role of feedback control
We employ the linear model of feedback control presented in the thesis introduction in Eq.
1.3, which is a form of ‘relaxed replication’ as each mtDNA molecule replicates and degrades
according to Poisson processes with rates λ(w,m) and µ, respectively [1, 2]. We assumed only
the replication rate to be a function of w and m because control of biogenesis or autophagy
(i.e. degradation) yield similar behaviours [101]. To connect with experiments, we use µ ≈ 0.07
day−1 corresponding to a half-life of about 10 days [119]; this will be the default value of
µ throughout this thesis unless specified otherwise. For clarity, the assumed deterministic
dynamics of w(t) and m(t) are provided in Equation 4.5.
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4.2.1.1 A wide range of control strategies induces similar mtDNA behaviour
and admits quantitative analysis.
Whatever the quantity being controlled, in healthy cells the intuitive aim of homeostatic
mtDNA control is to guarantee cell functionality by keeping wildtype copy numbers around
a particular value and within certain bounds. Many possible control strategies can be pa-
rameterised to give rise to nearly identical means and variances for wildtype, mutant, and
heteroplasmy dynamics up to long times (e.g. a human life-time) (Figure 4.1A,B,C, Figure
B.1B,C,D). This is mainly true when mtDNA copy numbers fluctuate around their steady
state values, in which case a linear control forms a good first order approximation to the com-
plex ‘true’ feedback control function. In this case, it is not the manner in which the controlled
quantity is being controlled, but which quantity is controlled that is the most important. For
example, the extent to which mutants and wildtypes contribute to the replication feedback
function (determined by the parameter δ) determines how their relative means and variances
evolve (Figure 4.1D, and Chapter 5), and contains more information on the dynamics than the
functional form of λ(w,m) for fixed δ.
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Figure 4.1: A) - C) A wide range of cellular control strategies can yield similar dynamics. Stochastic sim-
ulations were used to compare three structurally distinct cellular controls (see legend), each reflecting a different
function of the underlying sensed quantity w + δm with δ = 0.5. All controls are set to have the same wildtype
mean and variance in the absence of mutants (Section B.1). Figure (C) illustrates the difference between cellu-
lar mean and tissue homogenate heteroplasmy. D) Control tradeoffs are required when multiple species are
present. The more strongly one species is controlled, the more control is lost over the other. Changes in variances
as described by the linear noise approximation (Section C.1.5) are shown (intermediate times). For long times, fix-
ation occurs and the variance of the surviving species saturates. In the most-right figure we depicted the case in
which mutants contribute less to the control than wildtypes (δ < 1).
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We stress the difference between two types of average heteroplasmy, as was also stressed in
Ref. [2]: the individual cellular mean heteroplasmy 〈h〉cellular = 1ncells
∑
cells i
mi
mi+wi
and the tis-
sue homogenate heteroplasmy 〈h〉homog = (
∑
cells i
mi)/(
∑
cells i
(mi + wi)). The difference between
individual and homogenate means is clearly seen in Figure 4.1C. When no explicit selection
is present for either mtDNA species, the mean cellular heteroplasmy remains constant at its
original value, i.e.
〈h〉cellular = m0
m0 + w0
(4.1)
where w0 and m0 denote the initial wildtype and mutant copy numbers, respectively. These
dynamics can be described by a random walk in heteroplasmy space (as there is no bias towards
increasing or decreasing h) (see also Chapter 5). For long times, the percentage of cells that
fixate on mutant species (i.e. h = 1) is then given by m0/(w0 +m0) and these cells have mean
copy number Nss/δ (see Section 1.4.4), whereas wildtype cells have mean copy number Nss.
We can now calculate the homogenate heteroplasmy at long times (i.e. times at which all cells
have fixated) as∗
〈h〉homog, t→∞ = m0
m0 + δw0
. (4.2)
It is clear that when mutants contribute little to the feedback control (small δ), tissue homogenate
heteroplasmy can reach high values, and even approach 〈h〉homog = 1, without explicit selection.
A tissue can thus appear, when studying the homogenate heteroplasmy, to show selection for
one type of mtDNA over another, whereas in fact mean cellular heteroplasmy is unaltered and
both mutant and wild types have the same proliferation rates.
The observation of constant 〈h〉cellular despite a drop in 〈w〉 as well as an increase in 〈m〉 may
seem unintuitive. However, this can be explained by the fact that cells with higher heteroplasmy
levels have higher total mtDNA copy numbers when δ < 1. For example, imagine 1000 cells
all initialized at the state (w,m) = (200, 200) which forms a deterministic steady state when
δ = 0.1 and Nss = 220. Due to the lack of explicit selection, at long times we expect 50%
of cells to fixate on mutant with mean copy number Nss/δ = 2200 and 50% to fixate on
wildtypes with mean copy number Nss = 220. We thus find that, for long times, 〈m〉 = 1100
and 〈w〉 = 110 whereas initially we had 〈m〉 = 〈w〉 = 200. In this example, 〈w〉 decreased,
〈m〉 increased, 〈h〉homog increased from 0.5 to ∼ 0.91, and 〈h〉cellular remained constant at 0.5.
The increase 〈h〉homog is caused by cells homoplasmic in mutant having a ten times higher copy
number (due to δ = 0.1) than cells homoplasmic in wildtype. Heteroplasmy distributions evolve
asymmetrically if δ 6= 1, examples of which are shown in Figure 5.1D,E.
∗We note that Equation 4.2 only holds when δ > 0.
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4.2.1.2 Nonlinear cost functions predict changes in tissue maintenance
The model we use to describe mtDNA dynamics is an example of a birth-death model (see
Section 1.4.4) which can be stochastically described by a master equation. Because the replica-
tion rate λ(w,m) represents the birth rate of each individual mtDNA molecule, the total rate
at which birth occurs is nonlinear, in which case the master equation often cannot be solved
analytically. Approximation methods such as the van Kampen system size expansion (SSE)
[294] can be used to predict mtDNA variances (Section C.1.5), showing good agreement with
stochastic simulations up to hundreds of days [101]. Table 4.2 shows the first order solution of
the SSE which is known as the linear noise approximation (LNA). Applying this approximation
to a general form of mtDNA control (Section C.1.5), we find that i) if only one species is con-
trolled, the variance of the controlled species quickly reaches a constant value (see also [101]), ii)
when both species are controlled with equal strength their variances increase at identical rates,
iii) in general the more tightly controlled species has a more slowly increasing variance, and
iv) the rate of increase of heteroplasmy variance depends, to first order, only on mtDNA copy
number and turnover (as found in [101]). (Figure 4.1, Table 4.1(I)). Eventually, all variances
reach a constant value due to complete fixation though this may take many years depending
on initial heteroplasmy values and mtDNA turnover rates.
What are the biological implications of these findings? A given mtDNA state (w,m) will
accrue a cost to the cell, denoted by C(w,m), which can e.g. be an energetic cost or some
other metric of tissue burden. If this cost function is nonlinear, increasing variances in w and
m can lead to changes in mean cost 〈C(w,m)〉 even when mean cellular copy numbers 〈w〉, 〈m〉
remain constant (Methods) because the mean of a nonlinear function of random variables is
not generally equal to the function of the mean of those variables (as seen above with cellular
vs homogenate heteroplasmy). Therefore, the mean cost of maintaining a tissue may increase
over time, even if tissue demands stay the same and mean mtDNA levels are constant (Table
4.1(II)). However, these increases may be small and their significance depends on the details
of the cost function: hence the need to consider explicit forms, as we do in the next section.
4.2.2 Cost: an effective mitochondrial energy-based cost function
Having compared various statistics of different functional forms of control, we want to in-
vestigate their different energetic burdens which requires the construction of a cost function.
Therefore, we attempt to build a cost function that assigns a cost to a given mtDNA state
(w,m) and allows a general quantitative investigation of the tradeoffs in maintaining cellular
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λ(w) λ(m) λ(w,m) (including λ(w +m))
σ2w(t)
µ
∂wλ
(
e2wss∂wλt − 1
)
2 wssmssµ(wss +mss)t+ · · ·
2µmsswss(wss+mss)
(mss∂mλ+wss∂wλ)
2 (∂mλ)
2 t+ · · ·
σ2m(t) 2
mss
wss
µ(wss +mss)t+ · · · µ∂mλ
(
e2mss∂mλt − 1
)
2µmsswss(wss+mss)
(mss∂mλ+wss∂wλ)
2 (∂wλ)
2 t+ · · ·
σ2h(t)
2msswssµ
(mss+wss)3
t
Table 4.2: Analytical expressions for the means and variances according to the linear noise approxima-
tion. Solutions are shown for wildtype, mutant, and heteroplasmy variances for various types of control. Dots indi-
cate constant or exponentially decaying terms; full solutions are given in Section C.1.5. Note that the initial rate of
increase of heteroplasmy variance only depends on mtDNA copy number and turnover (see also [101]).
mtDNA populations. The ‘true’ energy budget of a cell with a given mitochondrial popula-
tion is highly complex, involving many different metabolic processes in which mitochondria are
involved [4–6]. We provide a simpler description, focussing on ATP production as a central
mitochondrial function, and removing kinetic details in favour of a coarse-grained representa-
tion, to provide qualitative rather than quantitative results. We aimed to make most of our
parameters biologically interpretable.
4.2.2.1 General cost function structure
Three important terms involved in the energy status of a cell are: i) the energy demand D,
ii) the net energy supply S, and iii) the efficiency with which the energy is supplied. Here we
define efficiency as the amount of energy that is produced per unit of resource consumed. For
this study, we focus on mitochondria as the central bioenergetic actors in the cell, with wildtype
and mutant mitochondria consuming resource and producing energy currency.
We express our effective cost function as:
C(w,m) = |D − S(w,m)|+ α(wrw +mrm) (4.3)
where α is a constant, and ri gives the rate of resource consumption of a mitochondrion of type
i (w or m). The second term assigns a cost to the usage of resource. The terms in this cost
function are expressed as rates: S and D then correspond to net energy production (supply)
and demand per unit time. The demand can be considered to represent energy requirements
of all cellular processes besides mitochondria (whose costs are incorporated in their net supply
S(w,m)), which we assume to be constant. We are therefore modelling post-mitotic cells in
stable environments, as demands are expected to change throughout the cell cycle. This cost
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function assigns the lowest cost to a state that satisfies demand in the most efficient way, and
both an excess or deficit of supply are penalised.
The net energy production of a state (w,m), S(w,m), is modelled as
S(w,m) = w
(
sw(rw)− ρ1
)
+m
(
2sw(1rw)− ρ1
)
− (w +m)
(
ρ2λ+ ρ3µ
)
(4.4)
where ρ1,2,3 are mitochondrial maintenance, building, and degradation costs, sw(rw) denotes
the energy production rate (per second) for a single wildtype mitochondrion given a resource
consumption rate rw (Methods, Section B.3), and λ and µ (which can be functions of w and
m) denote the birth and death rates in units per second. Mutant mtDNA molecules are
distinguished by the parameters 1, 2 ∈ [0, 1] describing the mutant resource uptake rate (1)
and efficiency (2) relative to that of the wildtypes. A low 1 could represent reduced flow
through the electron transport chain due to e.g. damaged respiratory complexes, whereas a
low 2 could denote increased proton leakage.
The more detailed structure of our cost function, which has been very general so far, comes from
specifying the relation sw(rw). In other words, how does the energy output of a mitochondrion
depend on its resource consumption rate? Various experimental studies find this relation to be
linear [295–297]. However, we have several reasons to consider an additional relation. Firstly, a
linear function si(ri) implies that mitochondrial energy production rate increases forever with
increased resource consumptions rates, whereas it may seem more natural for si(ri) to saturate
at high ri. Secondly, a linear si(ri) means that the lowest cost is assigned to a state which
satisfies demand with a minimally required number of mitochondria, all using their maximum
resource consumption rates (Section B.2). Such a state, however, is not robust to fluctuations
in both mitochondrial copy numbers and demand. Moreover, mitochondria are known to have
large spare capacities [298, 299] indicating that in resting state they do not operate near their
limits. A saturating function si(ri) solves these issues (Section B.2).
We thus consider two different types of cost function, which we refer to as the ‘linear output
model’ and the ‘saturating output model’. We compare these two models qualitatively, as we are
mainly interested in how a saturating output function, which is arguably more natural, affects
the qualitative structure of both the cost function as well as optimal control strategies. We
fitted the parameters of the linear output model using data provided in Ref. [295] (Section B.2),
and set the parameters of the saturating model such that the two models behave similarly at
low ri. Further details on the choice of parameter values, and their biochemical interpretations,
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are given in Section B.3; default values are provided in Table 4.3.
We will assume that the cell acts to minimise cost, meaning that we consider the wildtype
steady state copy number (in the absence of mutants) to be optimal. Throughout most of this
chapter, we therefore refer to Nss (introduced in the thesis introduction) as wopt. We consider
two different cost function parameterisations for both the linear and saturating output models,
one for high and one for low copy number cells, meaning we investigate four different systems
in total, each with their own value of wopt (Table 4.3).
4.2.2.2 Intermediate heteroplasmies may be inefficient and resource avail-
ability can dictate the cost of mtDNA states
Figure 4.2 shows heatmaps of the cost function in (w,m) space for different mutant pathologies
(here modelled as different values of 1). We observe clear qualitative differences in cost function
structure between the saturating and linear output models. In the former, it is possible for
intermediate heteroplasmy states to be more expensive than states homoplasmic for either
species (Figure 4.2A, B). The linear output model, on the other hand, always shows higher
costs at higher heteroplasmy (for fixed total copy number) (Figure 4.2C).
What is the reason behind expensive intermediate heteroplasmies? Increasing heteroplasmy
while keeping total copy number constant can be interpreted as replacing a wildtype mito-
chondrion with a mutant, leading to a tradeoff. The changed mitochondrion (from wildtype
to mutant) produces less energy than before; all other mitochondria need to consume more
resource to maintain a constant total output, and so become less efficient due to output satura-
tion. However, the changed mitochondrion itself has become more efficient because of its lower
resource consumption rate. The tradeoff between these two factors depends on h itself; a more
detailed discussion is given in Section B.4. The result is that in the saturating output model,
it is possible for intermediate heteroplasmies to be the least efficient and the most expensive
(Figures 4.2 and B.4).
How general is the existence of a state with h 6= 1 being more costly than a state with h = 1
or h = 0? When the relation sw(rw) is saturating and mutants use (at any given time) a lower
resource consumption rate than wildtypes, then the mutant species will effectively be more
efficient, leading to the tradeoff discussed above. Therefore, under the above two assumptions
we may expect an expensive intermediate heteroplasmy state to exist. In our specific cost
function, the existence of a high-cost intermediate heteroplasmy value is a relatively general
feature of the saturating output model. We calculated the value of h with maximum cost (at
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Par. Description Default value
D Mitochondrial energy demand in ATP/s. The default values given are in
units of 2.6× 105 ATP/s, as explained in Section B.3.8. We introduce two
values of D, one for high and one for low copy number cells.
5110.7 (high)
1022.1 (low)
R Maximum rate of resource supplied by the cell per second to be used by the
mitochondria. We use the term ‘resource’ as an amalgamation of different
mitochondrial resources, e.g. NAD(H), pyruvate, lactate, succinate, ADP,
Pi, and oxygen. Two different values for R are used, corresponding to high
and low copy number cells.
3800 (high)
760 (low)
φ φ is related to the effective P/O ratio of a wildtype mtDNA molecule, it
represents the slope of the linear relationship between rw and sw given in
equation (B.1).
2.0
β β denotes the resource consumption rate (in ‘resource’ per second) at zero
energy production, and is therefore a measure of proton leak. Because we fix
the maximum resource consumption rate to be 1 (Section B.3.1), β provides
the fraction of resource consumption that is destined for ‘futile’ leakage.
0.1
k Parameter describing the saturation of the saturating model. 3
smax An indication of the aximum energy supplied by a wildtype mtDNA
molecule in the linear model in ATP/s.
1.54
rmax Maximum rate of resource uptake by an mtDNA molecule (i.e. by a mito-
chondrion containing the mtDNA molecule). This can be interpreted as the
maximum flow through the respiratory chain.
0.95
ρ1 The mitochondrial maintenance cost in units of 2.6× 105 ATP/s. 0.04
ρ2 The mitochondrial building cost in units of 2.6× 105 ATP. 3828
ρ3 The mitochondrial degradation cost in units of 2.6× 105 ATP. 383
1 The mutant energy production efficiency (the energy produced per unit of
resource consumed) relative to that of wildtype mtDNA molecules. A low
value of 1 can be caused by a high proton leak or a deficient ATP synthase.
free parameter
1 ∈ [0, 1]
2 The mutant resource uptake rate relative to that of wildtype mtDNA
molecules. We will mainly use 1 = 1 and 2 < 1 because mtDNA mutations
usually affect the proton pumping electron transport chain complexes. A
defect in e.g. complex I will reduce its activity and therefore also the rate
of consumption of NADH.
free parameter
2 ∈ [0, 1]
α Scaling parameter in the cost function in front of resource consumption
term.
0.1
wopt The cheapest value for w when m = 0, using all of the above parameter val-
ues. We have four values for wopt, corresponding to the linear and saturating
output models at low and high copy number.
1524 (sat. low)
7616 (sat. high)
638 (lin. low)
3129 (lin. high)
Table 4.3: Parameters used in our mitochondrial cost function with their descriptions. Parameter values
are derived and motivated in Section B.3. In this table, ‘high’ and ‘low’ refer to high and low copy numbers, re-
spectively, and the abbreviations ‘sat.’ and ‘lin.’ are used to indicate our saturating and linear output models.
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Figure 4.2: Intermediate heteroplasmies can be less efficient than either wildtype or mutant homo-
plasmy. A visualization of the cost function in (w,m) space is shown for both saturating and linear output mod-
els, for various mutant pathologies (described by 1). White regions correspond to states in which cellular demand
is not satisfied though cells may still survive by e.g. increasing glycolysis (effectively reducing mitochondrial de-
mand). This figure assumes high copy numbers, results are qualitatively similar for low copy numbers. A) The ma-
genta (solid) and black (dashed) lines show the contour of the demand-satisfying region when demand is increased
by 10%, or demand is increased by 50% and cellular resource availability is increased by 35%, respectively. B) The
orange line corresponds to constant total copy number; moving up along this line increases heteroplasmy. Cells in
region 1 or region 3 are more efficient, and show a lower cost, than cells in region 2. C) The linear mitochondrial
output model does not show a decreased efficiency at intermediate heteroplasmy values.
constant total copy number), denoted by hmax, as a function of several model parameters. We
find that hmax = 1 at values 1 . 0.3 due to very low mutant functionality. However, at higher
values of 1 (1 & 0.5) we find hmax ∼ (0.5 − 0.8) over a large range of several of our cost
function parameters (Section B.4.2). The size of the effect, however, may be small.
It was previously found that it possible for two mtDNA variants in mice to function normally
at homoplasmy, but show deficiencies in heteroplasmic states [140]. We do not claim that our
model is the reason behind these observations, we merely show that it can account for them in
a relatively simple manner. The insights we obtained are that different resource consumption
rates between distinct mtDNA species may play an important role in causing cells heteroplasmic
in two different species (which are functional at homoplasmy) to show dysfunctions. We do
not make any quantitative claims as we appreciate our cost function is phenomenological and
the more detailed aspects of our outputs will depend on the exact structure we have imposed.
It will be interesting to see whether the two mtDNA variants show different levels of oxygen
consumption in heteroplasmic cells, as predicted by our model, though this may be difficult to
measure experimentally.
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4.2.3 Combining cost and control: comparison and optimisation of both cel-
lular control and treatment strategies
4.2.3.1 Timescales and energy sensing in optimal control of mtDNA popula-
tions.
Here we compare the mean cost over time of four different plausible cellular control strategies.
The first two consist of the linear feedback model λ(w,m) = µ+c1(wopt−(w+δm)) with (I) δ = 0
(only wildtypes are sensed) and (II) δ = 1 (total mtDNA copy number is controlled without
differentiating between mutant and wildtype). We further consider two control strategies that
are optimised under our imposed cost function. We identify the optimal parameterisations that
minimise steady-state cost for (III) a linear feedback control and (IV) the ‘relaxed replication
model’ [1, 2]†.
First, we need to choose the parameter values that are not being optimised. We are mainly
interested in how the different controls influence changes in mtDNA dynamics due to the pres-
ence of mutants, and therefore demand that they induce similar dynamics when only wildtypes
are present. We do this by setting the wildtype mean and variance (in the absence of mutants)
to be identical under all controls. The mean is chosen to be wopt and the variance is set by
fixing the parameter αR in the relaxed replication model (see footnote) to αR = 10, as its value
was originally estimated to lie in the range (5 − 17) [1]. Setting αR = 10 then fixes the value
for c1, which is identical for models (I)-(III) (Table B.1). We optimise the parameters δ and η
in models (III) and (IV), respectively.
To optimise a control, both an optimization time-scale T and a set of initial conditions are
required. Here we use T = ∞, corresponding to the steady state limit, and a set of initial
conditions with heteroplasmies in the range h0 ∈ [0, 0.2]; we later consider finite values of T .
Figure 4.3 shows the mean cost of our four controls up to ∼ 80 years resulting from stochastic
simulations; cost variance, as well as mutant and wildtype dynamics, were also computed
(Figure B.6). The relaxed replication rate control and our linear feedback function behave very
similarly when δ and η take their optimal values. A control with δ = 0 shows an exponential
increase in cost (due to an exponential increase in mean mutant copy number (Chapter 5)),
†The relaxed replication model assumes a constant death rate µ and a birth rate of the form λ(w,m) =
µ
w+m
(
αR
[
wopt − (w + ηm)
]
+ w + ηm
)
with αR > 1 and η constants [1, 2]. We have renamed the parameters
of the original model for convenience. Note that both αR and η influence the mutant contribution to λ(w,m)
(rather than a single parameter in our linear model).
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Figure 4.3: A control that senses no mutations shows an exponentially increasing cost, which is most
noticeable in low copy number cells. A) + B) Here we show the mean cost (3 × 104 repeats) for the following
four controls: linear feedback controls λ(w,m) = µ + c1(wopt − (w + δm)) with I) δ = 0, II) δ = 1, and III)
δ = δopt, and IV) the optimised ‘relaxed replication control’ [1, 2]. Controls were initialised in steady state at
h0 = 0.15. Both figures used the saturating output model; figures (A) and (B) correspond to low and high copy
number cells, respectively. We used 1 = 0.3; other control parameters used are specified in Section B.4.3. C) A
control based on sensing mitochondrial energy output may be generally a good strategy. This plot shows
the optimal value of δ in our linear control as a function of 1, for the linear and saturating model and for both low
(h0 = 0.1, solid line) and high (h0 = 0.8, dashed line) initial heteroplasmies. Here we used T = 100 and high copy
number values for both models. Similar plots for T = 104 are shown in Figure B.7, Section B.4.3.
though it still takes ∼ 12 years and ∼ 65 years for this control to become 10% more expensive
than the others in our low and high copy number cells, respectively. We conclude that: i) a
control lacking any mutant contribution only becomes notably costly on the order of 10 years,
and ii) effects of particular control strategies are more pronounced in low copy number cells
(Table 4.1(III)).
We now investigate how the optimal value of mutant sensing for the linear control (δopt) depends
on timescale T , initial heteroplasmy h0 and the ‘mutant pathology level’ described by parameter
1. Biologically, this question reflects how the cell should optimise its processing of mtDNA
state as the mutant load and severity changes. Intuitively, values of 1 ' 1 have δopt ≈ 1: when
wildtypes and mutants are equivalent, having a steady state with w +m = wopt is desirable.
Values for δopt were found for the linear and saturating model, with low and high initial het-
eroplasmy values, for T = 100 days (Figure 4.3C). Having δ ≈ 1 means wildtypes and mutants
are fed back similarly, whereas δ  1 means mutants are fed back much less. For very deficient
mutants (low 1), a low δopt ensures that wildtype copy number remains close to its optimal
value to compensate for the mutants. Generally, as 1 decreases, δopt decreases. In the linear
model δopt becomes negative for low 1 values; as mutant copy number increases, a negative δ
leads to an increase in wildtype to compensate for the deficient mutants. Similar results are
found for longer timescales T (Section B.4.3).
When mitochondrial energy outputs are sensed, the quantity ‘w + δm’ can be considered to
represent the cellular energy production rate. A mutant with a low value of 1 is less able to
produce energy, and would automatically obtain a low value of δ as it contributes less to the total
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energy production rate. This means that in the setting of energy sensing, the relation between
1 and δ automatically obeys the trend shown in Figure 4.3C (i.e. δ decreases as 1 decreases).
Therefore, control strategies based on the energy status of the cell will often outperform controls
based on mtDNA copy number (which always have δ = 1) or sensing mtDNA mass (which would
work well for deficient deletion mutants, but would be suboptimal for deficient point mutations)
(Table 4.1(IV)).
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Figure 4.4: Locally optimal controls show nonlinear behaviours close to demand-satisfying regions, but
linear optimal dynamics far away from these regions. We used streamplots in (w,m)-space to visualise the
dynamics resulting from a locally optimal control, for various parameters of 1. At each point, arrows show the
direction corresponding to the largest decrease in cost. Regions are coloured according to the magnitude of the
decrease in cost when moving in the optimal direction. Black arrows illustrate general trends in these regions.
A) Region (1) shows that at high copy numbers, both mutant and wildtype mtDNAs should be decreased in an
evenhanded manner; region (2) shows the possibility that the optimal control involves an increase in mutant copy
number. B) A higher value for the parameter 1 is used, meaning mutants are less pathological. C) the locally
optimal control for the linear output model more closely resembles a linear control. In both (A) and (B) we see a
divergence point (red asterisk) illustrating the fact that both high mutant and high wildtype states constitute local
attractors of low cost (as in Figure 4.2).
Locally optimal control strategies map the control space of mtDNA popula-
tions.
With the use of our cost function it is possible to identify locally optimal controls : controls
that, for each state (w,m), move the system in the direction of the largest decrease in cost.
The dynamics resulting from these locally optimal controls are shown in Figure 4.4.
When heteroplasmy is high, the main priority is not always to decrease mutant copy number,
but to increase wildtype copy number even if this means an increase in mutant load (region 2
in Figure 4.4A). It is only after wildtype copy number has sufficiently increased that the focus
should be on decreasing m. At high copy numbers the optimal dynamics are to decrease all
mtDNA in an evenhanded manner (region 1) rather than decreasing m at a faster rate than
w. For the saturating model, we also observe a divergence point in the space of local optimal
strategies, reflecting the two local cost minima (high wildtype and high mutant) observed earlier
(Figure 4.2). Hence, there are several regions of state space where even for pathological mutants,
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reduction of mutant mtDNA alone is not always the optimal control strategy (Table 4.1(V)).
Finally, the less pathological the mutants become (e.g. Figure 4.4B), the more the locally
optimal control starts to resemble a linear control. In the linear output model, the optimal
control always shows linear behaviour (Figure 4.4C).
4.2.3.2 A parameterised model of artificial mtDNA control for disease treat-
ment
While the locally optimal controls identified above may not be achievable by the cell (for exam-
ple, the cell may not be able to decouple biogenesis of wildtype and mutant mtDNA), genetic
technology gives us the ability to artificially exploit these optimal strategies. Mitochondrially
targeted Zinc Finger Nucleases (mtZFNs) [142, 143, 293, 300, 301] and mitoTALENs [144, 292]
are able to produce shifts in heteroplasmy by specifically cutting mutant mtDNA; these tech-
nologies thus offer the prospect of gene therapeutic treatments for some mitochondrial diseases.
Though results are promising, treatments with endonucleases are not perfect and can have sub-
stantial dose-dependent off-target effects [142].
To develop predictive quantitative theory to understand and tune the effects of these interven-
tions, we model nuclease transfection as inducing selective increases in mtDNA degradation,
on the background of the linear cellular feedback control used throughout this chapter. Our
transfection model introduces three new parameters describing strength (I0), duration (b), and
selectivity (ξ) of nuclease treatment. We assume that for every mutant that is cleaved by the
endonucleases, ξ wildtypes are cleaved. For example, when ξ = 1 there is no distinction be-
tween mutants and wildtypes, and when ξ = 0 there is no off-target cleavage. We fit these
treatment parameters, as well as our feedback control strength parameter c1, to recently ob-
tained experimental data [142]. These data involve heteroplasmy and mtDNA copy number
measurements during iterative treatments with mtZFNs of 80% heteroplasmic human osteosar-
coma 143B cybrid cells. Four sequential cycles of transfection and recovery were performed,
where each recovery period lasted 28 days [142].
Our nuclease treatment model is a work in progress. We initially fitted our parameters using
simulated annealing, an approach which provides an approximation to the global optimum of a
function but does not provide information on parameter uncertainties. We decided to improve
our parameter estimates by using a Metropolis sampler, thereby obtaining posterior parameter
distributions. One limitation of our analysis is the little amount of data we currently have. At
this moment, more data is being collected (for details see below) to improve future model fits.
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Simulated annealing provides good point parameter estimates
Here we use simulated annealing to produce a point estimate of the parameters I0, b, ξ, and
c1 (Methods). Results are shown in Figure 4.5A, B, illustrating the ability of this simple
model to capture the dynamics resulting from nuclease activity. The first mtZFN treatment
experimentally shifted heteroplasmy from approximately 0.8 to 0.6 [142], meaning we expect
the selectivity parameter ξ to be about ξ ∼ 0.6/0.8 = 0.75, agreeing with our predicted value
of ξ ≈ 0.76. We note that we imposed a periodicity of 28 days in our model (Equation (4.11)),
representing the experimental protocol.
Nuclease treatment and a subsequent recovery phase will have the net effect of mapping an
initial heteroplasmy value hi to a mean final heteroplasmy value, hf . We simulated this mapping
of initial to final heteroplasmy values in the presence of cellular feedback control (Figure 4.5),
and observed that the heteroplasmy shifts are similar in low and high mtDNA copy number
cells (the variance of the shift is slightly lower for high copy number cells), and that the shift is
largest for intermediate heteroplasmies. Interestingly, for high h values, it is possible to end up
with a higher heteroplasmy value after treatment, especially if ξ ' 1 (Figure B.8).
A) B) C)
Figure 4.5: A simple model of treating cells with mitochondrially targeted endonucleases captures exper-
imental observations of cellular mtDNA statistics. A, B) Our treatment model was used to fit recent exper-
imental data [142], good agreement was found for both deterministic and stochastic simulations; details about the
fitting produce are given in Methods. The periodicity of our model is fixed to represent experimental protocols of
sequential rounds of transfection and recovery (Methods). Vertical dashed lines indicate transfection events (once
every 28 days). C) A given initial mean heteroplasmy value maps to a final mean value after a round of treat-
ment and recovery. Stochastic simulations were performed for both low (blue, 1000) and high (green, 5000) copy
number cells. The orange line denotes identity, and the purple trajectory shows heteroplasmy shifts for multiple
treatments starting at h = 0.8. Further details of the fitting procedure are given in Methods.
Knowledge of the heteroplasmy distribution of a tissue is important in de-
terminining how effciently the tissue can be treated.
To explore the effect of the heteroplasmy distribution on treatment efficacy, we consider three
different initial h distributions with different heteroplasmy variances, but identical homogenate
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A)
B)
C) D) E)
Figure 4.6: Knowledge of the heteroplasmy distribution is important in predicting how efficiently a tissue
can be treated. A, B) The effect of four consecutive treatments on three different initial heteroplasmy distribu-
tions is shown; all initial distributions have identical means (〈h〉 = 0.8) but different variances (increasing from
left to right). The higher the variance of the initial population, the harder to shift mean heteroplasmy values; mean
values after each treatment as well as P (h > 0.6) are shown more clearly in figure (B). In these simulations we
assumed that every cell gets transfected. Gentle but sustained treatments induce larger heteroplasmy shifts
than hard and brief treatments. C) Both the linear and saturating model show a sharp drop in the optimal
treatment strength I0,opt as the mutants become more functional (i.e. as 1 increases). D) Means and variances
of mutant and wildtype copy numbers were simulated during a round of treatment and recovery, using: i) fitted
parameters (blue), ii) a longer treatment duration (smaller b, green) and iii) a higher selectivity (smaller ξ, ma-
genta). The longer weaker treatment induces higher heteroplasmy shifts than the shorter stronger treatment. Not
surprisingly, a higher selectivity also leads to an improved heteroplasmy shift. Note that the variance of the final
values is lower for more selective treatments. Error bars show standard deviations (based on 104 stochastic sim-
ulations), further detailed are given in Methods. E) This figure again illustrates that gentle sustained treatments
lead to larger heteroplasmy shifts. Examples of treatment trajectories are shown; after a single treatment, an initial
heteroplasmy of 0.8 is mapped to 0.53 (short strong treatment) or 0.39 (long weak treatment).
means. We treat these populations multiple times using the parameters fitted through simulated
annealing in the previous section, and observe the shift in heteroplasmy distribution as well as
the change in heteroplasmy mean and the probability of crossing a pathogenic heteroplasmy
threshold P (h > 0.6) (Figure 4.6A, B).
High heteroplasmy variances require many cells close to the two extremes h = 0 and h =
1, which are challenging to shift. A striking reduction in treatment efficacy is predicted as
heteroplasmy variance increases while mean heteroplasmy stays constant (Figure 4.6A, B).
Threshold crossing probability (for example, P (h > 0.6)) also becomes harder to shift at higher
heteroplasmy variance. These differences in treatment efficacy depend on the value of δ (mutant
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sensing) in our model: lower δ will decrease the difference in efficacies. We conclude that
tissues with a high mean heteroplasmy levels will generally be harder to treat if the heteroplasmy
variance is high, especially if this high mean level is caused by a small percentage of cells, with
the strength of this effect dependent on mutant sensing (Table 4.1(VI)).
We can use our parameterised theory to find optimal treatment strengths I0,opt for a given
system. Figure 4.6C shows I0,opt as a function of 1. Intuitively, the strongest treatment
should be given to the least functional mutants, and when mutants are almost as functional
as wildtypes it is preferable not to treat at all. The optimal treatment strength drops rather
sharply as 1 increases, and does so sooner for the saturating model. This last observation
may be because at some point reducing heteroplasmy becomes more expensive as can be seen
in Figure 4.2B. Optimal treatment strengths for longer treatments (higher b) show similar
qualitative behaviour.
Figure 4.6D shows, using the identified values for I0,opt, the trajectories in (w,m) space through-
out a single treatment and recovery phase; we used 1 = 0.3 and the corresponding cost heatmap
is also shown. The three trajectories shown correspond to: i) a short and strong treatment (us-
ing the fitted parameter values), ii) a long and weak treatment, and iii) a short but more selective
treatment. It can be seen that treating longer but weaker results in a lower final heteroplasmy
value than treating short and strong (Table 4.1(VII)). A weaker treatment also reduces the
chance of a cell losing all its mtDNA molecules. Intuitively, a more selective treatment leads
to larger heteroplasmy shifts. The difference in treatment results for long compared to short
treatments is also illustrated in Figure 4.6E. We note that in finding I0,opt, we initialised all
cells at identical states. When a distributions of initial states is used, the variance that is now
present is likely to affect the optimal treatment strength.
A Bayesian model of nuclease treatment
To obtain knowledge of the uncertainty in our parameter estimates, we here use a Markov
Chain Monte Carlo (MCMC) model to fit our parameters (Methods). We note that this work is
motivated by reviewer comments obtained after submission to Cell Systems and is still a work
in progress. New data is currently being collected by our collaborator Payam A. Gammage
which will be incorporated in future versions of the model. This new data consists of: i)
total copy number measurements in the original 80% heteroplasmy cells, and ii) heteroplasmy
measurements at a finer time lattice compared to earlier measurements (which were taken at
1, 18 and 28 days post-treatment).
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The data shown in Figure 4.5A, B was obtained from cells transfected with mtZFNs without
any sorting based on mtZFN concentration ([mtZFN]) [142]. The authors collected similar
data from cells sorted for either low or high [mtZFN] [142], which we did not include in our
previous approach but which we will include in our MCMC model in an attempt to reduce
parameter uncertainty. Instead of a single mtZFN treatment strength I0, we now have a set of
strengths I
(N)
0 , I
(H)
0 and I
(L)
0 referring to ‘normal’ (i.e. unsorted), high and low initial mtZFN
concentrations. Because treatment efficiency was observed to depend on [mtZFN] [142], we also
assume three different selectivities: ξ(N), ξ(H), and ξ(L). The treatment duration b as well as the
cell’s feedback control parameter c1 are assumed to be shared between the three data sets.
Our posterior parameter estimates, obtained using a Metropolis algorithm (Methods), are
shown in Figure 4.8. It is clear that our MCMC model is not mixing properly (reasons for
which are discussed below), meaning our model is not efficiently sampling the available pa-
rameter space and the obtained posterior distributions do not represent the ‘true’ posteriors.
We show (approximate) Bayesian confidence intervals for heteroplasmy and total copy number
during treatment, illustrating that the posterior mean prediction of copy number dynamics is
slightly different from the prediction found through simulated annealing (Figure 4.7); this is
likely due to poor mixing.
From the sample values shown in Figure 4.8 we suspect a high correlation between the treatment
duration parameter b and the treatment strength parameters I
(N)
0 , I
(H)
0 and I
(L)
0 , which is
confirmed in Figure B.9A. This high correlation is due to a degeneracy in our model when
b µz, in which case Equation (4.10), describing mtZFN concentrations over time, reduces to
[ZFN ](t) = I0/b · e−µzt. In this regime, mtZFNs enter the cell in a pulse-like fashion, being
present at concentration I0/b at time t = 0 and exponentially decaying afterwards at rate
µz. A constant ratio I0/b will provide identical mtZFN concentration profiles (and therefore
heteroplasmy and copy number predictions), meaning the parameters I0 and b can be arbitrarily
large under our model as long as their ratio is conserved‡. The ratio I0/b, as expected, is higher
in the case of higher mtZFN concentrations (Figure B.9B).
The poor mixing of our MCMC model can be due to a variety of reasons. Firstly, we might
not have performed enough iterations. Iterations of our model are expensive because at each
iteration we numerically solve three ODE systems corresponding to the normal, high and low
parameter sets (Section 4.4). Due to a lack of time we have currently only performed 3 × 105
iterations (requiring ∼ 1.5 days), but this number can be increased by an order of magnitude
‡The parameter I0 and b cannot become arbitrarily small because in this case the condition b µz fails to
hold, meaning that changing b (and I0) influences the mtZFN dynamics and therefore our model predictions.
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in the future. Secondly, the degeneracy in our model (discussed above) is likely to reduce the
mixing efficiency. We may need to redefine our parameters or reconsider our nuclease model
to eliminate the degeneracy. Further improvement may be obtained by including the new data
that is currently being collected.
In conclusion, we have performed Bayesian inference to learn about the uncertainties in our
parameter values. As the current status of this model is not final, and our obtained posteriors
are only approximate, we cannot draw definite conclusions from our inference yet. However, we
were still able to predict some expected results, including a higher selectivity (Figure 4.8) and
lower treatment strength (Figure B.9B) for the low nuclease concentration setting compared to
the high concentration setting. Furthermore, we discovered a high (unsurprising) correlation
between treatment strength and duration (Figure B.9A).
A) B)
Figure 4.7: Bayesian confidence intervals for heteroplasmy and copy number dynamics. We inferred our
model parameters using recently observed experimental data [142] (Section 4.4) and use posterior samples to ob-
serve data fits. We note that four extra data points on total copy number (which are not shown in Figure 4.5B)
were provided by Payam A. Gammage. A) Drawing from our posterior distributions, we show the mean and 50%
and 95% confidence intervals of our heteroplasmy dynamics predictions during four rounds of treatment and re-
covery. Deterministic simulations were used. The dashed green line indicates predictions made through simulated
annealing (i.e. this line is identical to the deterministic trajectories shown in Figures 4.5A,B). Crosses indicate data
points. B) Similar to figure (A), but showing relative total copy numbers.
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Figure 4.8: Posterior mtZFN treatment parameter distributions. Here we show our posterior distributions
obtained after running our MCMC algorithm for 3× 105 iterations (left) as well as the corresponding sample values
(right). Our chains mix poorly, especially for the parameters I
(N)
0 , I
(H)
0 , I
(L)
0 and b, which show high correlations.
Priors distributions are provided in Methods.
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4.3 Discussion
In this work, we have built a quantitative theory bridging stochastic optimal control, costs of
mtDNA populations, and gene therapies. Our results contribute to a growing body of evidence
[32, 107, 302, 303] that the variance of mtDNA populations has important physiological and
therapeutic implications independently of mean heteroplasmy, and underline that stochastic
theory is required to understand this biologically and medically important quantity. We com-
pared different cellular strategies of regulating the mtDNA population by studying wildtype
and mutant mean and variance. We found that there exists a tradeoff between controlling one
species, or controlling the other. We introduced a mitochondrial energy-based cost function
enabling us to compare distinct control mechanisms and found that a control based on the
energetic status of the cell forms a good strategy in many situations. Recent experimental
data [142] was used to fit a therapeutic treatment model in which cells are transfected with
mitochondrially targeted endonucleases. We showed that long gentle treatments induce higher
heteroplasmy shifts than brief strong treatments, and that tissues with high heteroplasmy vari-
ances can be particularly hard to treat.
We appreciate that our cost function is phenomenological and contains many parameters. We
would argue, however, that most of these are biologically interpretable meaning their values
can be obtained or estimated from the literature. The main elements in our cost function are
quite general: terms involving supply, demand, and resource. We stress that we do not make
any quantitative predictions based on our cost function, but merely comment on its general
qualitative features. One interesting insight we obtained is that intermediate heteroplasmy
states may be the most expensive due to a combination of output saturation and lower resource
consumption rates of one of the mtDNA species. Experimental evidence for dysfunctional
heteroplasmic states (with normal functioning at homoplasmy) was found in mice [140]. As
mentioned before, we do not claim to have explained this effect, we only conclude that mutant
resource consumption rates may play important roles.
If the parameter δ is low, i.e. mutants are sensed less, mutant copy numbers at high hetero-
plasmies will be higher than wildtype copy numbers at low heteroplasmies. Experimentally,
it has been observed that heteroplasmic cells can have total mtDNA copy number values that
are 5-17-fold higher compared to cells homoplasmic in wildtype [97, 304–306]. The cell has
somehow allowed these mutants to expand, which may mean that they are less tightly con-
trolled; controls based on total energy output or mtDNA mass (which can result in δ < 1)
may lead to such behaviours. A control on mtDNA mass could explain why deletion mutants
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are often seen to expand [307, 308] and would also predict normal copy number levels in cells
harbouring mtDNA point mutations. Recently, it was found that samples with mtDNA indels
had very high mtDNA copy number levels, but single nucleotide variants did not [309]. The
cellular control mechanism could also be a mixture of copy number control, mtDNA mass con-
trol and energy sensing, meaning that mutations with different functionalities and masses all
have different values for δ and expand to different extents. In the next chapter, we continue the
discussion on the influence of δ and show that low-δ mutants can preferentially expand during
ageing.
We showed that heteroplasmy distributions in cell populations can provide important infor-
mation about the possibility of successfully treating these cells with endonucleases. A tissue
may be harder to treat if its high mean heteroplasmy level is caused by a small percentage
of dysfunctional cells. Experimental values of mean homogenate heteroplasmy in heart tissue
of patients with the 3243A>G mutation are roughly around 0.8 (though ranges can be large
[310–313]) and muscle tissue often shows mosaic structures, with deficient patches of cells ad-
jacent to healthy cells. These examples show that it may be that, at least in some cases, high
mean levels are indeed caused by a relatively low percentage of cells, meaning that there are
still challenges ahead for efficiently treating these tissues.
One of the features of our cost function is that resource limitations play an important role
in shaping the cost landscape. There are indications that cellular levels of NAD (a coenzyme
involved in OXPHOS) are limiting, and that a sufficient supply of NAD to mitochondria be-
comes critical [314–317]. An increase of intracellular NAD can lead to an increase in oxygen
consumption and ATP production [317] indicating that resource limitation may, at least in
some cases, be a genuine constraint. Adding various kinds of resources can significantly change
mitochondrial basal respiration rate [318–320].
We found that, under our model, it is more optimal to sense mutants to a lesser extent if the
mutants have a lower energy output. In this way, their presence has little influence on wildtype
copy number dynamics which then allows the wildtype mtDNA molecules to remain close to
their ‘natural’ (and assumed to be close to optimal) levels. This makes a control directly based
on the energetic status of the cell a good strategy. Measurements of mutant as well as wildtype
copy number values for different types of mutants, together with their energetic functionality,
are helpful for improving our understanding of the cell’s control mechanisms.
In modelling gene therapies, our fit to endonuclease data obtained through simulated annealing
yielded a high off-target cutting estimate, ξ = 0.76, which may be a result of a relatively
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high nuclease concentration in experiments: lower or even higher mtZFN concentrations were
experimentally observed to produce larger or smaller heteroplasmy shifts, respectively [142]. If
the parameter ξ is a function of the treatment strength I0, the values for I0,opt we found in Figure
4.5F will be different. We note that the value of ξ itself does not necessarily determine how
effective a treatment will be. For example, even if ξ = 0.95 a long enough treatment is likely to
eliminate all mutant species (unless the initial heteroplasmy was so high that wildtypes reach
extinction during treatment) because a slight selection against mutants can, for long times, still
lead to their extinction. Further work on the relationship between I0 and ξ will elucidate more
clearly the tradeoff between treating with a high strength and cleaving more mutants in the
process, and having a high selectivity and therefore low off-target cleavage.
Besides our simulated annealing approach, we used a Metropolis algorithm to fit the endonu-
clease data [142]. Using this model we were able to demonstrate an expected high correlation
between treatment duration and strength, introducing a degeneracy in our model which po-
tentially led to the poor mixing of our MCMC chains. The current status of this model is not
final and may be improved by increasing the number of MCMC runs, reconsidering our mtZFN
concentration model, and including new data.
Like any other model, our models have a defined range of applicability. A key baseline as-
sumption was using identical replication and degradation rates for mutants and wildtypes. As
discussed in the thesis introduction, various possibilities of distinct rates have been offered in
the literature, including faster mutant replication rates [38, 93, 94, 96, 97, 321], lower mutant
degradation rates [99], and higher mutant degradation rates [59, 191]. Including such differ-
ences, and other features such as de novo mutations, degradation control, and cell divisions
[31, 32, 101, 108], constitute natural extensions to our theory.
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4.4 Methods
Wildtype and mutant mtDNA evolution equations Wildtype and mutant mtDNA copy
numbers are considered to have birth rate λ(w,m) = µ+ c1(Nss− (w+ δm)) and death rate µ,
leading to the following evolution equations:
dw
dt
= w(λ(w,m)− µ)
dm
dt
= m(λ(w,m)− µ) (4.5)
We refer to Nss as wopt, the ‘optimal’ wildtype steady state which is present in the absence
of mutants. Though these deterministic equations are analytically solvable, the correspond-
ing stochastic system does not have an explicit solution due to nonlinearities. All stochastic
simulations in this chapter use the Gillespie algorithm [127].
Expected cost per unit time. Let the cost per unit time of state (w,m) be denoted by
Λ, and the cost corresponding to the steady state (wss, mss) by Λ¯. Even if steady state copy
numbers are constant over time (i.e. the mean values of w and m are always equal to wss
and mss) the mean cost per unit time is generally not equal to Λ¯. By performing a Taylor
expansion, the mean cost per unit time can be written as follows:
E[Λ](t) ≈ Λ¯
+
1
2
(
var(w(t))
∂2Λ
∂w2
+ var(m(t))
∂2Λ
∂m2
+ 2cov(w(t),m(t))
∂2Λ
∂w∂m
)
(4.6)
where E[Λ](t) is the expected cost per unit time given that the trajectory starts in state
(wss,mss), and all partial derivatives are evaluated at steady state.
Cost function structure. We assume that the net energy supply per unit time in a state
(w,m), called S(w,m), involves the following four terms: (i) the energy output per unit time
(si) produced by the mitochondria; (ii) a maintenance cost per unit time (ρ1) to maintain the
mitochondria, as their presence imposes some energetic cost (e.g. mRNA and protein synthesis);
(iii) a building cost (ρ2) for the biogenesis of new mitochondria; and (iv) a degradation cost
(ρ3) to degrade mitochondria. We will assume that every mtDNA molecule is associated to
a particular amount of mitochondrial volume which we refer to as a ‘mitochondrion’ (Section
B.3).
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At any time, mitochondria experience a certain energy demand and to meet this demand they
need to have a certain resource consumption rate ri (where i = w,m refers to wildtype or
mutant). Here we use the term ‘resource’ as an amalgamation of the substrates used for the
oxidation system. We need to specify the relationship between the power supply (si) and the
rate of resources consumed (ri) by mitochondria. We use two different models si(ri) which are
justified in Section B.2:
sw(rw) = φ(rw − β)
sw(rw) = 2
smax
1 + e−krw
− 1.1smax (4.7)
where φ, β, k and smax are constants respectively describing the mitochondrial efficiency, a
basal proton leak-like term, the saturation rate of the efficiency, and the maximum energy
production rate (Section B.3).
We assume that pathological mutants can have a deficient electron transport chain (which may
support a smaller flux leading to a lower resource consumption rate for mutants and therefore
a lower ATP production rate) and a lower energy production efficiency:
sm(rm) = 2sw(1rw) (4.8)
Here, 1, 2 ∈ [0, 1] describe the mutant resource uptake rate and the mutant energy production
efficiency relative to that of a wildtype, respectively. In the main text we set 2 = 1; other
values of 2 are discussed in Section B.3.7.
The mitochondrial maintenance cost is denoted by ρ1 and corresponds to the energetic cost
required to maintain the mitochondrion that contains the mtDNA. This energetic costs involves
factors like the synthesis and degradation of mitochondrial proteins and enzymes. We assume
the maintenance cost is the same for wildtype and mutant mitochondria (though for some
mutations this is quite possibly not the case). The net energy supply per unit time, S(w,m),
then follows as Equation 4.4.
To determine the value of rw for a given state (w,m), we first check whether the demand D
(which we assume is a constant) can be satisfied in this state. If it can, we set equation (4.4)
equal to D and solve for rw, i.e. we assume that if possible, the mitochondria will exactly
satisfy demand. It may, however, not be possible to satisfy demand, which can be because of
two reasons: i) there are not enough mitochondria present to produce enough energy, or ii)
there is not enough resource available to meet demand. In the former case, we set rw = rmax;
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the mitochondria work as hard as possible to keep their energy output closest to demand. In
the latter case, we assume that the total available amount of resource, R (which we consider to
be constant), is shared equally between the mitochondria: rw =
R
w+1m
. Cellular energy demand
will naturally fluctuate over time, and because of excess capacity of mitochondria [322], there is
no need to immediately increase mitochondrial biogenesis. In our model, a given state (w,m)
may be able to satisfy a range of demands by changing its resource uptake rate. Further details
of the cost function are given in Sections B.2 - B.4.
The parameters used in our cost function are summarised in Table 4.3 and motivated in Section
B.3. Despite our model being simple, most parameters are biologically interpretable.
Modelling control through mitochondrially targeted endonucleases. Experimentally,
cells are transfected with two mtZFN monomers: one which binds selectively to mutant mtD-
NAs, and one that binds mutants and wildtypes with equal strength [301]. We simplify this
picture by assuming an ‘effective’ mtZFN pool and use [ZFN ] to denote its concentration. The
increase in mtDNA degradation rate is then assumed to be proportional to [ZFN ].
Nucleases are imported into the cell and then degrade over time, meaning that their concen-
tration in the cell (and in the mitochondria) may be approximated by an immigration-death
model. This leads us to the following equation:
d[ZFN ](t)
dt
= I(t)− µz[ZFN ](t) (4.9)
where I(t) and µZ are the immigration and death rates of the effective mtZFN pool, respectively.
In the recent experiments [142], nucleases are expressed for short times meaning that the
immigration rate will increase sharply at the start of the treatment after which it decreases over
time, and we have chosen to model I(t) as an exponentially decaying function, I(t) = I0e
−bt,
where I0 is the initial rate right after the treatment is started and b is a constant describing
the duration of the treatment. The mtZFN concentration now becomes
[ZFN ](t) =
I0
µz − b
(
e−bt − e−µzt) (4.10)
which is shown for various parameter values in Figure B.8A. The data we use to fit our models
concerns heteroplasmy and total copy number measurements over four rounds of treatment,
each treatment consisting of mtZFN transfection followed by a 28-day recovery period. During
this recovery period, total copy numbers recover their initial values due to cellular feedback
control. We assume our mutant and wildtype mtDNA death rates at any time t (measured in
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days) to be given by
µ(t)m = µ+
I0
µz − b
(
e−b(t mod 28) − e−µz(t mod 28))
µ(t)w = µ+ ξ
I0
µz − b
(
e−b(t mod 28) − e−µz(t mod 28)) (4.11)
where µ denotes the normal baseline mtDNA degradation rate, 0 < ξ < 1 indicates how selective
the treatment is (if ξ = 1 no distinction is made between w and m, if ξ = 0 no extra wildtype
cleavage occurs during treatment), and ‘mod’ refers to the modulo operator.
Model fits using simulated annealing. To fit our nuclease model to recently obtained
experimental data [142] we use Equations (4.5) with our linear feedback control to model
mutant and wildtype dynamics, where the constant death rate µ is now replaced by the time-
dependent death rates µ(t)w or µ(t)m (Equations (4.11)) for wildtype or mutant molecules,
respectively. These new evolution equations incorporate the cellular feedback control as well
as the nuclease treatment which occurs in cycles of 28 days. We assume δ = 1 because total
mtDNA copy numbers were observed to be independent of heteroplasmy [142]. The mtZFN
degradation rate was assumed to be µz = ln(2) day
−1, corresponding to a half-life of 1 day.
This roughly matches the experimental observation that almost no mtZFN was present 4 days
post-transfection (with a half-life of 1 day, only 6% of initial copy numbers remain after 4 days).
We fitted four parameters in total: I0, b, ξ and c1.
Given a set of parameters, we numerically solve the ODEs describing mutant and wildtype
dynamics over a period of 112 days (i.e. four treatments), and calculate the mean-squared-error
between the observed data yi and our model predictions yˆi, which is given by
∑
i(yi − yˆi)2.
This error is then minimized through simulated annealing, provided an approximate global
optimal parameter set. Because mtDNA copy number in the cells used in the experiment is
not known we performed parameter fits using both low (1000) and high (5000) steady state
copy numbers, modelled as Nss = 1000 or Nss = 5000. The obtained parameter fits are:
(I0, b, ξ, c1) ≈ (38, 12, 0.76, 3 × 10−4) and (I0, b, ξ, c1) ≈ (40, 12, 0.76, 5 × 10−5) for cells with
copy number 1000 and 5000, respectively.
Model fits using Metropolis sampling. We performed our MCMC inference using the
Python package Pymc3, a package designed for Bayesian statistical modelling and probabilis-
tic machine learning. The data we use concerns three experimental conditions (treatments
with ‘normal’, high and low mtZFN concentrations), each of which involves measurements of
heteroplasmy and total mtDNA copy number [142]. We assumed our nuclease model parame-
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ter b (indicating the duration of treatment) as well ast he cellular control parameter c1 to be
shared between all three conditions, but allowed the parameters I0 (treatment strength) and
ξ (treatment selectivity) to vary. This leads to three sets of parameters, used to predict het-
eroplasmy and copy number dynamics in the three experimental conditions: (b, c1, I
(N)
0 , ξ
(N)),
(b, c1, I
(H)
0 , ξ
(H)) and (b, c1, I
(L)
0 , ξ
(L)) where N , H and L refer to normal, high and low mtZFN
concentrations. The parameter ξ is assumed to vary because it was experimentally observed
that treatment with lower mtZFN concentrations were more effective [142].
Like in the simulated annealing approach, we solve the evolution equations (Equations 4.5)
with µ replaced by µ(t)w or µ(t)m, but now we solve them three times using our three different
parameter sets as defined above. This provides us with three sets of heteroplasmy predictions
(all together denoted by yˆ
(h)
i ) and total copy number predictions (all together denoted by yˆ
(T )
i ).
We use a Gaussian error model, i.e. we assume that the observed heteroplasmy y
(h)
i and total
copy number y
(T )
i data are given by
y
(h)
i = yˆ
(h)
i +N(0, σ
2
h)
y
(T )
i = yˆ
(T )
i +N(0, σ
2
T ) (4.12)
where we allow for different noise variances for h and T (in general, different experimental
errors are expected as different methods are used to measure h and T ). A metropolis sam-
pler is then used for parameter estimation. The total number of parameters we infer is 10:
b, I
(N)
0 , I
(H)
0 , I
(L)
0 , ξ
(N), ξ(H), ξ(L), c1, σ
2
h and σ
2
T . Assuming an mtDNA copy number of Nss = 1000
in all the cells, our maximum a posteriori (MAP) estimation is (b, c1, I
(N)
0 , I
(H)
0 , I
(L)
0 , ξ
(N), ξ(H), ξ(L)) =
(15.4, 3.1×10−4, 55.4, 55.8, 36.1, 0.79, 0.88, 0.45). When comparing the estimates in the ‘normal’
setting with the ones found through simulated annealing (with Nss = 1000), we see that ξ and
c1 are very similar and, though both I0 and b were estimated to be higher according to the
MAP, their ratio is similar.
We used the following prior distributions: log-uniform priors for parameters I
(N)
0 (between 0
and 6.5), I
(H)
0 (between 0 and 6), I
(L)
0 (between 0 and 6), b (between 0 and 5) and c1 (between
-11 and -6); uniform priors (between 0 and 1) for the parameters ξ(N), ξ(H), ξ(L); and half-normal
priors for the noise variances σ2h and σ
2
T (with standard deviation 1.0).
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5
Apparent mtDNA selection in models
of random drift
Summary
Mutant mtDNA molecules expand during ageing, reaching high levels in a small fraction of cells
thereby inducing pathology. Understanding how mutant clonal expansion arises is important in
understanding the ageing process as well as disease progression. We deploy a random drift model
of mtDNA dynamics and show that, interestingly, it can give rise to changes in mean cellular
heteroplasmy without explicit selection. We investigate a setting of mtDNA exchange between
cells, relevant in skeletal muscle fibres, which can induce preferential mutant expansion during
ageing even if there is an active process selecting against the mutants. Using experimental data
from skeletal muscle fibres, we estimate that mutant load in aged tissue may be lower than
often assumed in model simulations. Finally, we provide a discussion on the role of random
drift in clonal expansion and suggest experiments to test our model and improve parameter
estimates.
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5.1 Introduction
Mitochondrial diseases are associated with a wide range of phenotypes [323], disorders can
present at any age, and they can involve a single organ or multiple organ systems. This
wide phenotypic variety is partly reflected in the heterogeneous behaviours of different mutant
species. For example, some mutations lead to increases (which can be 2-fold, 3-fold [324],
or even 21-fold [22]) while others lead to decreases in total mtDNA copy numbers [325]. As
mentioned in the thesis introduction, a good understanding of what causes the phenotypic
variety and why certain types are more likely to expand, is lacking.
MtDNA dynamics form a stochastic process and it is well known that models showing neutral
dynamics under a deterministic description can show non-neutral drifts when stochastic noise is
included (see e.g. [326–332]). When multiple species co-exist and have identical birth-to-death
ratios, deterministic treatments lack selection effects whereas a stochastic treatment shows
selection in favour of the slow species which, being less noisy, is more robust to invasions of
other species [327]. In this chapter, we find evidence for stochastic drift in neutral models of
mtDNA dynamics induced by a difference in carrying capacity between mutant and wildtype
species∗. This copy number difference introduces a drift (even with identical birth and death
rates for all species), this time in favour of the species with the highest carrying capacity. Just
like a low-turnover species, a high copy number species has lower variance and is less susceptible
to invasions.
We note that a recent paper studied population dynamics for a more general system (of which
ours is a subset) [328] in a similar setting of different carrying capacities between species. We
confirm some of their observations in our mitochondrial system, and use some of their analytical
results to gain intuition. One of the more interesting results observed by the authors, however,
was not accounted for; we provide a more thorough discussion of this, and expand upon their
work, in Section 5.2.1.4.
In this chapter, we show that, remarkably, the simple linear feedback model introduced in the
thesis introduction can account for a large variety of behaviours observed to be associated with
different types of mtDNA, by changing only the value of δ. We show that a skew in heteroplasmy
dynamics, caused by a nonlinear mapping between (w,m) space and heteroplasmy space due
to different mutant and wildtype carrying capacities, can be reproduced by a diffusion model
∗In this chapter we define the carrying capacity of a species as its steady state copy number in the absence
of any other species. Note that this is slightly different from the more common use of term as a maximum
population size.
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with a heteroplasmy-dependent diffusion coefficient. We investigate the possibility of mtDNA
exchange between cells, a behaviour which has recently been shown to occur across a variety
of cell types [333–335] and arguably forms a natural setting in skeletal muscle fibres (Section
5.2.1.3). Finally, we comment on how our results influence the rate of mutant accumulation
and ageing in skeletal muscle cells. We critique previous mathematical models of mtDNA
dynamics during ageing and discuss how these models can be improved upon by using the
insights developed in this chapter.
5.2 Results
5.2.1 A linear model of feedback control: non-trivial and skewed hetero-
plasmy dynamics
Our aim here is to show how a model without any explicit selection, meaning that mutant and
wildtype mtDNAs are given equal replication and degradation rates, can still give rise to skew
in heteroplasmy distribution. As shown in Chapter 4, and noted in previous studies [1, 2],
changes in tissue homogenate heteroplasmy are expected. Here, however, we observe changes
in cellular mean heteroplasmy. We use the linear feedback model introduced in Section 1.4.4
and mainly focus on a regime with 0 ≤ δ ≤ 1 as this seems to be the most relevant setting in
the context of ageing (Section 5.2.2.1).
However, certain behaviours simply cannot be explained by our simple linear models. For
example, it was observed that mtDNA copy numbers in leukocytes from patients with MELAS
or MERRF syndromes were increased at a young age (< 30), but decreased at an older age
[325, 336] (> 50) (i.e. non-monotonic changes in copy number). Such an effect is possible
by using a quadratic feedback structure (Figure 5.2C), or possibly by using time-dependent
parameters in our linear control.
5.2.1.1 A heteroplasmy-dependent diffusion coefficient leads to heteroplasmy
skew
We first investigate a population of cells in which each cell is initialised with equal mutant and
wildtype copy numbers. When δ = 1 the system is entirely symmetric in w and m, and the
cellular heteroplasmy distribution closely follows a normal distribution (as long as fixation is
negligible) whose variance increases with time (Figure 5.1D, E). For long times, as expected,
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chances of fixation on mutant or wildtype are 50:50. When δ 6= 1, however, asymmetry is
introduced and this is reflected in the heteroplasmy dynamics. Distributions become skewed
and, if δ < 1, the short-time probability of wildtype fixation (h = 0) is larger than mutant
fixation (h = 1) (Figure 5.1D). This is consistent with findings that it takes longer to hit
high than low heteroplasmy values (Figure 5.1A), and the probability flux into the absorbing
boundary h = 0 is, for short times times, much larger that the flux into h = 1 (Figure 5.1C).
For longer times, these asymmetries disappear and the probability of mutant fixation (i.e.
P (h = 1)) is equal to the initial mutant fraction that was present, regardless of the value of δ.
These findings are interesting as it means that if an experiment is set up with cells initialised at
h = 0.5, and single cell heteroplasmy values are measured some weeks later, then consistently
finding more cells homoplasmic in wildtype than mutant does not necessarily imply a selection
advantage of the former. In fact, mean cellular heteroplasmy values remain constant at h = 0.5,
and most cells have heteroplasmy values exceeding 0.5 (Figure 5.1 F, B).
The observed skew can be explained by noting that mutant and wildtype species have different
carrying capacities, which we define as the steady state copy number present in a cell homoplas-
mic in a particular species. Thus, mutants and wildtypes have carrying capacities of Nss/δ and
Nss, respectively (Equation 1.3) (unless δ ≤ 0, in which case a mutant carrying capacity must
be explicitly introduced, as shown in Figure 5.2C). This difference induces a drift along the
steady state line towards the species with higher carrying capacity [328], though the dynamics
in heteroplasmy space can be proven to be purely diffusive [328].
The intuition behind these dynamics is as follows. Due to the lack of selection, we expect
an equal number of cells to fixate on mutant and wildtype species, but a large difference in
carrying capacity means that, when δ < 1, fewer events are required to reach h = 0 than h = 1
(Figure 5.2A). We then might expect a drift along the steady state line towards mutants to
ensure equal fixation, as illustrated in Figure 5.2A. Due to the nonlinear mapping between
(w,m)-space and heteroplasmy space (Figure 5.2B), a small distance in (w,m)-space does not
necessarily correspond to a small distance in h-space. As illustrated in Figure 5.2B, though only
few events are required to go from h = 0.5 to h = 0, the ‘heteroplasmy distance’ is still equally
large as moving towards h = 1. The heteroplasmy dynamics can be described by diffusion with
an h-dependent diffusion coefficient, being larger for low h values. Figures 5.2A,B are purely
shown to gain intuition and do not provide a proof of these mechanisms. However, simulations
of a 1-dimensional random walk with a position-dependent diffusion coefficient can qualitatively
match the asymmetry in boundary fluxes shown in Figure 5.1C (Section C.1.1).
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A) B)
C) D)
E) F)
Figure 5.1: Difference in carrying capacity induces heteroplasmy assymetry. We performed Gillespie simula-
tions (5 × 104 repeats) using the linear replication rate feedback control λ(w,m) = µ + c1(Nss − (w + δm)) with
constant death rate µ. The legend shown in (A) applies to all subfigures. A) Starting simulations at h0 = 0.5, the
mean first hitting times are shown for various h values (error bars are too small to be visualised). When δ 6= 1 one
of the boundaries tends to be hit sooner than the other. B) This shows the probability of passing the initial het-
eroplasmy of 0.5, which first increases and then decreases, unless δ = 1 (blue). C) The flux (i.e. probability mass
per time unit) into the absorbing boundaries h = 0 and h = 1 are shown. They are identical if δ = 1, but when
δ < 1 the flux through h = 0 is largest for short times, but for longer times flux through h = 1 is larger. Only two
parameter sets are shown for clarity, others show similar behaviour. D) + E) heteroplasmy distributions at 500
and 2500 days. The distribution is normal if δ = 1 (in which case there is symmetry in w and m) but asymmetric
otherwise. F) Cellular mean heteroplasmy values remain almost constant.
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Figure 5.2: A nonlinear mapping between heteroplasmy and copy number space. A) This schematic illus-
trates a steady state line with δ = 0.1 which, when starting at the green dot at h = 0.5, shows that the copy
number distance to h = 1 is larger than to h = 0. A drift along the steady state line is required to obtain equal
fixation probabilities at long times. B) Equally spaced heteroplasmy values h = 0.1, 0.2, · · · , 1.0 are shown (dots)
along the steady state lines of controls with different values of δ. When δ < 1 copy number differences are higher
between h = 1.0 and h = 0.9 than between h = 0 and h = 0.1. C) Partitioning the regions in (w,m)-space ac-
cording to the value of δ. This cartoon is an extension of Figure 1.3 in the introduction. The parameters Nss
and Nmax denote the steady state and maximum mtDNA copy numbers, respectively. An example steady state
line of a quadratic control is shown (dashed line), which allows copy numbers to change non-monotonically with
heteroplasmy.
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When δ > 1 all the observations above are reversed, e.g. the heteroplasmy distributions in
Figure 5.1D, E are skewed in the opposite direction, and drift exists along the steady state line
towards the wildtype species. A setting with negative or zero values of δ is more complicated,
as the steady state line does not intersect with the h = 1 axis, and fluctuations along the
line quickly lead to diverging populations. These problems can be overcome by introducing a
maximum mtDNA copy number Nmax, caused by e.g. volume constraints and resource limita-
tions (Figure 5.2C). The results with δ < 0 in Figure 5.1 assume Nmax = 10
4. We have not
investigated the effects of this extra parameter on heteroplasmy statistics, and therefore one
needs to be careful comparing these simulations with ones using δ > 0.
In conclusion, a drift in copy number space can exist without explicit selection and is induced by a
difference in carrying capacities between species. Despite this drift, mean cellular heteroplasmy
values remain constant. What are the biological consequences of these findings? Most mtDNA
mutations that expand during ageing correspond to δ < 1 (Section 5.2.2), a regime in which total
mtDNA copy numbers increase with heteroplasmy. The skew in heteroplasmy distribution for
these type of mutations results, in the short term, in a relatively large fraction of cells crossing a
high heteroplasmy threshold. Though this ‘bias’ disappears at long times, the damage may have
already been done as the severity of pathology depends on the amount of threshold crossing.
It is the heteroplasmy distribution that determines the extent of dysfunctions, and a constant
mean cellular h may be misleading. The effects we have observed are small and more care is
required to determine their contribution to cellular dysfunction, an interesting future avenue
of research.
5.2.1.2 Analytical methods can be used to probe small δ regimes
As seen in Chapter 4, mean mutant and wildtype copy numbers can change over time, even
when trajectories are initialised in deterministic steady states. This is clear from the example
shown in Figure 5.2A: at t = 0 we have 〈m(0)〉 = 〈w(0)〉 = 200, but for long times, when fixation
of one species has occurred, 〈m(tlong)〉 = 1000 and 〈w(tlong)〉 = 100. A change in mean copy
number is not predicted by deterministic analysis, nor by the linear noise approximation [101]
(Chapter 4), but is predicted by considering higher order terms in the system size expansion
(SSE) (Section C.1.5). The linear changes predicted by these higher order terms are accurate for
short times, though cannot describe saturating behaviours which arise due to fixation (Section
C.1.5).
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When mutants are not sensed at all (δ = 0), their numbers can in theory fluctuate off to infinity.
The result is a constant wildtype but exponentially increasing mutant mean (Figure C.2) (with
mean cellular heteroplasmy still constant). This exponential increase can be described by the
higher order SSE if the linear term in 〈m(t)〉 is interpreted as the first term of a Taylor expansion;
results agree well with stochastic simulations (Section C.1.5). Incorporating a maximum copy
number leads to saturation of 〈m(t)〉, though an initial exponential increase is still present
(Figure C.2D). Thus, values of δ close to zero lead to very large increases in mean mutant copy
numbers which in turn increases tissue homogenate heteroplasmy values while cellular mean
heteroplasmy remains constant (Section 4.2.1.1). Increases in homogenate heteroplasmy were
found previously in a setting similar to our low-δ setting [1, 2].
In the case of δ = 0, wildtype dynamics no longer depend on m and this partial decoupling
allows for analytical treatments (Section C.1). Firstly, wildtype steady state distributions
can be calculated numerically giving excellent agreement with stochastic simulations (Figure
C.3). Secondly, time-varying solutions for mutant mean and variance can be approximated
by describing wildtype dynamics by an Ornstein Uhlenbeck process (mean-reverting diffusion)
and approximating wildtype mean and variance using a stochastic Lotka-Volterra (LV) model
(Sections C.1.4 and C.1.2). Results agree well with simulations and predict that 〈m(t)〉 follows
a log-normal distribution (Section C.1.2).
One interesting finding of these analytical treatments is that the stochastic and deterministic
mean steady state wildtype values values do not agree, the former being slightly lower. A
stochastic LV model predicts the following stochastic mean value:
〈w〉ss = 3
4
wss +
1
4
√
w2ss −
8µ
c1
(5.1)
where wss denotes the deterministic steady state (Equation (C.27)). Because the replication and
degradation rates are identical only at the deterministic steady state, the stochastic expected
replication rate is slightly higher than the degradation rate: this is the main reason for the
exponential increase in 〈m(t)〉. A very similar equation for 〈w〉ss is predicted by the higher
order SSE (Section C.1.5.1).
Biologically, a setting with δ being exactly zero seems unrealistic (as it is unlikely mutant
molecules are not sensed in any way), but it may be possible to Taylor expand the obtained
solutions around δ = 0 to obtain insight into a system with δ =  1. This particular regime
is very relevant as many mtDNA deletion mutations are experimentally observed at high copy
numbers (Section 5.2.2.1), corresponding to low δ values.
93
5.2.1.3 MtDNA exchange: a deterministic setting predicts small changes in
mean heteroplasmy
We here investigate the consequences of allowing cells, which have their own internal nuclear
feedback control, to exchange mtDNA molecules with their neighbours. We mainly show results
for 2-cell systems but also provide simulation results for 3- and 5-cell systems. This setting of
sharing/exchange of components is relevant in various biological systems, and is a key element
of the evolution of cooperation [337], examples of which are the production of ‘public goods’ in
yeast [338] and bacteria [339].
In humans, mtDNA exchange likely occurs in skeletal muscle fibres. These fibres are long
multinuclear cells, and it seems reasonable to assume that they contain local mtDNA control
regions. This is supported by findings of isolated patches in which both heteroplasmy and copy
numbers are high, while they are normal outside these patches; it is therefore not the entire
fibre’s mtDNA population that is affected by a local presence of mutant molecules. We argue
that single muscle fibres can be partitioned into ‘cells’ and assume a feedback control acts on
the level of these cells. Because fibres are continuous, mtDNAs are able to move from one cell
to another. Expansion of mtDNAs along fibres was proposed previously [340] and is supported
by findings that regions with high mutant levels tend to spread out along the fibre over time
[85, 341], with the same mutant species being found in the entire region [21, 85, 341]. The
mutant molecules must therefore have moved to neighbouring cells because it is unlikely that
the same mutation event occurred multiple times in different sections of the same fibre region.
We assume a linear feedback control in each individual cell (λ(wi,mi) = µ+c1(Nss−(wi+δmi))
where i denotes the ith cell), as well as a constant rate γ of mtDNA exchange between cells.
The whole system is considered to have fixated on mutants or wildtypes if all cells reach h = 1
or h = 0; an illustration is provided in Figure 5.3.
Deterministically, the dynamics in a 2-cell system are governed by the following set of ODEs:
dw1
dt
= w1c1
(
Nss − (w1 + δm1)
)
+ γ(w2 − w1)
dm1
dt
= m1c1
(
Nss − (w1 + δm1)
)
+ γ(m2 −m1)
dw2
dt
= w2c1
(
Nss − (w2 + δm2)
)
+ γ(w1 − w2)
dm2
dt
= m2c1
(
Nss − (w2 + δm2)
)
+ γ(m1 −m2) (5.2)
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Figure 5.3: A model of interacting cells, allowing mtDNA exchange. We extend the single cell model to an
n-cell model in which mtDNAs are exchanged at a fixed rate γ. Complete fixation has occurred when an mtDNA
species has reached homoplasmy in all cells.
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A) B)
Figure 5.4: A deterministic setting predicts small changes in mean cellular heteroplasmy due to dif-
ferences in carrying capacity. A) When two cells are initialised in a deterministic steady state with hetero-
plasmy values h1 = 0.2, h2 = 0, allowing intercellular mtDNA exchange leads to an increase (using δ = 0) in
mean heteroplasmy. Trajectories are obtained numerically by solving Equations (5.2). Other parameters used are
γ = 0.007, c1 = 10
−5 and Nss = 5000. B) The final steady state heteroplasmy value is shown as a function of
δ using Equation (5.3); parameters used are identical to Figure (A). Mean heteroplasmy is only conserved if δ = 1
(vertical line).
Denoting wi,ss and mi,ss as the wildtype and mutant steady state copy numbers in cell i, the
steady state of the system defined by equations (5.2) satisfies w1,ss = w2,ss, m1,ss = m2,ss and
wi,ss + δmi,ss = Nss. Here we have assumed that the same mutant species is present in both
cells; we later relax this condition and allow de novo mutations over time.
If two independent cells in steady state with heteroplasmies h1 and h2 are brought into contact
with one another, the final deterministic steady state heteroplasmy value (present in both cells)
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can be straightforwardly derived and is given by:
hss =
h1(δh2 + 1− h2) + h2(δh1 + 1− h1)
δh2 + 1− h2 + δh1 + 1− h1
≡ 1
θ1 + θ2
(θ1h2 + θ2h1) (5.3)
where θi = 1 − hi(1 − δ). We thus find that the new heteroplasmy value forms a weighted
average of h1 and h2. When δ = 1, the weights are identical and hss =
1
2
(h1 + h2). However,
when 0 < δ < 1 a larger weight is given to the larger heteroplasmy value, meaning that average
heteroplasmy has slightly increased (Figure 5.4A, B). When δ > 1, the lower heteroplasmy
value is weighted more heavily. The change in 〈h〉 is driven by the difference in carrying
capacities. For example, if δ < 1 the high-heteroplasmy cell has higher copy numbers, leading
to a relatively large flux into the low-heteroplasmy cell. Equation (5.3) does not hold for
all δ < 0 as the weights may become negative. In conclusion, we make the straightforward
observation that during cell equilibration, mean heteroplasmy can increase, decrease or stay
constant in a deterministic setting, depending on the difference in carrying capacity between
the different species.
5.2.1.4 MtDNA exchange: a stochastic setting introduces selection for low-
δ mutants
Extreme regimes: a limited increase in mean heteroplasmy
In a stochastic description, mean cellular heteroplasmy also changes and the rate of change
depends on the relative time-scales of mtDNA exchange between cells and mtDNA turnover
within cells. In the limit of very small γ, it is assumed that both cells reach fixation on either
species before an mtDNA molecule is exchanged. Note that there is no real interaction between
the cells as they both fixate independently. A wildtype molecule entering a fully mutant cell has
a probability of ∼ δ/Nss (its initial fraction) to fixate, whereas a mutant entering a wildtype
cell has a fixation probability of ∼ 1/Nss. A series of coin flips now determines the overall
fixation probabilities when starting with two cells at heteroplasmies h1 and h2, giving:
〈h(tlong)〉 = P (mutant fixation at long times)
=
(δ +Nss)(h1 + h2 − h1h2) + δ2h1h2(1 +Nss)
δ2(1 +Nss) + δ +Nss
(5.4)
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where tlong refers to a long-time limit at which all pairs of cells have fixated (derivation given
in Section C.2.1).
Equation (5.4) has a maximum at δ = 0, namely 〈h(tlong)〉max = h1 +h2−h1h2 (Section C.2.1).
Therefore, in the limit of very slow mtDNA exchange, mean cellular heteroplasmy can never
surpass the sum of the individual heteroplasmies before the two cells were brought into contact.
For example, when a cell with h1 = 0.2 is connected to a cell homoplasmic in wildtype, the
mean cellular heteroplasmy of the combined system cannot surpass 0.2. In the other extreme
limit, when rates of mtDNA exchange are much larger than intracellular dynamics, the system
behaves as a single cell with an effective population size twice that of the individual cells [328];
as expected, values of 〈h(t)〉 remain very close to 1
2
(h1 + h2).
Intermediate regimes: stochastic fluctuations drive up heteroplasmy mean
In the intermediate regime, when rates of mtDNA exchange and turnover are more compat-
ible, bringing two cells into contact initiates the following sequence of events: i) the high-
heteroplasmy cell experiences a decrease in mean heteroplasmy, whereas the other cell expe-
riences an increase, ii) once h1 and h2 have equilibrated, mean cellular heteroplasmy (which
is now present in both cells) continues to change until saturation is reached due to complete
fixation. We stress that this latter observation, which we refer to as a ‘stochastic drive’ in
heteroplasmy, is in contrast both to the deterministic setting (in which, as soon as the two cells
have equilibrated their heteroplasmy values, 〈h〉 remains constant) and a setting with indepen-
dent cells (in which case 〈h〉 always remains constant), and may have implications for mutant
accumulation rates during ageing (Section 5.2.3, Figure 5.8). We stress that though changes
in 〈h〉 were observed in a similar system previously [328], we believe that no account of the
stochastic drive we detect was provided.
When mutants have higher carrying capacity, 〈h(t)〉 increases after equilibration and we observe
that, unlike in the small-exchange limit, cellular mean heteroplasmy values can surpass the sum
of the initial heteroplasmies when mtDNA exchange and turnover rates are comparable, and
can increase even when negative mutant selection is present (Figure 5.5A, C). The effects can
be large, e.g. initializing 2 cells with h1 = 0.1 and h2 = 0 can lead to a four-fold increase in
〈h(t)〉 (from 0.05 to 0.2) (Figure 5.5A). Other parametrisations, however, show much smaller
change in 〈h(t)〉 (Figure 5.5B), meaning care must be taken in interpreting the results. We
discuss biologically relevant parameters in Section 5.2.2.3.
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A) B) C)
Figure 5.5: Stochastic dynamics can induce large increases in mean cellular heteroplasmy, even in the
presence of negative mutant selection that otherwise acts to lower mean heteroplasmy. A) Stochastic
simulations of a multicellular system (104 repeats) show mean cellular heteroplasmy increasing (δ = 0.1) over time
for various values of γ. When more exchanging cells are simulated, 〈h(t)〉 is higher at long times. One cell is ini-
tialised at h = 0.1, the rest at h = 0. µ = 0.07 was used. Decreases in 〈h(t)〉 are expected when δ > 1. B)
Similar to Figure (A) except that a weaker control strength (smaller c1) is used. Unlike the strong-control setting,
a smaller exchange rate gives larger increases in 〈h(t)〉. C) Negative selection against mutants is introduced in a
2-cell simulation by letting wildtype and mutant death rates be µ and µ(1 + ) with  ≥ 0, respectively. Both
without (green) and with a sufficiently small (blue) negative mutant selection, 〈h(t)〉 increases, whereas the neg-
ative selection would induce a decrease in heteroplasmy without mtDNA exchange (red). Other parameters are
δ = 0.1, c1 = 10
−3 and Nss = 500.
We compared 2-cell simulations with 3-cell and 5-cell simulations where each time all cells are
initialised at h = 0 except for one cell at h = 0.1. As expected, when more cells are included
〈h(t)〉 is lower for short times (as e.g. fast equilibration leads to 〈h〉 = 1
3
∑3
i=1 hi = 0.033
in 3 cells vs 1
2
∑2
i=1 hi = 0.05 in 2 cells). However, once appreciable heteroplasmy values are
reached, the stochastic drive in 〈h(t)〉 is exaggerated and final mean heteroplasmy values reach
higher values when more cells are allowed to exchange mtDNAs (Figures 5.5A,B), as long as
the rate of increase of 〈h(t)〉 is non-negligible.
An intuitive reason for the increase in 〈h(t)〉 when δ < 1 is that whenever a fluctuation in
h occurs in one cell, equilibration of heteroplasmies slightly increases the mean as it does
deterministically (Figure 5.4A). An increasing 〈h(t)〉 is then the result of many stochastic up
and down fluctuations. Perturbing the deterministic steady states by randomly introducing
small (symmetric) increases and decreases in h indeed induces increases in 〈h(t)〉, where these
increases are faster with larger perturbations (Figure 5.6A). This suggests a larger heteroplasmy
variance might lead to faster changes in 〈h(t)〉, which is also seen in the stochastic system
(Figure 5.6B). Because at long times h is either 0 or 1, the long-time variance can be written
as var(h) = 〈h〉(1−〈h〉), meaning that we do indeed expect the curves in Figures and 5.6B and
5.5A to show the same ordering at saturation.
The extent to which 〈h(t)〉 increases or decreases depends on a subtle interplay between rates of
mtDNA exchange, turnover, as well as the feedback control strength and δ. Some observations
we made are: i) a tighter control (high c1) leads to larger increases in 〈h(t)〉 (Figures 5.5A,
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A) B)
Figure 5.6: Stochastic heteroplasmy fluctuations induce changes in mean, which are larger when het-
eroplasmy variance is high. A) The deterministic system is perturbed as follows: i) two cells are initialised in
steady state with heteroplasmies 0.1 and 0.05, ii) the final equilibrated hss is calculated using Equation (5.3), iii) a
perturbation +dh or −dh (with equal probability) is applied to one cell, followed by equilibration, iv) if both cells
reach h < 0.001 or h > 0.999 then we assume fixation at h = 0 or h = 1, respectively, after which the sim-
ulation is terminated. The last two step are repeated. Mean heteroplasmy increases over time and does so faster
for larger dh (the observed saturation is caused by fixation). The dashed line indicates mean heteroplasmy without
any perturbations. Error bars denote s.e.m. (5000 repeats). B) Heteroplasmy variances are shown using the same
simulations as presented in Figure 5.5. Note the similarity between these mean and variance simulations.
A) B)
Figure 5.7: Investigating the dependence of heteroplasmy mean on model parameters A) The mean cel-
lular heteroplasmy at long times (t = 96 years) is highest for a strong control (high c1). Here we used 5 cells and
show 〈h〉 = 15
∑
i〈hi〉 with i = 1, · · · , 5 denoting the i-th cell. We note that not all simulations reached saturation
at 96 years. We used µ = 0.07, δ = 0.1. B) Long-time steady state heteroplasmies (in a 5-cell simulation) can be
an increasing or decreasing function of the ratio γ, depending on the control strength c1. For a high degradation
rate (i.e. higher turnover) µ, the increase in heteroplasmy is lower. δ = 0.1 was used.
B and 5.7A), ii) the magnitude of c1 can determine whether the change in 〈h(t)〉 is higher or
lower for high or low γ; for example, the long-time mean heteroplasmy increases with γ for a
strong control, but decreases for a weak control (Figures 5.5A,B and 5.7A, B), and iii) a larger
degradation rate µ (i.e. larger turnover rate) tends to decrease 〈h(tlong)〉 at fixed γ (Figure
5.7B). The absolute change in 〈h(t)〉 is likely some function of all parameters involved and
though we currently do not know this function, some speculations on this topic are made in
Section C.2.2.
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Low-δ mutants preferentially expand during ageing
Finally, we simulated an ageing tissue by initializing all cells at h = 0 and allowing mutants
(with δ = 0.3) to occur during replication. We observe that the more cells are connected, the
faster the rate at which mean heteroplasmy (the mean taken over all cells) increases (Figure
5.8A). Though the initial rate at which mutants reach a high heteroplasmy threshold is lowest
in the 3-cell simulation, it increases quickly and eventually surpasses that of the 1- and 2-
cell systems (Figure 5.8B). Therefore exchange of mtDNAs protects the population from mutant
accumulation in the short term, but leads to more high-heteroplasmy cells in the long term when
δ < 1. The delay in accumulation may be due to wildtype influx of neighbouring cells, and
the eventual higher mutant levels are a combination of the stochastic drive observed earlier, as
well as the effective higher mutation rate (as mutations in any one of the cells has a chance of
expansion). Mutants with δ > 1 will have less chances of expansion for all times.
In all previous simulations we used a single type of mutant with a single δ value. However, at
any time during ageing a mixture of different mutant types may be present. We investigated
this possibility in the simple setting of each mutation having two possible δ values with equal
probability, namely δ = 1 or δ = 0.1. Without any selection or mtDNA exchange, we expect
to observe 〈δ〉 = 0.55 in cells with non-zero heteroplasmy, as is indeed the case (Figure 5.8C).
However, mtDNA exchange leads to lower values of 〈δ〉 (Figure 5.8C), meaning that mutant
species with low values of δ preferentially expand during ageing without an explicit selection
advantage, and do so to a larger extent when more interacting cells are present.
A) B) C)
Figure 5.8: MtDNA exchange induces higher mean heteroplasmy and preferential mutant expansion
during ageing. A) We compared mean heteroplasmy levels (here defined as 1/n
∑
i hi with n the number of
interacting cells) during ageing between i) single cells without interactions, and allowing mtDNA exchange be-
tween ii) 2 cell, iii) 3 cells, or iv) 5 cells. All cells are initialised at (w,m) = (500, 0) and a mutation probability
Pmut = 5 × 10−5 is used (denoting the probability that a wildtype replication event results in mutation). Other
parameters used are µ = 0.07 day−1, c1 = 2.9 × 10−5, Nss = 500 and δ = 0.3. Stochastic Gillespie simula-
tions are performed with 5 × 104 repeats. B) The probability of crossing the heteroplasmy threshold h = 0.6 (for
one individual cell) is shown for the system system in figure (A). The 5-cell exchange system starts off lowest but
then quickly surpasses the others. C) Low-δ mutations preferentially expand during ageing as observed by a drop
in 〈δ〉(t) (which denotes the mean over all cells). Every new mutation was assigned either δ = 0.1 or δ = 1 with
equal probability. The value of 〈δ〉 corresponds to the most abundant mutant.
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To summarise, we found that allowing neighbouring cells to exchange their mtDNA molecules
can qualitatively alter heteroplasmy dynamics. This finding, as well as being interesting in
itself, may have biological implications for the rate of mutant accumulation in ageing tissues,
as discussed further in Section 5.2.3. Our main findings of this section are: a ‘neutral’ model,
with no explicit selective advantage for either species, can i) lead to systematic changes in mean
cellular heteroplasmy, ii) induce heteroplasmy increases even in the presence of negative mutant
selection, and iii) can lead to certain types of mutants preferentially expanding during ageing.
These results all stem from a difference in carrying capacity between distinct types of mtDNA.
5.2.2 Connecting with reality: parameter estimations and biological inter-
pretations
5.2.2.1 Mapping known mtDNA mutations onto values of δ
Here we investigate whether our linear model can account for experimentally observed mtDNA
dynamics. First, we summarise the effect δ has on cellular mtDNA copy numbers (Table 5.1,
Figure 5.9) by considering five ranges of δ: i) δ > 1, ii) δ = 1, iii) 0 < δ < 1, iv) δ ≈ 0, and v)
δ < 0. Possible physiological advantages and disadvantages corresponding to these ranges, and
what kind of mutant characteristics could give rise to them, are also discussed in Table 5.1.
The last column of Table 5.1 indicates changes in wildtype (w) and total (T ) copy numbers
that are expected to be observed when comparing a heteroplasmic cell with a cell homoplasmic
in wildtype. For example, a high-heteroplasmy cell with δ = 1 is expected to show no change
in total copy number but a reduction in wildtype copy numbers.
Second, we aimed to link existing mtDNA mutations to the defined ranges of δ. We stress that
we did not perform an exhaustive literature search to classify a large set of mutant species, but
instead linked at least one mutation with each range (Table 5.2). We note that the majority of
mtDNA mutations we investigated were associated with increases in copy number, consistent
with δ < 1 which would lead to their preferential expansion during ageing (Figure 5.8).
Of course a linear feedback model will not be the only model that is able to qualitatively
account for the observed data. In fact, the experimental linkage provided holds for the relaxed
replication model [1, 2] which also predicts straight steady state lines in (w,m)-space whose
slope is influenced by a parameter denoting mutant contribution to replication rates. One
advantage of our modelling approach is that we are able to decouple the feedback control
strength (c1) from the mutant feedback contribution (δ), whereas the relaxed replication model
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[1, 2] cannot. We do not claim that our model represents the ‘true’ feedback control which, if
one can even define such a mechanism, is likely to be highly complicated. However, we believe
our model provides a good first order approximation of the underlying complex dynamics and,
importantly, allows for predictions and intuitive reasoning.
w increased, T increased
w constant, T increased
w decreased, T increased
w decreased, T constant
w decreased, T increased
w
m
constant h
= wildtype cell
= high-h cell
= total copy number: (w + m)T
Figure 5.9: Mapping mtDNA mutations to values of δ. This figure complements Table 5.1 and explains the
expected changes in wildtype copy number w and total mtDNA copy number T = w + m as provided in the table.
To find the value of δ of a particular mtDNA mutation, one can measure the values of w and T in a cell hetero-
plasmic in the mutation of interest (red) relative to a fully wildtype cell (green). For example, if δ = 0 the mutant
cell is expected to have, relative to the wildtype cell, a similar wildtype copy number (because w is constant along
the deterministic steady state line) but a higher total copy number.
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Hypotheses on the advantages, disadvantages and mechanisms of having muta-
tions within the indicated ranges of δ.
Changes
w , T
δ > 1 Advantage: Mean cellular heteroplasmy will tend to decrease when intercellular
mtDNA exchange is possible. If δ  1 then cells with high heteroplasmy may
not have sufficient numbers of total mtDNA to survive; selection on cellular level
may occur, favouring cells with low heteroplasmy.
Disadvantage: Might lead to higher apoptosis rates and relatively high mutant
fixation for short times (Figure 5.1 with the roles of w and m reversed).
Mechanism: Mutants producing excessive ROS may induce lowered mtDNA
replication rates with increasing m.
∆ T
∆ w
↓
↓
δ = 1 Advantage: Stable mtDNA copy numbers are ensured (Figure 5.3A).
Disadvantage: If mutants are pathological, decreases in w as h increases may
be undesirable.
Mechanism: Mutants and wildtypes contribute identically to the quantity that
is fed back on.
∆ T
∆ w
-
↓
0 < δ < 1 Advantage: If mutants are deficient in their energy production, higher copy
numbers are required to meet demands; 0 < δ < 1 ensures this is true.
Disadvantage: Leads to high mutant copy numbers at high heteroplasmy values,
and mean cellular h increases if intercellular mtDNA exchange is possible (Figures
5.5 and 5.8).
Mechanism: Mutants contribute less to the quantity that is fed back on. For
example, if ATP levels or the size of the mRNA pool are important in the cellular
feedback, this δ range occurs if mutants produce less energy or generate less
mRNA molecules.
∆ T
∆ w
↑
↓
δ ≈ 0 Advantage: A stable wildtype population is maintained (Figure 1.3).
Disadvantage: This situation is unstable leading to very high mutant copy
numbers (‘runaway dynamics’), until some maximum is reached. Such high copy
numbers may introduce extra dysfunctions.
Mechanism: Mutants do not contribute to the quantity that is fed back on. For
example, if ATP levels or the size of the mRNA pool are important in the cellular
feedback, this δ range occurs if mutants produce no net ATP or do not generate
mRNA molecules.
∆ T
∆ w
↑
-
δ < 0 Advantage: A negative value for δ ensures that wildtypes copy numbers in-
crease with heteroplasmy (for low levels of heteroplasmy, Figure 1.3) which may
be required to compensate for the presence of very deficient mutant species.
Disadvantage: This situation is unstable, leading to very high total copy num-
bers (‘runaway dynamics’), until some maximum is reached. Such high copy
numbers may introduce extra dysfunctions.
Mechanism: If mutants are energy sinks, consuming more energy than they
produce, the cell may want to upregulate mtDNA replication to increase energy
production. If mutants produce excessive ROS, the cell might interpret this as
a dysfunction in its mitochondria and could respond by increasing total mtDNA
replication rates.
∆ T
∆ w
↑
↑
Table 5.1: A breakdown of the different linear feedback regimes. This table summarises possible advantages
and disadvantages of particular δ regimes, and speculates on how various mutant characteristics may have given
rise to these regimes. We also show an overview of the changes in total copy number (∆T) and wildtype copy
number (∆ w) with increasing heteroplasmy: these quantities can increase (↑), decrease (↓) or remain constant (-
). These changes are expected to be observed in heteroplasmic cells when compared to homoplasmic wildtype cells,
allowing for the corresponding value of δ to be identified (as we did in Table 5.2).
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Total
copy number
changes
Experimentally found mutations showing evidence for the indicated change in copy numbers (increased,
decreased, or constant). Where possible, a more specific range of δ is given.
increased δ < 0
(δ < 1) C. elegans worms with high proportions of the large 3.1-kb deletion uaDf5 were observed to have a slightly
higher total mtDNA copy number than wildtype worms; wildtype copy number also slightly increased with
increasing mutant copy numbers [278]. The worms harbouring the mutation generally had a larger spread
in copy number values, indicating homeostatic control is stronger for wildtype mtDNAs [278]. A smaller
179-bp deletion mptDf1 showed similar dynamics.
Human skeletal muscle fibre sections with the m.3243A>G MTTL1 point mutation showed stable wildtype
copy numbers up until ∼ 80% heteroplasmy, after which wildtype copy number increased ∼6-fold [104].
0 < δ < 1
Human muscle fibres with the 4.9-kb common deletion, as well as a 2.3, 3.9, 4.5 and 7.1 kb deletion (associated
with Kearns-Sayre syndrome or isolated ocular myopathy) showed very high mutant copy numbers almost
always accompanied by a decrease of wildtype copy numbers [305].
Human muscle fibres with the 4.9-kb common deletion showed an increase in total copy number as hetero-
plasmy increased, accompanied by a decrease of wildtype copy numbers [104].
The point mutation m.10010T>C MTTG also led to larger total copy number and lower wildtype copy
numbers in human muscle fibres with higher heteroplasmy levels [104].
Human COX− muscle regions containing high levels of mtDNA deletion mutations were found to have
higher total mtDNA copy numbers, and often lower wildtype copy numbers (compared to COX normal fibre
regions) [85].
δ < 1 (either δ < 0 or 0 < δ < 1)
Increases in total copy number were seen in most tissues examined from MELAS patients harbouring the
3243A>G point mutation [304].
A mutation interfering with the expression of complex I subunit ND6 caused excessive ROS production and
led to a ∼3 fold increase in total copy number in mouse cybrid cells [324].
qPCR performed on muscle samples of a patient with a large mtDNA deletion measured ∼ 9700 mtDNA
molecules per diploid genome. In comparison, measurements in control samples were ∼ 1000−2000. Another
patient with the A8344G point mutation was found to have 4,245 mtDNA copies per diploid genome in muscle
[342].
The vast majority of human COX− fibres (most of which had a high percentage of mtDNA deletion muta-
tions) showed increased mtDNA copy numbers as compared to COX normal fibres (up to 21-fold) [22].
decreased In human leukocytes with the m.3243A>G MTTL1 point mutation, a decrease in total mtDNA copy number
was seen [343].
(δ > 1) Profound mtDNA depletion was found in muscle and kidney samples of patients with various deletion
mutations. mtDNA copy numbers per diploid genome in muscle samples from three patients were 261± 45
(n = 3), 361± 18 (n = 2), and 26± 12 (n = 2) (compared to ∼ 1000− 2000 in controls) [342].
∼ 9% of human COX− fibres (most of which had a high percentage of mtDNA deletion mutations) showed
lower mtDNA copy numbers compared to adjacent normal COX fibres [22].
constant Human osteosarcoma 143B cybrid cells with point mutation m.8993T>G were observed to have reduced
heteroplasmy but constant total copy number [142].
(δ ≈ 1) No consistent trend was found between heteroplasmy levels of the 3243A>G point mutation in human cybrid
cells and mtDNA copy number [344].
Total mtDNA copy number was observed to remain constant despite changes in heteroplasmy in cybrid
HeLa cells [80].
Table 5.2: An overview of the effect of known mtDNA mutations on copy number levels. Here we map
existing mutations onto our δ ranges (Table 5.1). Simultaneous measurements of wildtype and mutant copy num-
bers were not always performed, and therefore we split the different mutations in three main classes based on
changes in total copy number, indicating more specific δ ranges when possible. We managed to link each of our
five specified ranges to multiple mutations. Note that we can never be certain about the range of δ correspond-
ing to a given mutant species, and our linear model is an approximation to more complicated behaviour; also, the
changes in copy numbers may be due to other causes than a specific cellular feedback control.
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5.2.2.2 Providing a target mutant load: skeletal muscle data predict low
mutant accumulation rates
As mentioned in the thesis introduction (Section 1.4.2), the mutation probability used in math-
ematical modelling, Pmut, is chosen such that predicted mutant loads match the ones experi-
mentally observed. Most models seem to use the following end-of-life targets for both humans
and rodents: (5-10)% of cells must have reached a heteroplasmy level of ≥ 60% [34, 36, 38].
We will refer to these two quantities as the threshold fraction and threshold value, respectively.
We have various reasons to believe, as outlined in Box 5.1, that these target loads may be over-
estimating the actual load in post-mitotic tissues and therefore provide our own estimations
based on skeletal muscle data.
We collected data from studies that simultaneously measure the threshold fraction and threshold
value. We mainly focus on studies of skeletal muscle fibres of healthy mammals (which have
been analysed in great detail in a variety of organisms) and we require that measurements were
performed longitudinally along single fibres. Serial sections along fibres, rather than studying
a single transverse section [19], give more information on the distribution of dysfunctional
regions because of the mosaic structure of defective cells and because multiple mutated regions
of varying lengths can exist along a fibre. Because we aim to study mtDNA dynamics in healthy
subjects with age, we did not include studies involving patients with mtDNA diseases [340].
Summaries of the studies we included, which involve humans, rhesus monkeys and rodents,
are provided in Table 5.3, Box 5.2 and its Figure 5.10. Briefly, hundreds of serial sections (∼
10µm) were cut along muscle fibres and stained for cytochrome c oxidase (COX) and succinate
dehydrogenase (SDH) activities. COX negative regions identify mitochondrial dysfunction, and
SDH activities indicate whether the original problem lies within the nucleus or represents an
actual mtDNA dysfunction†. Abnormal fibre regions, i.e. regions containing mitochondrial
dysfunctions, were shown to contain high levels (> 90%) of deletion mutations, we therefore
set our threshold value at 90%.
†Succinate dehydrogenase refers to complex II of the respiratory chain, the only complex fully encoded by the
nucleus. Negative SDH activities indicate a nuclear defect, whereas normal or hyperactive activities (alongside
negative COX activities) point towards mtDNA defects.
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Box 5.1: Possible overestimations of mutant loads in aged subjects
Mathematical models of mtDNA dynamics during ageing often assume that in aged individuals, (5-10)%
of cells have reached a heteroplasmy level of ≥ 60% [34, 36, 38]. Where do these numbers come from? The
threshold value of 60% is obtained from a study showing that a 5196 base pair mtDNA deletion mutation
needs to accumulate to > 60% of the total mtDNA population before a reduction in COX activity is seen
[80]. This result was obtained in cybrid HeLa cells and, as heteroplasmy threshold values are cell-type
dependent [345], may not be representative of human or rodent post-mitotic tissues. For the threshold
fraction of 5% [34, 36] (or even 10% [38]), three studies [19, 346, 347] are often cited. In the first study,
the 5% threshold value represented the upper bound of a range of values, (0.1-5)% [19]. The second study
found a maximum of 0.37% COX-negative fibres in human limb muscle over a large age range [346]. The
last study did observe high percentages of COX− muscle fibres (∼ 40%) but, as explained later in this
section, this does not mean that 40% of single cells show COX-deficiencies.
A sensitive mtDNA quantification method applied to mice revealed mutation loads two orders of mag-
nitude lower than those obtained using polymerase chain reactions (PCR) [348], indicating that PCR
artefacts may have played a role in earlier studies.
Box 5.2: Measuring heteroplasmy levels along skeletal muscle fibres
Taken together, the experimental studies summarised in Table 5.3 found that ∼ (0.1 − 1)% of fibres
contained abnormal regions (COX− regions) at some point along their investigated length (∼ 1000-
2000µm). This percentage is very low compared to fibres of mtDNA disease patients, e.g. COX-negative
regions in two patients carrying the ‘common’ deletion were present in 7% and 65% of sampled fibre
sections [340]. In all studies in Table 5.3, deletion mutations were found in the abnormal regions but
never in COX-normal sections of the same fibre. Abnormal regions were characterised by: i) very high
mutant levels (> 90% and sometimes close to 100%), ii) high mtDNA copy numbers compared to normal
fibre regions, iii) a single deletion mutation (rather than a mixture of different ones) being present in the
entire region, iv) different deletion mutations being present in different abnormal regions, v) transition
regions with relatively low mutant levels flanking both sides of the abnormal region (Figure 5.10, see
also [305, 340]), and vi) a tendency to slowly increase in size with age, expanding longitudinally along
the fibre (Figure 5.10). MtDNAs do not seem to spread between different fibres as COX negative fibres
are randomly arranged rather than forming clusters [349] (though a recent study did find clusters of
COX-negative skeletal muscle fibres in rats [350]).
Tissue homogenate measurements showed a mixture of deletions, some present at very low levels, with
deletion breakpoints scattered randomly throughout the genome [21]. Clonally expanded mutations in the
abnormal regions, however, showed less random breakpoint positions with the vast majority of deletions
occurring in the major arc of the mitochondrial genome [21, 22, 85, 92, 351].
Expanding 
with age
= Founder mutation occurred
= COX-deficient region
= Nucleus
h
h
~0.9
Transition regions
~0.9
Figure 5.10: Visualisating of mutants spreading along muscle fibres with age. Heteroplasmy profiles
in COX-deficient regions are shown. Transition regions can have an intermediate COX-phenotype.
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To estimate the fraction of cells with high heteroplasmy values in aged tissue, we make the
following assumptions: i) a single muscle fibre can be partitioned into smaller ‘cells’ (as argued
in the previous section) in which the feedback control acts, ii) an abnormal fibre region is the
cause of a single mutation event which spreads along the fibre, and iii) each abnormal region
contains a different mutation. Though it may be that nearby abnormal regions in a single fibre
are the result of a single mutation event, this was not observed in the studies we investigated.
One way of estimating the rate at which a mutation accumulates and expands in a cell is
to combine the rate of mutation per µm of fibre length (λmut) with an estimation of cellular
length (Lc). In aged human Vastus Lateralis (VL) muscle, after analysing 10652 fibres along
2000 µm, 98 abnormal regions were found (Table 5.3). Therefore, the rate of the occurrence of
expanded deletion mutations is λmut =
98
10652·2000 ≈ 4.6× 10−6µm−1. Note that λmut represents
the rate per µm at which a mutation occurred and expanded to ∼ 90% in its original cell as
well as neighbouring cells. A natural way of defining cell size is to use inter-nuclear spacing.
Measurements in mouse skeletal muscle found a nuclear density of ∼ 30 nuclei per mm of fibre
length, meaning ∼1 nucleus per 30 µm [352]; we thus assume Lc = 30µm. The number of cells
that were included in the measurements described above is now N = 10652·2000
30
, meaning that
the probability of observing a ‘mutation generating cell’, defined as a cell in which a mutation
occurred and subsequently spread towards other cells, becomes Pobs = 98/N ≈ 1.42 × 10−4.
Other estimations of λmut and Pobs are provided in Table 5.4.
Additionally, we can estimate the expected number of fibres that show an abnormal region any-
where along their length; using a total fibre length of 6.5 cm in human VL muscle, the probabil-
ity of observing at least one abnormal region in an entire fibre is given by 1−e−λmut6.5×104 ≈ 0.26
for a 92-year old human subject [85]. Again, other such estimations are shown in Table 5.4.
Organism λmut(µm−1) Pobs Whole fibre Ref.
& age (×10−4) mutation prob.
Human
92 years
4.6× 10−6 1.42 26% .[85]
Rhesus
monkey
32 years 7.0× 10−6 2.1 24% .[341]
33 years 8.9× 10−6 2.7 30% .[341]
34 years 1.5× 10−5 4.5 45% .[341]
Table 5.4: Estimations of mutation rates in skeletal muscle fibres. λmut: the rate per µm at which a muta-
tion occurred and expanded in its original cell as well as neighbouring cells. Pobs: the probability of observing a cell
(with a length of 30µm) in which a deletion mutation occurred and subsequently spread towards other cells. Es-
timations of Pobs of a similar magnitude were made in Refs. [85, 341], though it is unclear how these estimations
were obtained. All values are calculated in a similar manner as outlined in the main text.
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In conclusion, we find a threshold value and fraction of ∼ 90% and ∼ 0.01% (Pobs), respectively,
very different from the often-used combination of 60% and 5%. Several factors to keep in mind
are i) more cells are expected to have passed the threshold h = 0.6 compared to h = 0.9, ii)
when modelling single cells, it is possible that many more than ∼ 0.01% reach the threshold as
some mutants may not (yet) succeed in taking over neighbouring cells, iii) the threshold value
and fraction may differ between cell types, and iv) measuring mutation levels is difficult and
different measuring methods do not always agree [348]. Nonetheless, our estimations suggest a
much lower percentage of high-heteroplasmy cells in aged mammals than assumed in previous
models. Our lower estimate is due to our assumption that a single fibre consists of many
individual cells – even if 100% of fibres are observed to contain an abnormal fibre region, the
percentage of high-heteroplasmy ‘cells’ may still be low. Additionally, we assume that each
abnormal fibre region is the result of an expansion of mutant mtDNA molecules in a single cell
followed by a spread into neighbouring cells. Even if 5% of cells are experimentally observed to
have h = 0.9, demanding that 5% of single cells in simulations without mtDNA exchange reach
h = 0.9 is too strict of a condition because it is much easier for a cell to reach high mutant
levels if its neighbouring cell contains high mutant levels.
5.2.2.3 Estimating mtDNA exchange rate and control strength
Movement of nucleoids, and therefore mtDNA molecules, through the mitochondrial network
can be caused by intra-mitochondrial nucleoid diffusion and/or mitochondrial movements com-
bined with frequent fusion and fission events. Various experimental studies suggest that the
latter process is the largest component of mtDNA movement [190, 191, 353, 354]. Skeletal
muscle fibres, however, are densely packed and mitochondrial longitudinal movement is not
readily observed [260], meaning nucleoid movement in fibres is likely caused by slow diffusion
through mitochondria. As mtDNA nucleoids are closely associated with (and likely attached
to) the inner membrane [355], we used both diffusion coefficients of nucleoids and inner mem-
brane proteins (which have been measured more abundantly) for our estimation of the mtDNA
exchange rate γ. Additional estimations can be obtained using the rate at which abnormal
fibre regions spread during ageing.
Our final estimates for γ lie in the range γ ∈ [0.09, 6.0] day−1, where we consider the lower
part of this range more likely, as derived in Section C.2.4. Our large uncertainty reflects the
complexities involved in mtDNA movement as well as experimental difficulties of measuring
diffusion rates. How do these mtDNA exchange rates compare to intracellular mtDNA turnover
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rates? The half-life of mtDNAs (indicative of turnover) was estimated to be 1 − 3 weeks,
corresponding to a death rate in the range µ ∈ [0.02, 0.1] day−1. Though estimates for both µ
and γ span orders of magnitude, it is likely that the mtDNA dynamics do not lie in the extreme
regimes γ  µ or γ  µ, but rather in an intermediate regime which allows for the stochastic
drive observed earlier (Section 5.2.1.4).
Next, we estimate the feedback control strength c1, which we deduce from the coefficient of
variation (CV) of mtDNA copy number, a more robust quantity to consider. We explored
different ways of estimating the CV, including using variations in mtDNA copy number along
muscle fibres [21, 85] and intuition about biologically plausible copy number distributions (Sec-
tion C.2.3). Our final estimate for the CV lies in the range CV ∼ [0.02, 0.25] where we consider
the upper part of this range more likely (Section C.2.3). Using Nss = 500 and µ = 0.07 (as in
Figures 5.7 and 5.5), this corresponds to c1 ∼ [5.5× 10−6, 7× 10−4].
In Figure 5.11 we show a heatmap visualising the extent to which mtDNA exchange can induce
changes in mean heteroplasmy dynamics. Our estimated parameter ranges for γ and the CV
are indicated, showing that a non-negligible effect size is possible under biologically plausible
parameterisations. We thus conclude that intercellular mtDNA exchange forms an interesting
avenue for future research that needs further exploration.
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Figure 5.11: Significant effects of mtDNA exchange on heteroplasmy mean in physiological settings are
plausible. Here we show an overview of the extent to which mtDNA exchange increases mean heteroplasmy val-
ues at long times, as a function of both γ and the CV. The black straight lines indicate the parameter regions we
estimated to be biologically plausible. We use data obtained from simulations and show the fold-change in mean
heteroplasmy when comparing i) heteroplasmy values without cellular exchange (γ = 0), and ii) mean cellular het-
eroplasmy values at 90 years in a 5-cell interaction system (i.e. 15
∑
i〈h(t = 90 years)〉i). Four cells were initialised
at h = 0, and one cell at h = 0.1 (i.e. without cellular interaction mean heteroplasmy is 0.02 and the colour map
reflects the fold-change increase from this). Parameters used in simulations are Nss = 500, µ = 0.07 and δ = 0.1.
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5.2.3 Clonal expansion and random drift - Challenges and perspectives
The basic observation has been that to make random drift models accumulate the observed
levels of mutated fibres in the lifespan of short-lived animals (e.g. rodents) the mutation rate
has to be very high; this high mutation rate leads to a level of mutational diversity that is
not observed experimentally [36, 38]. The neutral models thus dismissed, authors have moved
to look at more exotic mechanisms. Here we present various arguments which mostly point
towards reducing this problem, either through 1) lower values of Pmut or through 2) a lower
number of distinct mutations (independent of Pmut). Though the influence of each of these
arguments may be small, together they might make a difference and therefore more detailed
analyses are required to exclude random drift as a possible driver of clonal expansion.
MtDNA exchange can lead to increased rates of expansion. Our work in the previous sections
suggests a stochastic drive in heteroplasmy, generated without explicit selection (or even with
negative selection on mutants), might serve to increase mutant load. If our model is relevant,
lower values of Pmut can account for observed levels of mutation. However, mtDNA exchange
can cause the fraction of cells crossing a certain heteroplasmy threshold to be lower at short
times (Figure 5.8B), increasing the value of Pmut required in the short-term.
Mutant loads may be lower than expected. Our estimated mutant loads in aged tissues are orders
of magnitude lower than the ones used often in modelling (Section 5.2.2.2), allowing for lower
values of Pmut. Experimentally, it also appears previously assumed mutant levels are too high,
as measurements of mutant fractions in aged tissues are lower when using methods supposedly
less prone to artefacts [348].
Low heteroplasmy levels at birth increase accumulation rates. It is not clear to what extent
mutations observed in older individuals are the result of de novo mutations throughout life, or
of the expansion of low-heteroplasmy mutants that were present at birth [17]. Some evidence
exists for the latter [20, 133, 356, 357]. Though, 95% of mutations that occurred during early
development in human colonic and buccal epithelium were observed to be non-pathogenic [20],
this does not necessarily imply all pathogenic mutations accumulate after birth. Initializing
cells with low-h mutants will decrease the time required to reach the target value and threshold
[357], allowing for a lower Pmut.
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Different mutants have different mutation probabilities and cannot mutate indefinitely. Not all
mutations are equally likely to occur and it is therefore incorrect to assume a constant Pmut for
each mutation. Ideally, each mutant is considered unique with its own Pmut (its probability of
occurring) and its own δ. Higher mutation probabilities or lower δ values for specific mutations
increases their chance of expansion relative to others. Some of the models arguing against
random drift allow for the possibility of an arbitrary number of sequential mutations [38] and,
given that they aim to match deletion mutation levels, this implies the occurrence of deletion
upon deletion upon deletion, etc. As certain parts of the genome nearly always remain intact
(e.g. the origins of replication are often preserved [85]), a maximum number of sequential
deletions should be imposed. All these factors may reduce the number of distinct mutations
observed at the end of simulations.
The presence of many low-frequency mutants may not be detected experimentally. Even when
many mutant types are present, some may exist at very low frequencies and may not be detected
experimentally (i.e. predicting distinct mutants through simulation may not be at odds with
observing ∼ 1 mutation experimentally). This was partly accounted for by keeping track of
the most dominant mutant fraction [34, 36, 38], arguing that if h is high but the dominant
mutant frequency is low, other mutations present must be detectable. However, considering
the average number of distinct mutations may be ∼ 30 in simulations of short-lived animals
[36, 38], it can still be that almost all of these are present below detection threshold. Ideally,
one would keep track of copy numbers of all the different types of mtDNA present.
A mixture of different mutations is not necessarily pathological because the deficiencies of one
can be complemented by another [358], meaning that cells with many low-frequency mutations
need not be COX-negative. In many models, however, cells with h > 0.6 are considered
COX-negative and heteroplasmy values are calculated by combining all mutants [34, 36, 38].
Alternatively, one could classify a cell as COX-negative once the most dominant mutant passed
the threshold value, which would automatically reduce numbers of distinct mutants in cells
passed threshold. However, different deletions may not complement each other as they often
lack similar regions in the genome [21, 22, 85, 92, 351].
Reductions in copy number during ageing may increase the number of high-heteroplasmy cells.
Mean mtDNA copy numbers have been reported to increase or decrease during ageing in various
tissues [72, 359–364]. Other studies, however, do not find a change in mtDNA copy number with
age (e.g. in human skeletal muscle and myocardium [69]). These discrepancies were suggested
to be due to distinct measuring techniques as well as tissue-specific age-related dynamics [359].
112
It was shown that a sudden (temporary) drop in copy number can significantly increase the
fraction of cells having crossed a high heteroplasmy threshold during ageing [22], and the same
may be true for slow consistent decreases in copy number (as we expect stochastic effects to be
more pronounced at low copy number). A lower Pmut would then be required to reach a given
target load. It will be interesting to simulate a slowly decreasing steady state copy number
value and discuss the effect on mutant accumulation rates.
Higher turnover rates in rodents increases rates of mutant expansion. Higher mtDNA turnovers
– which may be expected in rodents due to their high metabolic rate – will accelerate mutant
accumulation [37]. When simulations of clonal expansion in rodents are performed with higher
turnover (currently, the turnover rate is often assumed constant for both human and rodent
simulations), the required Pmut will be lowered.
5.3 Discussion
Stochastic systems can produce non-neutral dynamics when deterministic treatments do not,
and we argued that this may apply to mtDNA dynamics, where stochastic selection is caused
by differences in carrying capacities. The novel contributions of this work are: i) allowing
intercellular mtDNA exchange, a setting relevant in skeletal muscle fibres due to their long
multi-nuclear structure, can induce increases in cellular mean heteroplasmy even in the presence
of selection against mutants (Section 5.2.1.4), ii) particular mutant mtDNA species can expand
preferentially during ageing without explicit selection (Section 5.2.1.4), and iii) differences in
carrying capacity induce heteroplasmy skew which can lead to temporary high fractions of cells
passing some heteroplasmy threshold (Section 5.2.1.1). Additional results we obtained are: i)
behaviours of many different mtDNA mutations can be explained by varying a single parameter
(which is also true for the relaxed replication model [1, 2]) (Section 5.2.2.1), and ii) mutant loads
in aged tissues may be lower than previously thought (Section 5.2.2.2). We further provide a
critical overview of various model assumptions and suggest possible extensions. The overall
conclusion is that random drift may be more influential than previously thought (though our
model does not exclude any mutant selection advantages).
If relevant (see below) what would be the biological implications of our results? Our model may
explain why only deletion mutations are seen to expand during ageing, and why they occur at
high copy numbers. A recent study found no correlation between the length of COX− regions
and the deletion size within that region, arguing against faster replication of shorter genomes
[365]. In our model, even with a constant exchange rate γ, low-δ mutations are expected to
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expand faster, suggesting δ is not directly linked to deletion size. Because there is a direct link
between δ and total copy numbers in high-heteroplasmy regions, it will be interesting to test
the existence of a correlation between the size of COX− region and copy number within.
One particular gene lacking in many deletion mutations is ND4, encoding for a subunit of
complex I of the respiratory chain. ND4 transcription rates were suggested to reduce mtDNA
replication, causing mutants which lack this negative feedback loop to obtain a replicative
advantage [38]. This interpretation requires a (leaky) link between genotype and phenotype
as the amount of transcripts and proteins produced by an mtDNA influences its own, but not
others’, replication rates. Frequent mitochondrial fusion and fission events, however, allow for
mixing of proteins and blur the link, though there are indications that a leaky link nevertheless
exists [188]. Our model allows for an identical interpretation but with the assumption that
the link is sufficiently leaky such that local feedback is negligible. Instead of a local lack of
transcripts failing to reduce replication of the nearest mutant, our model might, in this light,
be interpreted as suggesting a global reduction in transcripts (due to mutant presence) fails
to decrease replication, leading to a higher total population size as heteroplasmy increases. A
complete absence of mutant transcript would be equivalent to using δ = 0. Whether δ is related
to ND4 can be tested by e.g. downregulating ND4 expression to various degrees and testing
for a correlation with steady state copy numbers.
At the moment it is hard to speculate to what extent intercellular mtDNA exchange affects het-
eroplasmy dynamics in real biological systems, due to the large uncertainties in our parameter
estimates (Section 5.2.2.1). To partially deal with this problem, we performed simulations with
parameters varying over several orders of magnitude (Figures 5.7A, B) and commented on the
different parameter regimes in which 〈h(t)〉 is likely to show significant changes (Figure 5.11).
We note, however, that our results may be influenced by other factors such as i) changes in nu-
clear positions due to fibre damage [366], ii) inhomogeneous mitochondrial densities along fibres
due to the banding pattern of myofibrils and across fibres due to steep oxygen gradients [367],
and iii) changes in mitochondrial density induced by exercise [368, 369]. Despite the effect-size
of our results being uncertain, we would argue that the possibility of mtDNA exchange forms an
interesting and worthwhile component of mathematical models of clonal expansion that needs
further exploration.
Our mutant load estimations predicted that at old age (∼ 90 years in humans and ∼ 30 in
rhesus monkeys) in ∼ 0.01% of cells a mutation event occurred, clonally expanded within that
cell, and spread along the fibre infecting other cells. When simulating an entire muscle fibre,
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such affected regions can easily be counted. However, when only simulating one, three or five
cells, if a mutation expanded to > 90% does that mean it would also have expanded in 50 cells?
Would it have shown up as an affected region at the end of the simulation or not? We would
argue that low-δ mutations are likely to continue expanding due to their much higher carrying
capacity, but mutations with δ ≈ 1 may be more easily eliminated again by chance. Some care
must be taken in interpreting few-cell simulations.
What evidence is there for faster mutant proliferation? It was initially found that cells homo-
plasmic in deletion mutations recover at a faster rate (after induced copy number depletion)
than cells homoplasmic in wildtype [370]. However, this in principle does not imply a different
birth rate for mutant and wildtype‡, and does not straightforwardly extend to heteroplasmic
cells. A later study by the same group on heteroplasmic cells found that h increases after
depletion [283]. Heteroplasmy values were not measured directly after depletion and it may
be that the treatment itself, instead of the recovery dynamics, changed heteroplasmy, though
higher mutant replication rates still form the simplest explanation. We note that even if dele-
tion mutants show a replicative advantage when replication rates are maximal, this does not
necessarily imply such an advantage is significant in more physiological settings without severe
depletion. Some mutations close to regulatory sites of replication do genuinely seem to show a
replication advantage [371].
The work we presented here is a work in progress and can be extended in a variety of ways.
The number of coupled cells can be increased, and cells can be assumed to lie on a lattice
(making transverse motion possible, as has been observed experimentally [372]). It would also
be interesting to investigate the consequences of allowing variation in steady state cellular
copy numbers between cells, and copy number reductions over time. Analytically, an equation
predicting (or approximating) the initial rate of increase of 〈h(t)〉 in the two cell setting seen
in Figure 5.5, or even its final steady state value, is highly desirable. This will gain us a deeper
understand of the process. For more analytical treatments one could take an approach similar
to one in Ref. [328], namely deriving stochastic differential equations for motion along steady
state lines. The authors results are valid in limits of slow or fast exchange of components, but
may be extended to include intermediate regimes. Experimental tests suggested throughout
this chapter are summarised in Table 5.5.
‡A heteroplasmic cell with Nss = 500, δ = 0.1 and h = 0.7 has steady state copy numbers (w,m) ≈ (400, 950).
Depleting copy numbers (while preserving heteroplasmy) to e.g. (w,m) = (30, 70), means that mutant and
wildtype copy numbers need to increase by 880 and 370, respectively, to return to their original state; a faster
mutant replication rate during recovery may therefore be expected.
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To connect with previous studies [34, 36, 38] we need to simulate mutant expansion in short-
lived animals (incorporating some of the extensions suggested in Section 5.2.3). We can find
the value of Pmut required to match experimentally observed mutant loads through simulations,
and determine the corresponding number of distinct mutant types in high-heteroplasmy cells.
An analytical example route to pursue is to approximate Pmut analytically by predicting the
number of abnormal fibre regions at a given age (given Pmut) and matching with experiments.
For example, we could assume that a mutation is likely to spread along a fibre when it reaches a
macroscopic fraction of ∼ 10% in a single cell. The number of abnormal regions at a given time
then roughly corresponds to the number of times we expect a mutation to have reached h = 0.1
(which may be estimated by using information on single cell copy numbers, turnover, and
mutation rate). Such estimations allow us to quickly predict the value of Pmut and speculate
on its plausibility. By performing these estimations and simulations we will able to make
statements on whether random drift can account on for clonal expansion in short-lived animals
in the context of cellular mtDNA exchange.
Suggested experiments to test model predictions or improve parameter
estimations.
Non-destructive mtDNA copy number measurements (using e.g. fluorescent staining of nu-
cleoids) in single cells over time will provide useful information on natural fluctuations in
copy numbers. This method of estimating c1 is arguably better than measuring copy num-
bers across a population of identical cells, as it eliminates the problem of heterogeneity caused
by e.g. differences in cell volume.
We predicted a correlation between the length of a COX− region and the total copy number
within the region, this can easily be tested.
If the gene ND4 is related to our parameter δ, downregulating its expression in cells should
increase steady state copy numbers in those cells.
Depleting mtDNA copy number to various degrees and measuring initial rates of repopulation
will provide insight into the feedback control strength as a function of distance from steady
state, and will therefore indicate the shape of the control function (i.e. whether it is nonlinear
and at what point these nonlinearities become apparent).
Table 5.5: An overview of possible experiments to test model predictions and improve parameter esti-
mates.
We conclude this thesis by highlighting a connection between mitochondrial dynamics (i.e.
Chapters 2 and 3) and mtDNA dynamics (i.e. Chapters 4 and 5). Just like mitochondria reside
inside cells and may be exchanged between cells – through e.g. diffusion or tunneling nanotubes
[333, 373, 374] – mtDNA molecules reside inside mitochondria and can be exchanged through
fusion events. The model of intercellular mtDNA exchange introduced in this chapter can be
applied to any system in which particles undergo controlled dynamics in subcompartments
and are exchanged between these subcompartments. This includes both mtDNA molecules
being exchanged between mitochondrial fragments, and mitochondria and/or mtDNAs being
exchanged between different mitochondrial subpopulations inside single cells. In these situ-
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ations, it may be possible for mutant mtDNA molecules to preferentially expand (if δ < 1)
inside single cells without explicit selection. Such possibilities of local control in mitochondrial
fragments or cellular subcompartments are not studied in this thesis but form an interesting
extension of the work presented here.
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A
Supplemental information
complementing Chapter 2
This appendix is split into three sections:
1. The first section contains quantitative and mathematical details of various models pre-
sented in Chapter 2. Several of these models follow the philosophy of ‘back-of-the-
envelope’ calculations, rough estimations of quantities which are increasingly recognised
as powerful tools to gain insights and intuition about the behaviour of biological systems
[375, 376]. The models we use are:
• Ordinary differential equation model for selection bias through selective fusion;
• Model for diffusion on a lattice with fluctuating bonds;
• Fusion of charged spherical capacitors;
• Calcium stimulation and energy output of fused mitochondria;
• Mechanisms of calcium uptake;
• Fusion buffers fluctuations in membrane potential.
2. The second section contains descriptions of additional hypotheses mentioned in Chapter
2:
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• A genetic reservoir created through fusion;
• Fusion increases ATP synthesis through (i) inner membrane shape change; (ii) de-
creases in proton leak; (iii) decreases in mitochondrial degradation.
• Fusion creates distributional ‘power cables’
• Meso- and hyperfusion have no function
3. The third section contains tables summarising quantitative and qualitative data on the
following topics:
• Observations of hyperfusion;
• Mitochondrial morphology in different cell types;
• Diffusion constants of mitochondria proteins;
• Post-translational modifications of Drp1;
• Additional functions of mitochondrial fission and fusion proteins.
A.1 Quantitative and mathematical models
A.1.1 Model for increased selection bias through selective fusion
In Section 2.4.1 of Chapter 2 we introduced a simple ordinary differential equation (ODE)
model to show that increased fusion strengthens the bias towards degrading dysfunctional
mitochondria. The set of ODEs provided in Equation (2.1) can easily be derived by first
writing the system in the intuitive form (for parameter definitions see Chapter 2)
c˙hs = (B −M − γhf )chs + γfchf
c˙us = (B −M − γhf )cus + γfcuf
c˙hf = chf (B − γf ) + γhfchs
c˙uf = cuf (B − γf ) + γufcus. (A.1)
The first two equations state that the fragmented population can be increased through biogene-
sis (B) and fission of fused mitochondria, while it can be decreased through mitophagy (M) and
through fusion. The latter two equations lack a term involving mitophagy due to our assumption
that only fragmented mitochondria can be degraded. Constant total population size is obtained
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by assuming B ·(chf+cuf+chs+cus) = M ·(chs+cus), i.e. M = B ·(chf+cuf+chs+cus)/(chs+cus).
Equations (2.1) in Chapter 2 are now simply obtained by eliminating M from Equation (A.1).
A cell can increase the connectedness of the mitochondrial network by either increasing fusion,
decreasing fission, or both. When fusion rate is increased, while keeping the ratio γhf/γuf
constant, we found that the population of dysfunctional mitochondria decreases faster (Figure
2.2B). Figure A.1A shows that the ratio cus
chs+cus
, denoting the fraction of the fragmented popu-
lation that is dysfunctional, is slightly lowered at high fusion rates, meaning a relative increase
in the number of healthy mitochondria being targeted for mitophagy. Similarly, though de-
creasing fission (as well as increasing fission) leads to a slower decay of unhealthy mitochondria
(Figure 2.2B), the number of degraded healthy mitochondria is relatively lower (Figure A.1A).
Figure A.1B shows the total level of fusion (defined as (chf + cuf )/(chs + cus + chf + cuf )) in
the four different parameters settings we consider, showing a similar network connectedness for
the settings of increased fusion and decreased fission (which we impose in order to properly
compare these settings).
We note that, in reality, there will be a rate at which functional mitochondria become dys-
functional. This rate is very low if one only considers dysfunctionalities caused by rare events
(like mtDNA mutations), in which case the model described above may be used as an approx-
imation; e.g. mitochondria with a certain mtDNA mutation will be removed from the network
before the next mtDNA mutation occurs. However, mitochondria can become dysfunctional in
other ways (e.g. depolarization events or oxidative damage), in which case the described model
is not sufficient. Extra terms can be added to Equations (2.1) to account for the possibility
that a healthy mitochondrion becomes unhealthy. These extra terms allow for the possibility
of steady states with a nonzero population size for all of the populations. In this scenario,
increases in fusion rate (at constant γhf/γuf ) induce increases in the steady state ratio
chf+chs
cuf+cus
(i.e. the higher fusion rate, the higher the fraction of functional mitochondria in steady state).
A.1.2 Model for diffusion on lattice with fluctuating bonds
Diffusion on lattices with ‘flickering’ bonds (bonds that can appear and disappear over time)
has been studied in Refs. [232, 233], using the theory described in Ref. [377]. An analytical
approach, taking into account the state of all the bonds, is intractable and we therefore use an
effective medium approximation [232, 233]. The fluctuating lattice is approximated by a static
lattice in which the transition rate to a nearest neighbour is the same for all nearest neighbour
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A) B)
Figure A.1: Increased fusion leads to a relatively smaller unhealthy fragmented population. A) We con-
sider the same four parameter regimes as defined in Figure 2.2 of Chapter 2. Increased fission rates (relative to
the default setting) cause the fraction of unhealthy mitochondria in the fragmented population to be lower. This
means that, relative to the default parameter setting, mitophagy events are more likely to degrade a healthy mito-
chondrion. Changes in fission rate have the opposite effect. B) Here we show the fraction of mitochondria that is
fused for our four different parameter settings. In the setting of decreased fission (dotted line), we chose the value
of γf such that the level of fusion was identical to that in the setting of increased fusion; this led to γf = 0.55.
pairs and is given by we (the effective transition rate), satisfying
p− we
pc(1− we) = 1−
1
1 + ncweτ
G
(
0, 1− 1
1 + ncweτ
)
(A.2)
where p is the fraction of bonds that are present, nc is the number of nearest neighbours per
site, pc =
2
nc
, τ is the characteristic relaxation time of the fluctuating bonds, and G(0, z) is the
appropriate lattice Green’s function evaluated at the origin [232], which in the case of our 2D
square lattice model is
G(0, z) =
2
pi
K(z2) (A.3)
where K is the complete elliptical integral of the first kind.
This approximate model is equivalent to random diffusion on a lattice with a hopping rate
given by we and therefore we can be interpreted as the diffusion coefficient D. Equation (A.2)
is used to generate Figure 2.3A in Chapter 2.
A.1.3 Fusion of charged spherical capacitors
Here we explain how fusion of two charged objects can lead to a non-averaging of potentials,
as claimed in Section 2.4.3 of Chapter 2. Suppose we have two charged shells, a small one with
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radius rin and a bigger one with radius rout. The spheres are assumed to have opposite charges,
i.e. one has charge Q and the other charge −Q. Applying Gauss’ law, the potential difference
between the shells is given by
V =
Q
4pi
· rout − rin
rinrout
. (A.4)
where  is the dielectric permittivity of the medium between the charged spheres. Because the
capacitance C is given by C = Q
V
, Equation (A.4) leads to
C =
4pirin(rin + d)
d
(A.5)
where we have denoted the distance between the inner and outer radius by d. In this model, rin
and rout are meant to represent the inner and outer radii of the mitochondrial inner membrane
(i.e. d denotes inner membrane thickness). We do not model the outer membrane because the
electrochemical gradient only exists across the inner membrane.
We now consider a ‘fusion’ of two capacitors, while assuming that total volume and charge are
conserved. We denote the inner radius and charge of capacitor i by ri and Qi, respectively,
and label the initial two capacitors by ‘1’ and ‘2’, and the resultant fused capacitor by ‘3’.
If we maintain a spherical structure in the resulting fused capacitor, conservation of volume
translates into the constraint r33 = r
3
1 + r
3
2. Conservation of charge gives Q3 = Q1 + Q2. The
capacitance of the fused capacitor is then given by
C3 =
4pir3(r3 + d)
d
=
4pi(r31 + r
3
2)
1/3
[
(r31 + r
3
2)
1/3 + d
]
d
, (A.6)
and the potential V3 can now be calculated as follows:
V3 =
Q1 +Q2
C3
=
V1C1 + V2C2
C3
=
V1r1(r1 + d) + V2r2(r2 + d)
(r31 + r
3
2)
1/3 [(r31 + r
3
2)
1/3 + d]
. (A.7)
For a mitochondrion, the thickness of the inner membrane is about 5 nm and is two orders of
magnitude less than the value for rin which can be around 0.5 µm. Using d ri ∀i, Equation
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(A.7) becomes
V3 =
V1r
2
1 + V2r
2
2
(r31 + r
3
2)
2/3
=
V1A1 + V2A2
(A
3/2
1 + A
3/2
2 )
2/3
, (A.8)
where Ai = 4pir
2
i is the surface area of capacitor i. When the two fusing capacitors have
identical surface area (i.e. A1 = A2) the above equation reduces to
V3 = (V1 + V2)2
−2/3 ≈ 0.63 (V1 + V2) (A.9)
This means that the voltage of the fused capacitor is higher than the average of the voltages
of the identically-sized pre-fusion capacitors.
In this toy model, we have assumed that the inner and outer radii of the mitochondrial inner
membrane are spheres, i.e. we have ignored cristae. Instead of assuming Ai = 4pir
2
i , we may
assume Ai ∝ rxi with x ∈ (2, 3); the higher x, the more the inner membrane fills up the volume
of the mitochondrion. The final result given in Equation (A.9) stays the same. However, if we
also assume that Vi ∝ ryi with y ∈ (2, 3) then Equation (A.9) changes into
V3 = (V1 + V2)2
−2/y < 0.63 · (V1 + V2) for y ∈ (2, 3) (A.10)
The amount by which the voltage V3 exceeds the average of V1 + V2 decreases as y decreases
from 3 to 2, with V3 =
1
2
(V1 + V2) if y = 2. This means that in mitochondria, because of the
membrane invaginations, the fused potential will be closer to the average than predicted by this
simple toy model (i.e. if V3 = x (V1 + V2) then x will be lower than 0.63, but still potentially
higher than 0.5).
A.1.4 Energy output by calcium stimulation as function of the number of
fused mitochondria
We will discuss a very simple model that describes how the total ‘energy output’ of a group
of mitochondria depends on the number of fused mitochondria connected to a calcium source.
This simple model explains the shape of the curve drawn in Figure 2.5B of Chapter 2.
We assume that all mitochondria that are not exposed to a calcium source have a basal
[Ca2+]matrix, given by cb. If calcium is emitted from a source (for example, a calcium channel
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in the ER), a mitochondrion adjacent to the source will experience an increase in [Ca2+]matrix,
denoted by csig, meaning its concentration becomes cb + csig; mitochondria far from calcium
channels keep their basal concentration.
We use a simple approximation where the energy output of a mitochondrion is sigmoidally
dependent on [Ca2+]matrix [244]. By using the generic term ‘energy output’ we are avoiding
committing to a particular physiological variable and rather seek to demonstrate the principle
at play. Specifically, we denote by s(c) a sigmoidal function giving the energetic output of a
mitochondrion with internal calcium concentration c. The total output of the mitochondrial
system, E, is then defined as
E =
∑
i
s(ci) (A.11)
where i indexes mitochondria, and ci is the calcium concentration in the ith mitochondrion.
We can now model the effect of fusion on total mitochondrial energy output. If there are N
mitochondria in total, with one mitochondrion near a calcium channel (this number can easily
be generalised) and n mitochondria fused to this mitochondrion, then total output is given by
E = (N − n) · s(cb) + n · s(cb + csig/n) (A.12)
where the first term describes the output generated by the (N − n) isolated mitochondria, and
the second term gives the output of the n fused mitochondria.
Figure 2.5B of Chapter 2 illustrates how E depends on n. To generate this figure, we chose csig
to be two orders of magnitude larger than cb (as has been observed in neurons [378]) and we
chose an arbitrary sigmoid function. The details of the shape of the curve depend on the form
of the sigmoid used, but the general behaviour shown in the figure (E increases first and then
decreases) will be conserved. With this simple model we show that, inspired by the sigmoidal
dependence of TCA cycle enzyme activity on calcium, there exists an ‘optimal’ number of fused
mitochondria corresponding to maximal energy output. The quantitative details of this result
will depend on the exact sigmoidal form of enzyme activity and on the value of the parameters
cb and csig.
A.1.5 Mechanisms of calcium uptake and amount of mitochondria-ER contact
Here we provide some additional information that serves as criticism of the calcium hypothesis
discussed in Section 2.4.4 of Chapter 2. Controversy exists over kinetics of mitochondrial
124
calcium uptake and the mechanisms involved. Besides the uniporter, other mechanisms such
as the Rapid Mode of uptake (RaM) and ryanodine sensitive transporters have been identified
[203]. Ryanodine sensitive receptors located on the inner mitochondrial membrane become
active around [Ca2+]cyt ∼ 100 nM [379], whereas the mitochondrial uniporter is thought to
have a low affinity for calcium with a dissociation constant around 10 µM [380]. We note that
the activity of the uniporter is itself [Ca2+]-dependent and the details of mitochondrial calcium
influx (reviewed in Ref. [381]) are not fully understood. If uptake through ryanodine sensitive
transporters is significant, then calcium uptake is not limited to mitochondria close to high
[Ca2+]cyt domains.
It is not certain what percentage of the total mitochondrial network has close contacts with the
ER. There are studies suggesting this concerns ∼5-20% of the total mitochondrial surface [245],
while others observe that 90% of fission events occur at sites of ER-mitochondria contact [253].
Mitochondria in the perinuclear region seem to have more ER-associations than those in the
peripheral region [382]. It has been suggested that the amount of contact between mitochondria
and the ER changes over time [383].
A.1.6 Increasing mitochondrial size buffers fluctuations in membrane poten-
tial
A.1.6.1 Changes in membrane potential upon changes in permeability of the
inner mitochondrial membrane
Here we provide arguments for why fluctuations in membrane potential are of smaller magnitude
in larger mitochondria (as stated in 2.4.5 of Chapter 2). We will use a physical model to
consider how a perturbation that increases the flux of some charged chemical species into the
mitochondrion (motivated by, for example, transient opening of the permeability transition
pore, or proton leak), affects the membrane potential of mitochondria of different size.
The flux per unit area jX of some chemical species X with charge z through a membrane (here
the mitochondrial inner membrane) of width L is given by the Goldman equation
jX =
β∆ψDXz
L
(
[X]out − [X]ineβz∆ψ
1− eβz∆ψ
)
, (A.13)
where β = F
RT
, F is the Faraday constant, T the temperature, R the gas constant, ∆ψ the
membrane potential, DX the diffusion coefficient for chemical species X and [X]in, [X]out are
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the concentrations of species X on either side of the membrane. Written in this way, the flux
jX is the net flux into the mitochondrion through a piece of unit surface area. Assuming a
spherical mitochondrion with area A = 4pir2 the total flux of X through the membrane is given
by
JX =
∮
A
jXdA = 4pir
2α∆ψz
(
[X]out − [X]ineβz∆ψ
1− eβz∆ψ
)
, (A.14)
where α = DXβ/L is a measure of the permeability of the membrane.
We aim to explore how robust the membrane potential is with respect to perturbations includ-
ing, for example, opening of the mitochondrial permeability transition pore or proton leak. In
equilibrium, the net species’ flux is zero. Setting equation (A.14) to zero we can solve for ∆ψ
to obtain
(∆ψ)equilibrium =
1
βz
ln
[X]out
[X]in
(A.15)
We consider small perturbations to this equilibrium state, resulting from changes in the internal
concentration of a charged species [X]in. For a small transient perturbation, we have:
d∆ψ
dt
=
−1
βz[X]in
d[X]in
dt
, (A.16)
where we have assumed that [X]out, the cytoplasmic concentration of X, stays constant due to
its large volume compared to the mitochondrion.
Changes in [X]in are caused by net flux of X into the mitochondrion. Not all of these ions
flowing in will increase [X]in as some of them may bind to proteins or ionic species inside the
mitochondrion. This effect can be accounted for by a buffering factor, γ, which results in
d[X]in
dt
= γ
JX
4
3
pir3
, (A.17)
where we have related the absolute flux JX to the change of concentration [X]in by normalizing
by the volume of a (spherical) mitochondrion. The perturbation by which this influx is manifest
is considered to cause an increase in permeability of the membrane, which we represent by
scaling the permeability constant α→ α′ > α. Using equation (A.14) we obtain
d[X]in
dt
= γα′∆ψz
(
[X]out − [X]ineβz∆ψ
1− eβz∆ψ
)
3
r
(A.18)
meaning that
d∆ψ
dt
=
−γα′∆ψ
β[X]in
(
[X]out − [X]ineβz∆ψ
1− eβz∆ψ
)
3
r
(A.19)
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This means that for large r (large mitochondria) fluctuations of ∆ψ will be of smaller magnitude,
even if the perturbation in a larger mitochondrion happens over a larger surface area because
the internal pool of ions is larger still (r3 > r2).
Treating mitochondria as spheres, we have neglected the invaginated structure of the inner
membrane. Including these invaginations changes the r−1 dependence of ∆ψ to ry with y ∈
(−1, 0). Because, in spherical mitochondria (even when assuming membrane invaginations),
volume will always scale with a larger power of r than surface area, fluctuations in ∆ψ will
always be less in larger mitochondria. Fusing mitochondria into large networks thus protects
them from perturbations.
A.1.6.2 Ising-type model for mitochondrial robustness
Alternative arguments independent of volume and surface area scaling can be given supporting
the hypothesis discussed in Section 2.4.5. We will briefly discuss a picture based on the Ising
model, an often-used class of physical models for collective dynamics. In the Ising model, a set
of elements (originally spin domains) exists, with each entity i having a state si which may be
−1 or 1. In a simple incarnation of the Ising model, the overall energy of the system is given by
E =
∑
i
∑
j≥i Jijsisj, summing over all individual elements and pairs of elements in the system,
and Jij is a matrix determining any energetic couplings (interactions) between elements i and
j. The dynamics of the system can then be simulated by applying random perturbations to
the states si and considering the change in energy that a given perturbation provokes.
If coupling is strong in a system (many off-diagonal elements of Jij are of large magnitude),
the effect of changing the state of one element depends strongly on the states of the elements
with which it interacts. Consider an interaction matrix structured such that it is beneficial for
interacting groups of elements to be in the same state (corresponding to a ferromagnetic regime,
if elements represent spin domains). Strong coupling between elements will then disfavour
events whereby one element changes to a state different to the state shared by its neighbours
(for example, an element surrounded by elements of state 1 changing from 1 to −1). By
contrast, if coupling between elements is weak, the energetic effect of such a change is localised,
and the disfavouring of an isolated element changing state will be less pronounced.
We now draw an analogy to the mitochondrial system. Consider representing individual mi-
tochondria as elements within the Ising model described above. Elements interact (with a
non-zero Jij term) if the corresponding mitochondria are fused; elements corresponding to iso-
lated mitochondria do not interact with any others. We will consider the states 1 and −1 to
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be heuristic markers of ‘functionality’ and ‘dysfunctionality’ respectively, but it is not difficult
to picture more physical interpretations involving, for example, different states of matrix alka-
linisation or membrane potential. Then, for an isolated mitochondrion to go from a functional
to dysfunctional state, a change ‘(1) → (−1)’ has to occur. If several mitochondria are fused,
the required change is now placed in a coupled context e.g. ‘(1)(1)(1)→ (1)(−1)(1)’. If inter-
actions favour similar states in coupled elements (a ferromagnetic picture), the latter change
will be less favoured and will occur with lower frequency. Such ferromagnet-like interaction
are appropriate when we consider e.g. concentrations of chemical species within a contiguous
fused matrix (or membrane potential across a continuous membrane), where perturbations are
expected to equalise across the continuous domains involved. If, for example, a mitochondrion
in a fused chain experiences a sudden change in membrane permeability, ions from neighbouring
mitochondria will buffer the resulting change in ∆ψ.
A chain of n fused mitochondria is then represented by a sequence of n digits and a mito-
chondrion chosen randomly from this chain is likely to have two neighbours that influence its
state. Glauber dynamics [384] are useful for developing intuition about such a system. In short
chains, randomly chosen elements have a higher probability of having fewer neighbours, and
greater variability in their individual states is therefore supported. In longer chains, strings of
identical digits are more likely to occur because of the tendency of elements to take the same
value as their neighbours. This, combined with the observation that mitochondria with higher
∆ψ have a higher fusion probability (in our picture, elements that are fused to a chain are more
likely to be in state 1 than −1) results in an all-1 state being more favoured in longer chains
than shorter chains.
The system described above is only of use as a coarse-grained model for collective dynamics of
fused mitochondria. Further progress could be made by considering continuous states (allowing
elements to have states si ∈ [−1, 1]), which is more appropriate as e.g. chemical concentrations
and membrane potential are continuous variables. With a more realistic representation of
mitochondrial ‘state’, specific estimates of appropriate interaction terms Jij could be explored.
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A.2 Additional hypotheses on the function of mitochondrial meso- and hy-
perfusion
A.2.1 Fusion allows for the possibility of creating a genetic reservoir
Summary. If mitochondria are fused, they are protected from mitophagy [148, 158]. This
means that mutant mtDNA molecules within a fused chain are safe from degradation, allowing
the creation of a ‘genetic reservoir’ of mutations. Having a reservoir of a variety of mtDNA
mutations in a population can be beneficial as it allows for adaptation to the environment,
increasing the ‘evolvability’ of the population [385]. This idea is also briefly mentioned in Ref.
[179].
Experimental support. Mitochondrial ‘microheteroplasmy’ [386], the universal presence of
low levels of heteroplasmy, has been observed in human cells [88], supporting the idea that a
pool of genetic variation is present in the mitochondrial population.
Limitations/Critique. (i) It is not immediately clear how important mitochondrial meso-
or hyperfusion are in creating a genetic reservoir because the cell can fine-tune the level of
quality control by changing the amount of mitochondrial biogenesis or the rate of mitophagy.
(ii) We believe that even during hyperfusion, quality control is present in the background
(γfis 6= 0) which may reduce the size of the reservoir created. A form of static hyperfusion, where
mitochondria are permanently locked together, would likely be physiologically damaging (as
suggested by studies on hFis1 or Drp1 knockouts [59, 64, 151, 173]). (iii) This hypothesis states
that fusion prevents damaging mtDNA mutations from being lost because if the mitochondrion
carrying the mutation had been fragmented, it would eventually have been degraded. However,
if a mutation causes damage to a mitochondrion, then the mitochondrion may not even be
able to fuse because only mitochondria with sufficiently high ∆ψ are capable of doing so [59].
Mutations that are not harmful may indeed survive longer if they reside inside a fused network,
but they could have survived without a network too, especially if the mutation gives them a
proliferative advantage. (iv) The link between genotype and phenotype in mitochondria is leaky
[191], meaning that it may be hard for mitochondrial quality control mechanisms to select for
mutated mtDNA and therefore even without increased fusion mtDNA mutations can survive.
Experimental tests. Start with a population of wildtype heteroplasmic cells (where one type
of mtDNA is pathological) and then induce mitochondrial network forming in half of them (by
either decreasing fission or increasing fusion). In both populations, the relative frequencies of
the two types of mtDNA can be determined. One can measure these frequencies again at a
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later time and observe whether the number of pathological mtDNAs that survived is higher in
the cells with highly fused mitochondria.
A.2.2 Fusion increases ATP synthesis; hypotheses (i), (ii) and (iii)
Three hypotheses that complement Section 2.4.3 of Chapter 2 are briefly discussed here, though
in less detail than the hypotheses discussed in the chapter.
A.2.2.1 Hypothesis (i): Higher [ATP] is caused by fusion-induced changes in
inner membrane shape
Summary and Experimental support. Upon fusion, the activity of OPA1 can change
cristae morphology [193–195] which may cause changes in respiratory capacity. Because ATP
synthase dimers are mainly located at the crista membrane [45, 46], changes in cristae shape
can alter the number of ATPase dimers embedded in the membrane [46].
Various experimental studies show support for the idea that fusion-induced reshaping of the
crista membrane increases respiratory capacity [148, 149]. ATP synthase dimers may be able
to curve the inner mitochondrial membrane, possibly leading to the formation of new cristae
[387]. Indeed, not only the ratio of ATP synthase dimers to monomers was increased during
starvation, also the number of cristae per unit mitochondrial surface area was increased [148].
Another way in which changes in shape of the inner membrane can modulate energy output is
by inducing changes in proton densities. Membranes with high curvature can accommodate a
higher proton density than membranes with low curvature [388].
Limitations/Critique. It is not clear why fusion should be required to allow for changes
in inner membrane shape; presumably a fragmented mitochondrion can do this on its own.
Indeed, it has recently been found that cristae regulation by OPA1 is independent of its role in
fusion [196]. It is interesting, however, that the protein involved in inner membrane fusion is
also responsible for reshaping the cristae structure. It could be that there is a reason these two
processes are linked, perhaps fusion provides more space (and more lipids) to change cristae
structure.
Experimental tests. Measure the number of cristae and ATP synthase dimers in fused
filaments of mitochondria with different lengths, to search for a correlation between filament
size and the number of cristae and ATP dimers. Similar experiments have been performed
previously, in which both cristae- and dimer number were observed to increase upon starvation-
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induced hyperfusion [148]. Starvation, however, will affect cell metabolism and it may be that
the increases in cristae and dimer number are not a direct consequence of increased fusion.
A.2.2.2 Hypothesis (ii): Higher [ATP] is caused by fusion-induced decreases in
proton leak
Summary. Proton leakage across the inner mitochondrial membrane leads to decreased effi-
ciency of the electron transport chain machinery [389]. Fusion could lead to a decrease in the
amount of proton leak, meaning that ATP production would become more efficient in a fused
state (more ATP produced per substrate reduced).
Experimental support. This idea is supported by the observation that mitochondrial frag-
mentation in brown adipose tissue promotes a shift from using nutrient oxidation for ATP
synthesis, to using it for heat generation (which is caused by increased proton leak) [197]. The
authors find that fragmentation is required to induce this increased proton leak in hormonally
stimulated brown adipocytes [197]. Mitochondrial dynamics might thus change the efficiency
of ATP production, with efficiency being high if mitochondria are fused and low in fragmented
states.
Limitations/Critique. This hypothesis is based on measurements of leak in brown adipose
tissue; it is not clear whether the results hold for other tissues as well. Brown adipose tissue is
specialised in heat generation and proton leak may play a less important role in other tissues.
Moreover, the mechanism causing the changes in leak involved the protein Uncoupler Protein
1 (Ucp1) [197] which is specific to brown adipocytes and therefore this mechanism may not
exist in other tissues (other tissues do contain isoforms of Ucp1, called Ucp2, Ucp3, Ucp4 and
Ucp5).
Experimental tests. Measure whether there exists a correlation between the amount of
proton leak and the length of a mitochondrial filament in cells other than brown adipocytes.
To avoid side effects from overexpressing or downregulating specific proteins, one can use the
natural heterogeneity of mitochondrial length in wildtype cells.
A.2.2.3 Hypothesis (iii): Higher [ATP] is caused by fusion-induced decreases
in mitochondrial degradation
Summary. Mitochondria that are part of a large network are spared from mitophagy and it has
been suggested that hyperfusion is a mechanism to protect mitochondria from degradation [148,
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158]. The cause of less degradation during hyperfusion can simply be that only mitochondria
under a certain threshold size can be captured by an autophagosomal membrane. Degradation
of mitochondria, however, occurs for a reason and stopping this degradation can have negative
consequences.
Experimental support. Inhibiting mitophagy causes both reductions in cellular ATP levels
and increased ROS production, most likely because damaged mitochondria are unable to be
removed [390]. Fragmentation of damaged mitochondria was observed to precede mitophagy
[148]. Upon starvation, which causes mitochondrial elongation in wildtype cells, mitochondrial
proteins were degraded faster in cells lacking OPA1 (i.e. cells unable to fuse their mitochondria)
while they were retained in cells lacking Drp1 (i.e. cells unable to fission their mitochondria)
[148]. Similar observations were made in Ref. [158].
Limitations/Critique. This hypothesis relies on an increase in mitochondrial mass as a result
of a decrease in mitochondrial degradation. Whether this is true, however, is not clear. The
cell may have control over total mitochondrial mass (energy production is crucial for the cell
and one may expect it to be highly controlled) and reduce mitochondrial biogenesis in response
to decreases in mitophagy. There could of course be other reasons for wanting to reduce rates
of mitophagy that we are yet unaware of.
Experimental tests. Measure mitochondrial mass and the amount of mitophagy in a frag-
mented state and a hyperfused state, to see whether decreases in mitophagy levels (which
occur in hyperfused states) lead to increases in mitochondrial mass. It would also be inter-
esting to measure whether mitochondrial biogenesis is decreased as a response to a decrease
in mitophagy. Such a homeostatic control is assumed in the models of mtDNA dynamics we
discuss in Chapters 4 and 5.
A.2.3 Fusion creates distributional ‘power cables’
Summary. Fused mitochondria facilitate the distribution of respiratory capacity through the
cell. If mitochondria form long extended networks, then the electrochemical gradient (i.e. the
proton motive force) may equilibrate across the whole network by movement of protons or
other cations along mitochondria. This makes it possible for a mitochondrion at one end of a
fused chain to use the electrochemical potential generated by a mitochondrion at another end
of the chain to create ATP. Oxygen and nutrient levels will be higher at the cell’s periphery and
therefore mitochondria in central regions of the cell can take advantage of the electrochemical
gradient produced by peripheral mitochondria. Mitochondrial networks may thus be used as
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‘power cables’ to enable power transmission across the cell [180–186]. An illustration is given
in Figure 2.6B of Chapter 2.
The cable mechanism suggests several cellular advantages of mitochondrial fusion. 3D diffusion
of ATP or oxygen through the cytoplasm can be replaced by 1D movement of cations along
mitochondrial filaments; the speed of energy transmission is therefore likely to increase due to
the reduced dimensionality and increasingly directed nature of the motion. Another advantage
is that cabling may reduce damage by reactive oxygen species (ROS) in the core of the cell
where nuclear DNA is present. This is because ROS is generated at sites where the ETC is
active and the power cabling hypothesis predicts that this is mainly at the cell periphery.
Experimental support. When ATP is used more in certain parts of the cell, mitochondria
tend to cluster around these parts suggesting that ATP supply from distal mitochondria to
these regions is not sufficient [391]. Several tissues have very limited mitochondrial movement
(e.g. heart cells [261]); cabling could provide a way to ensure adequate ATP supply to these
regions. A recent study found evidence for tight electrical coupling between peripherally and
centrally located mitochondria in skeletal muscle [184], and similar observations were made in
cardiomyocytes [185]. Moreover, the authors of Ref. [184] observed the density of complex IV
(involved in creating the proton gradient) to be highest at the cell periphery, whereas complex
V (which uses the gradient to synthesise ATP) was most abundant in intra-fibrillar regions,
further away from oxygen-supplying blood vessels. A later study by the same authors suggested
that proton movement along mitochondria is not sufficient to equilibrate the proton motive
force between the peripheral and central regions in skeletal muscle cells at high respiration
[186]. Instead, they suggest movement of K+ and Na+ (whose concentrations are much higher
compared to protons) which can be exchanges for protons via K+/H+ and Na+/H+ antiporters
at either end of the mitochondrial chain (Figure 2.6B).
Coarse-grained quantitative model. To make progress exploring the implications of the ca-
ble hypothesis for ATP production, we first estimate the speed gain obtained though cabling by
comparing the diffusion time of oxygen through the cytoplasm with that of H+ along mitochon-
drial membranes. Performing this calculation with values measured in biological experiments
suggests that cables facilitate an order-of-magnitude increase in ATP production (see below),
thus providing a quantitative suggestion that mitochondrial power cables can be beneficial to
the cell. We note, however, that this estimation may be of limited use because of the recent
finding that protons are unlikely to be the main contributors to equilibration of potential [186].
Further modelling. The flow of electricity in a leaky cable (a long cylindrical piece of mem-
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brane) is described by the cable equation [392]. The cable equation is used to study electrical
flow in neurons but may be applied to a chain of electrically continuous mitochondria as well,
providing more fine-grained physical insight into the electrochemical dynamics of mitochondrial
power cables.
Limitations/Critique. The speedup of ATP synthesis rate obtained by using cables is likely
to be reduced because silent fission events, i.e. fission events without physical separation, will
slow down the diffusing cations (these type of events were measured to occur with a probability
around 50% over five minutes in a filament not longer than 4µm in COS7 cells [207]). The
respiratory complex that uses oxygen (complex IV) has a reaction capacity which normally
exceeds the maximal rate of the respiratory chain and can operate at low oxygen tension [393],
which weakens the statement that oxygen supply is a rate limiting step in respiration. The
cabling hypothesis may represent a reason for mitochondrial fusion in skeletal muscle cells
because these are highly dependent on oxygen supply and have high ATP demands. It is less
clear, however, how meso- and hyperfusion can be explained in other tissues less dependent
on oxygen and with lower ATP demands. The hypothesis also has difficulties explaining the
high frequency of fission and fusion rate. Finally, H2O2, a source for ROS damage, is able to
diffuse freely across several cell lengths and can thus induce damage far from the site of ROS
generation [394], questioning the ability of cabling to reduce ROS damage in the core of the
cell where nuclear DNA is present.
Experimental tests. The power cabling hypothesis predicts that there exists an oxygen
gradient between the periphery of the cell and the cell core, which can be tested experimentally.
Measurements of pH differences and cationic fluxes between the peripheral and central regions
will further elucidate the mechanisms by which the proton motive force is transported along
the cables.
A.2.3.1 Order of magnitude increase in energy production using mitochon-
drial power cabling
We here provide an explanation of the claim made above that cabling facilitates an order-of-
magnitude increase in ATP production. This quantitative argument proceeds by considering
the ATP generation in a central region of the cell where oxygen concentration is low. We will
compare two cases. Firstly, a ‘null’ case with no cabling, where oxygen must diffuse from a
peripheral region of the cell to act as an electron acceptor for ETC complexes in this central
region. Secondly, a ‘cabling’ case, where proton pumping is performed by ETC complexes in
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the oxygen-rich peripheral region, then protons are ‘cabled’ to central, low-oxygen region to
facilitate ATP production.
We will discuss diffusion of oxygen in skeletal muscle cells because the cable hypothesis was
developed studying these cells. We will use a diffusion coefficient of DO2 = (2.7 ± 0.3) × 10−7
cm2/s [395, 396] for oxygen diffusing through the cytoplasm. For protons we set DH+ =
(5.7 ± 0.7) × 10−5 cm2/s [397]. The proton diffusion coefficient was calculated assuming 2D
diffusion so in our estimation we should treat it as such [397] (the calculated value of DH+
would be different if 1D diffusion was assumed, so the diffusion constant obtained in Ref.
[397] is specific for 2D diffusion). We argued before that proton diffusion along mitochondrial
membranes can be described as a 1D diffusion process which increases the diffusion speed. We
are merely providing an order of magnitude estimation here so for our purposes we can ignore
dimensionality ambiguities. Assuming random diffusion (no bias) then the ratio of the time for
oxygen to diffuse across a distance x, tO2 , to that of protons, t
+
H , is given by
tO2
t+H
≈ D
+
H
DO2
≈ 214± 36. (A.20)
Suppose the number of protons necessary for the production of one ATP molecule is n (n ≈ 3).
The net reaction of complexes I, III and IV of the respiratory chain is
2NADH + 22H+matrix +O2 → 2NAD+ + 20H+IMS + 2H2O, (A.21)
hence, for every oxygen molecule used, 20 protons are pumped into the intermembrane space.
We now compare ATP production in the case that oxygen concentration is limiting. We assume
that the flux of n protons down the electrochemical gradient and through complex V is required
to create one ATP molecule. The presence of one oxygen molecule thus facilitates the production
of about 20/n ATP molecules, or 20 times more than are produced through the presence of
one proton. The rate at which oxygen is supplied to a mitochondrion can thus be 20 times
less than the rate at which protons are supplied while still resulting in the same rate of ATP
synthesis. Combining this with Equation (A.20), we estimate that using proton diffusion along
mitochondrial membranes to generate ATP where oxygen diffusion is limited, the rate of ATP
production will be about an order of magnitude larger.
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A.2.4 Meso- and hyperfusion have no function
Summary. It is possible that mitochondrial meso- and hyperfusion do not provide any addi-
tional advantage to the cell. Changes in the balance between fusion and fission events can arise
naturally as a consequence of changes in activities of mitochondrial fission and fusion proteins;
large-scale fusion may thus represent an epiphenomenon. Mesofusion may also be a side effect
of mitochondrial clustering in regions of high ATP demand.
Experimental support. Mammalian mitochondria are connected to microtubules via motor
proteins that mediate their (ATP-dependent) transport, which can cause long strings of mito-
chondria to form [398]. These ‘long bundles’ of mitochondria have been observed in cardiomy-
ocytes [261]. When changes occur in the activities of mitochondrial fusion/fission proteins, this
manner of alignment can facilitate connected filaments to arise because the mitochondria are
already lying end-to-end, ready to form a continuous filament. Changes in the microtubule
network may also alter mitochondrial morphology.
The main fusion and fission proteins, OPA1, MFN1,2 and Drp1, all have other functions in
the cell and Drp1 can undergo numerous post-translational modifications. Overviews of these
additional functions and post-translational modifications are given in Tables A.4 and A.5.
OPA1 also undergoes modifications and can be cleaved to shorter isoforms by various proteins
[236, 399–403]. We stress that the fact that many different proteins and post-translational
modifications have effects on mitochondrial morphology can lead to two entirely different con-
clusions: i) mitochondrial dynamics has a highly important function and needs to be controlled
by various pathways, and ii) mitochondrial dynamics is an epiphenomenon and changes in
morphology occur because of natural fluctuations in the activities of the mitochondrial shaping
proteins.
Experimental tests. We do not propose approaches to model or experimentally test this case,
but instead suggest that it is regarded as the ‘null hypothesis’ against which other alternative
hypotheses for mitochondrial network formation may be compared.
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A.3 Tables
Condition under which ex-
tended fusion is observed
Cell type Cause of extended fusion. Ref.
G1-S or G1 phase of the cell
cycle
Normal rat kidney cells
(G1-S) and human os-
teosarcoma cells (G1)
Not reported [151,
404]
Various kinds of stress includ-
ing starvation, oxidative stress,
UV irradiation and cyclohex-
imide
Various cell types includ-
ing MEFs, mouse pri-
mary fibroblasts, hepato-
cytes, human HeLa and
Cos-7 cells and HEK293T
cells
In the case of starvation,
decreased Drp1 Ser-616
and increased Drp1 Ser-637
phosphorylation was ob-
served [148, 158]. The stress
induced hyperfusion studied
by [149] was suggested
to be caused by increased
fusion rather than decreased
fission
[148,
149,
158,
167,
405]
In long-living individuals
(100.67 ± 2.88 years) mito-
chondria formed more fused,
elongated structures than in
young (27.83 ± 3.97 years)
or old (75.67 ± 10.86 years)
individuals
Dermal fibroblasts The cause was suggested to
be mainly decreased fission
rather than increased fusion
[154]
Mitochondrial length increased
during aging, senescent cells
shows long and interconnected
mitochondria
HUVEC cells A reduced expression of
hFis1 and Drp1 was ob-
served
[254]
Prolonged incubation with 20
nM MitoQ, an antioxidant
HeLa cells and normal hu-
man fibroblasts
Suggested to be decreased
fission
[406]
Cells grown in glucose rather
than galactose media
HeLa cells Not reported [407]
Table A.1: Occurrences and causes of hyperfusion in wildtype cells. Here we list conditions under which
wildtype cells show highly fused mitochondrial structures. The cause of the fused morphology (increased fusion,
decreased fission or both) is reported if known.
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Normal morphological state Cell type Ref.
- 1 day old cells show mainly tubular or intermediate (both frag-
mented and elongated) morphologies
C. elegans body
wall muscle
[408]
- 5 days old cells show an intermediate morphology
- 11 days old cells show intermediate or very fragmented mito-
chondria
- 16 days old cells show mostly very fragmented mitochondria
Typical cells show mitochondria dispersed throughout the cytosol
and their shape seems to be round, ellipsoid-, or sausage-like
human Cos-7 cells [409]
Wildtype cells typically show a tubular network structure MEFs [62]
Under standard culturing conditions, 40% of the cells had mostly
tubular mitochondria, 50% mostly fragmented mitochondria and
10% of the cells had an intermediate state (in which both frag-
mented and branched mitochondria coexisted in roughly equal
amounts).
human osteosar-
coma cells
[404]
Mitochondria in wildtype cells grown in media containing galac-
tose appear interconnected. Shifting cells from aerobic to anaer-
obic growth did not affect mitochondrial structure (at least not
within 7 hours)
yeast S. cerevisiae [410]
Both glucose and glycerol-grown cells show a single large mito-
chondrial component with few fragmented smaller ones. The large
mitochondrial component was about four times more branched in
glycerol grown cells, and mitochondrial volume was three times
larger in glycerol grown cells
yeast S. cerevisiae [411]
- Cells grown in media with 2% glucose showed an elongated mi-
tochondrial structure
yeast S. cerevisiae [412]
- in media with 0.5% glucose mitochondria appeared shorter
- in media with 4% glucose mitochondria had few connections and
branches
- Cells grown in glucose cultures show elongated and branched
mitochondria
yeast S. cerevisiae [413]
- Cells grown in ethanol have smaller/shorter mitochondria com-
pared to those grown in glucose cultures (total mitochondrial vol-
ume was the same)
- Cells in aerobic glucose-limited chemostat cultures have many
short mitochondria
- Cells in anaerobic fermentative chemostat cultures have elon-
gated mitochondria
Table A.2: Typical mitochondrial morphology in a variety of cells. To obtain a better idea of the ‘normal’
morphological state of mitochondria, we provide an overview of observed ‘typical’ mitochondrial distributions. One
has to keep in mind that the morphological state depends on cell function and cell cycle. Many studies investi-
gate mitochondrial morphology by staining with TMRE, JC-1 (both of which are dyes for mitochondrial membrane
potential) or matrix targeted GFP (Green Fluorescent Protein). However, as was stated in Ref. [207]: ‘the non-
fragmented shape of the web as revealed by TMRE alone does not reliably predict the boundaries of a network’. It
is therefore hard to know exactly how fused mitochondria actually were in studies that do not check for continuity
with photoactivatable GFP.
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Species of interest Diffusion coefficient
(µm2/s)
Ref.
Complex V:
(mobile fraction) 0.082 ± 0.002 (s.e.m.) [190]
(less mobile fraction) 0.019 ± 0.001 (s.e.m.) [190]
(immobile fraction) 0.006 ± 0.001 (s.d.) [190]
Complex II:
(mobile fraction) 0.140 ± 0.005 (s.e.m.) [190]
(less mobile fraction) 0.039 ± 0.002 (s.e.m.) [190]
(immobile fraction) 0.004 [190]
(mobile fraction) 0.161 [353]
(less mobile fraction) 0.003 [353]
Matrix targeted GFP 20-30 [234]
Matrix targeted EYFP:
In stationary mitochondria
In moving mitochondria
22 ± 2.1 (s.d., N = 12)
18 ± 4.7 (s.d., N = 46)
[414]
Mobile fraction of TFAM la-
belled mtDNA
0.05 ± 0.01 [191]
mtDNA stained with ethidium 10−3 [354]
Mobile fraction (93 ± 6%) of
outer membrane protein TOM7
0.7-1 [415]
Mobile fraction (93 ± 5%) of
outer membrane protein hFis1
0.4-1 [415]
Outer membrane protein Tom40 0.5 [416]
Table A.3: Diffusion constants of several mitochondrial proteins. GFP and EYFP stand for Green Fluores-
cent Protein and Enhanced Yellow Fluorescen Protein, respectively.
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Modifier Modification effect on Drp1 Ref.
Protein Kinase A
(PKA)
Phosphorylation of Drp1 at Ser-637 which pre-
vents Drp1 from tethering to mitochondria.
Drp1 remains retained in the cytosol instead
[417]
CaM kinase Iα,
ROCK1
Phosphorylation of Drp1 at Ser-637 which
caused increased mitochondrial fission
[418, 419]
Cdk1, Cdk5,
PKCδ, Erk1/2
Phosphorylation of Drp1 at Ser-616 which ac-
tivates Drp1
[420–423]
Calcineurin Dephosphorylation of Drp1 at Ser-637 making
Drp1 capable of translocating to mitochondria
[424]
MAPL,
SUMO1,2,3
Sumoylation of Drp1 which affects it GTPase
cycle
[425, 426]
O-GlcNAc-
transferase
and N-acetyl-
glucosaminidase
O-linked-N-acetyl-glucosamine glycosylation
of Drp1 at threonine 585 or 586. This de-
creases phosphorylation at Ser-637 and results
in increased translocation of Drp1 to mito-
chondria
[427]
Bax and Bak Promotion of sumoylation of Drp1 during
apoptosis
[428]
MITOL/MARCH5 Ubiquitination of both hFis1 and Drp1 [429, 430]
Table A.4: Overview of various post-translational modifications of the GTPase Drp1 which mediates
mitochondrial fission.
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Protein
name
Processes other than fu-
sion and fission in which
the protein is involved
Role of the protein Ref.
OPA1
Regulation of cristae mor-
phology
OPA1 oligomers may wrap around crista junctions
to keep them tight
[193,
194]
Apoptosis By tightening crista junctions, cytochrome c is kept
inside the cristae instead of diffusing into the cytosol
and inducing apoptosis
[58, 193,
194]
Depolarization events OPA1 causes reversible depolarization events after
matrix contractions
[431,
432]
MFN2
Mitochondria-ER interac-
tions and calcium home-
ostasis
MFN2 tethers mitochondria to the ER [433]
Oxidative phosphoryla-
tion gene expression
Independently of its role in fusion, MFN2 regulates
expression of OXPHOS genes
[434]
Apoptosis A MFN2 mutant has been observed to increase cy-
tochrome c release following DNA damage and ROS
damage, suggesting that MFN2, just like OPA1,
works to keep cytochrome c inside the cristae
[161]
MFN1 Apoptosis MFN1 may regulate activation of the pro-apoptotic
protein Bax
[435]
Drp1 Apoptosis Drp1 is transported to mitochondria upon apoptosis
induction. Inhibition of Drp1 can prevent apoptosis
[436]
Table A.5: Functions of the mitochondrial fusion and fission proteins other than inducing mitochondrial
fusion or fission.
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B
Supplemental information
complementing Chapter 4
This appendix complements Chapter 4, and is split into five sections:
1. In the first section we provide details on our choice of parameters in comparing different
control strategies
2. In the second section we define and motivate our linear and saturating output models
3. In the third section we estimate, derive and/or motivate all parameter values used in our
cost function
4. In the fourth section we show various cost function outputs and illustrate the cause and
robustness of expensive intermediate heteroplasmy states
5. In the last section we show predictions based on our nuclease treatment model
B.1 Feedback control of a heteroplasmic mtDNA population
Figure 4.1 in Chapter 4 shows the near equivalence of mean wildtype, mutant, and heteroplasmy
dynamics between three different forms of control, all of the form λ(w,m) = λ(w + δm): i)
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c0 − c1(w + δm), ii) d0 + d1/(w + δm) and iii) s0 − s1(w + δm)2 with c0, c1, d0, d1, s0, s1 > 0.
Here we complement this figure by showing that the variance dynamics are also nearly identical
(Figure B.1A, B, C).
We merely show that these different controls can give rise to similar dynamics by parameterising
them such that they do. First, we set the variances of each control to be equal in the absence of
mutants. From Table 4.1E it can be seen that the wildtype variance is now completely specified
by the mtDNA degradation rate µ, the steady state copy number wss and the control derivative
∂wλ(w) evaluated at steady state. The latter quantity is given by i) −c1, ii) −d1/w2ss and iii)
−2s1wss for the three controls defined above. These expressions were all set to be −7.21×10−6,
a value that was chosen such that the wildtype steady state distribution has a coefficient of
variation of CV = 0.1. This value is arbitrary, other choices of give similar results. We use a
deterministic wildtype steady state of 1000 (in the absence of mutants), which fixes the other
control parameters. Note that it is not surprising that these different controls yield similar
dynamics after we have parameterised them to do so; we want to illustrate these similarities to
stress that which quantity is being controlled can be more important than how it is controlled.
This is particularly true when dynamics are close to steady state, in which case a linear control
forms a good approximation to many non-linear controls.
A) B) C)
Figure B.1: Equal variances for different feedback control mechanisms. Related to Figure 4.1A-C; Three
different controls (see legend), all of the form λ(w + δm) with δ = 0.5, show nearly identical wildtype, mutant
and heteroplasmy variances. Other parameters used are Nss = 1000 (referring to the steady state copy number
present in the absence of mutants), µ = 0.07 (corresponding to a half-life of 10 days), and initial copy numbers
(w0,m0) = (920, 160) (corresponding to an initial heteroplasmy of ∼ 0.15).
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B.2 The relationship between resource consumption and energy production:
si(ri)
B.2.1 A linear output model
In our cost function we need to specify how si, the power supply measured in ATP/s (including
leak) of a mitochondrion of type i, depends on ri, a quantity resembling the resource con-
sumption rate of the mitochondrion. For robustness, we use two different equations for si(ri)
.
The first model is based on measurements in isolated mitochondria which found a linear rela-
tionship between ri and si (e.g. [295–297]). Specifically, we use the following equation:
sw(rw) = φ(rw − β) (B.1)
where φ can be mapped to the effective P/O ratio (explained in Section B.3.1) and β indicates
the respiration rate at zero energy production and therefore specifies the amount of leak. We
used the data from Ref. [295] to fit the parameters of this linear model (Table 4.3, Section
B.3.1), the result of which is shown in Figure B.2A in Section B.4.
It is not clear, however, whether the observations made in isolated mitochondria, without any
interactions between the mitochondria and the nucleus or the endoplasmic reticulum, still hold
in vivo. This is one of the reasons to also consider another type of model, as described below.
B.2.2 A saturating output model
Our cost function contains a term which penalises the consumption of resources, meaning that
the cheapest state is the one that satisfies demand with the smallest net resource consumption
rate. A linear function si(ri) then implies that, for a given demand, the optimal number of
mitochondria is the minimum number required to satisfy the demand with these mitochondria
respiring as fast as they can (as can be seen in Figure B.2E). However, containing a minimally
required number of mitochondria will make a cell less robust to stochastic fluctuations in both
mitochondrial copy numbers and demand. Moreover, mitochondria are known to have large
spare capacities [298, 299] indicating that in resting state they do not operate near their limits.
We therefore expect that there is some extra cellular cost associated with this ‘maximally
respiring’ state, causing it to be non-optimal in resting conditions.
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This is why we have chosen to use a second model which describes a saturating relationship
between ri and si (visualised in Figure B.2A). Note that we do not claim that mitochondria
become less efficient as they respire faster, we impose the saturating shape merely to effectively
assign a higher cost to high respiring states. By imposing this saturation, the variable on the
y-axis of Figure B.2A can be interpreted an ‘effective energy production’. We will refer to the
two models as ‘the linear output model’ and ‘the saturating output model’.
A changing energy production efficiency is not entirely unreasonable, though, because in ex-
periments with isolated mitochondria one usually uses a particular substrate (or a particular
combination of substrates) whereas a larger mixture of substrates will be available in the cell,
and the relative presence of each substrate may fluctuate over time. The efficiency of respira-
tion depends on the kind of substrate that is used, so it may be possible that at high demand
(and high respiration) the substrate of first choice has become limited and another less efficient
substrate is used instead. Also, it was suggested that spare capacity can be caused by an
increase in substrate entrance in the TCA cycle∗ [437]. This would mean that a state of high
respiration is caused by an increase in electron transport chain substrates (e.g. NADH and
FADH2). A ‘push’ to the proton pumping complexes instead of a ‘pull’ at the ATP synthase
would lead to an increase in the electrochemical gradient across the membrane and therefore
an increase in leak. These arguments are speculative but show that the saturation model may
not be unreasonable.
The saturating model is defined by the equation:
sw(rw) = 2
smax
1 + e−krw
− (1 + ∆)smax
sw(rw) = 2
smax
1 + e−krw
− 1.1smax (B.2)
where k is the rate at which the model saturates, smax is an indication of the maximum energy
production rate, and ∆ > 0 is introduced to ensure that, like in the linear model, a nonzero
amount of resource is required to maintain a zero energy output (due to proton leak). As proton
leak accounts for ∼ 10% of the total energy production in the linear model, we chose ∆ = 0.1.
We will set the parameter values k and smax such that the saturating and linear model show
similar behaviour for low values of rw (Section B.3.5), as shown in Figure B.2A of Section B.4.
∗The tricarboxylic acid (TCA) cycle represents a series of reactions and provides, amongst others, the
reducing agent NADH which is used as an input to the electron transport chain.
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B.3 Parameter values for the cost function
Some of our results will be a consequence of the exact structure of our cost function, and might
have been different if another type of cost function was used. We would argue, however, that
the main elements in our cost function are quite general: terms involving supply, demand, and
resource. We aimed at making our cost function simple, and using biologically interpretable
parameters. We do not aim to give a detailed kinetic description of the energetic costs involved,
but present a simpler description that allows us to compare distinct strategies relative to each
other rather than providing absolute costs. We use our cost function as a tool to characterise
cost landscapes and begin to explore optimal control strategies.
In the spirit of ‘back-of-the-envelope’ reasoning in biology [116] we seek plausible and inter-
pretable parameter estimates, using both order-of-magnitude estimations and values found in
the literature. Default parameter values are summarised in Table 4.3.
The final goal is to obtain a cost for a state with a certain number of mtDNA molecules; we
therefore need to express our cost as a cost ‘per mtDNA molecule’. Because the density of
mtDNA molecules within the mitochondrial network seems to be roughly constant [280], we
assume every mtDNA molecule is associated to a particular amount of mitochondrial volume
which we here define as a ‘mitochondrial unit’. All our parameters refer to these mitochondrial
units.
B.3.1 Mitochondrial energy production and leak: φ and β
Mitochondrial respiration is a process by which energy from nutrients is converted into (amongst
others) ATP. Part of this process involves the pumping of protons across the inner mitochondrial
membrane to create an electrochemical potential across the membrane. Energy is released when
protons flow back into the matrix and this energy can be used to create ATP. However, the
coupling between proton pumping and ATP synthesis is not perfect and protons can leak
through the membrane, reducing the efficiency of respiration. An often measured quantity in
experimental studies is the mechanistic P/O ratio [438, 439] which refers to the theoretical
maximum amount of ATP (P) produced per oxygen (O) reduced by the respiratory chain. The
effective P/O ratio is more physiologically relevant and takes into account leak [297].
In our linear model we assume a linear relationship between mitochondrial ATP production
rate and mitochondrial oxygen consumption rate, based on experimental data [295–297]. In
Refs. [295, 296] measurements show an almost perfect linear relationship between these two
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quantities, which is consistent with data from Ref. [297].The parameters φ and β correspond
to the slope and intercept of the linear function, respectively. In Ref. [295] this slope was
measured to be 2.03 ± 0.13 for isolated pectoralis muscle cell mitochondria in the presence of
pyruvate and malate; we have decided to use φ = 2, mainly based on these experiments.
The value of β is an indication of the ‘leakiness’ of the mitochondrion: it represents the rate
of oxygen consumption that is required to balance the leakage of protons across the membrane
in order to maintain the mitochondrial membrane potential. To obtain a consistent value for β
we also use the data presented in Ref. [295]. Their measurements find that β is about a tenth
of the maximum respiration rate. This maximum respiration rate is obtained by adding high
(unlimited) concentrations of ADP; the state of the cell in these conditions is known as state
3ADP. Because state 3ADP does not necessarily correspond to in vivo conditions, we define the
respiration rate in this state as rmax,t: the maximum ‘theoretical’ respiration rate. We will fix
rmax,t = 1 and use this to scale our other parameters. This means that our parameter value for
β is β = 0.1.
We stress that though we have based our parameter values here on a specific study, changes
in their values will not affect the qualitative structure of our cost function but merely changes
the slope and intercept of the linear output function defined in equation (B.1).
B.3.2 Resource and supply and maintenance cost: rmax, rn and sn
A cell in vivo is unlikely to experience the high concentrations of ADP present in state 3ADP
(defined above). We therefore set our parameter rmax, the physiological maximum respiration
rate, to be slightly below rmax,t, i.e. rmax = 0.95 · rmax,t = 0.95.
We introduce rn and sn as the ‘normal’ respiration rate and ATP production rate which are
present in resting conditions, respectively. Their values are not used directly in our model
equations, but only to connect our parameter estimates to actual physiological values (Section
B.3.8). Mitochondria have spare capacity, i.e. in normal unstressed conditions they use only
part of their maximal oxygen consumption rate (OCR). The amount of spare capacity is usually
measured as the fold-change in OCR that occurs after adding FCCP to cells, a mitochondrial
uncoupler. Several measurements of the fold-change in OCR are: in the range (2-4)-fold [440],
1.4- to 2.5-fold [437], about 2-fold [298] and about 2.5-fold [299]. The maximum respiration rate
when adding FCCP is known as State 3FCCP, and is higher than State 3ADP (see e.g. [441]).
We interpret the spare capacity as the ratio State 3FCCP/rn, meaning that the ratio rmax/rn is
lower than this. We have decided to take rmax/rn = 1.5, meaning that rn = rmax/1.5 ≈ 0.63.
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For the linear output model, the value of sn is now simply sn = sw(rn) ≈ 1.1 (this abstract
value is related to actual values in ATP/s in Section B.3.8).
B.3.3 Maintaining, building and degrading: ρ1, ρ2 and ρ3
The model organism with the most quantitative data on mitochondrial energy budgets is bud-
ding yeast, Saccharomyces cerevisiae. Reasoning that the scales of biophysical costs of mito-
chondria are likely comparable across eukaryotes, we first draw from this literature to motivate
order-of-magnitude estimates for a range of essential mitochondrial processes. We will later
construct parallel estimates using other organisms.
We first focus on estimating the mitochondrial building cost ρ2 (in ATP). We provide three
distinct estimations and combine them to obtain our final estimate.
For the first estimation we use a list of mitochondrial proteins in yeast [442], and obtain
information on turnover rates, abundance (per yeast cell), and lengths (amino acid length) of
these proteins by using the Saccharomyces Genome Database [443]. We end up with a list of
∼ 200 mitochondrial proteins in yeast S. cerevisiae. We incorporate the observation that it
takes about 5.2 ATP molecules to elongate a growing peptide chain by adding an amino acid
[444], which means that the total synthesis cost of the mitochondrial proteins included in our
list is given by 5.2
∑
i lengthiabundancei ≈ 2× 1010 ATP per yeast cell. The known number of
mitochondrial proteins in S. cerevisiae is on the order of 1000 [445]; we will therefore assume
that the protein synthesis cost obtained from our protein list corresponds to roughly a fifth of
the total mitochondrial protein synthesis cost. We might expect that the proteins best known
[442] are the more abundant ones, meaning that our final cost is likely to be an overestimate.
We also assume that all of the mitochondrially associated proteins are used exclusively for
mitochondrial function. In E. coli, the mitochondrial protein synthesis cost represents ∼50% of
the total mitochondrial synthesis cost (two other major contributors are phospholipid synthesis
and RNA synthesis)[444]; we will make the assumption that this observation in E. coli holds
in mitochondria as well. This brings the total mitochondrial building cost in a single yeast cell
to be ∼ 1.9× 1011 ATP. Assuming 50-100 mtDNA molecules per yeast S. cerevisiae cell [446],
the building cost associated with a single mtDNA molecule (and therefore the building cost of
a mitochondrial unit) is given by (2− 4)× 109 ATP.
For our second estimation we use the total protein weight of a single mitochondrion which was
measured to be about 3 × 10−10 mg in rat liver [447], as well as the typical weight of a single
protein which is about 5 × 10−17 mg [444]. This means that a mitochondrion contains about
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6 × 106 proteins. Using that the typical length of a protein is 300 amino acids [444, 448, 449]
together with the 5.2 ATP cost of adding amino acids and the estimation that protein costs
represent 50% of the entire building cost, the mitochondrial building cost is estimated to be
2×1010 ATP. Note that this cost does not necessarily represent our mitochondrial unit because
it is unknown how many mtDNAs a ‘mitochondrion’ corresponded to when measuring its weight
in Ref. [447].
The third estimation is based on the building cost of an E. coli, which is about 1010 ATP
[444]. Keeping in mind that we want the building cost of a fraction of mitochondrial volume
corresponding to a single mtDNA molecule, we need to convert the building cost of an E. coli
(which has a volume of about 1 µm3) to represent our mitochondrial unit. It was estimated
that the total mitochondrial network length in yeast S. cerevisiae is about 25 µm with a total
mtDNA copy number of 50-100 [446]. Assuming that the mitochondria form tubules with
a constant diameter of 300 nm [178] gives a total mitochondrial volume of about 1.8 µm3;
another total mitochondrial volume estimate in yeast S. cerevisiae is 1.5 µm3 [178]. Uniform
distributions for the mitochondrial volume (1.5-1.8 µm3) and mtDNA copy numbers (50-100)
leads to a volume of (2.3± 0.5)× 10−2µm3 per mitochondrial unit. This means that rescaling
the E. coli building cost gives us an estimate of (2.3±0.5)×10−2 ·1010 = (2.3±0.5)×108 ATP
to build a single mitochondrial unit. Note that this may represent an overestimation because E.
coli is a unicellular organism, whereas the mitochondrion is an organelle which cannot survive
in isolation [450].
While there are differences in these estimates, arising both from uncertainty and different
quantitative lines of reasoning, they together give an overall scale for mitochondrial building cost
of around 109 ATP. Because in our model we only need a rough estimate of the mitochondrial
building cost, we use ρ2 = 10
9 ATP.
We interpret the maintenance cost, denoted by ρ1, as the cost in molecules ATP/s corresponding
to, for example, maintaining the mitochondrial lipid membranes, importing/exporting proteins,
and synthesizing new proteins. To obtain an estimation of ρ1, we again use the Saccharomyces
Genome Database [443]. We can calculate the cost of continuously turning over the ∼ 200 pro-
teins in our list (obtained from [442]), leading to 5.2
∑
i lengthiabundancei(degradation rate)i ≈
6 × 105 ATP/s per yeast cell. In other words, the maintenance cost per second of our set of
mitochondrial proteins is about five orders of magnitude less than their synthesis cost. We
therefore assume ρ1 = 10
−5ρ2.
The mitochondrial degradation cost ρ3 is the most challenging parameter to estimate, as the
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process of mitochondrial degradation remains poorly characterised. Protein production and
biosynthesis costs form the bulk of mitochondrial production requirements, and from cell-wide
studies on energy budgets are among the most considerable demands in cell biology. We
therefore assume that degradation has lower energy requirements than production, and set its
upper limit at ρ3 = 0.1 ·ρ2. Lowering ρ3 further has little impact on the outcomes of our model.
B.3.4 Demand and resource availability: D and R
We want to model two kinds of cells: low copy number cells (1000 wildtype mtDNAs in resting
state) and high copy number cells (5000 wildtype mtDNAs in resting state). Denoting this
desired number of ‘normal’ mitochondria by wn (which are assumed to operate at the ‘normal’
production rate sn (Section B.3.2)), we obtain
D = wn(sn − ρ1 − µρ3 − λρ2) (B.3)
where µ and λ are the degradation and replication rates per second. This equation states that
the overall net output of wn mitochondria exactly satisfies demand. Using wn = 1000 and
wn = 5000 leads to D ≈ 1055 and D ≈ 5275 ATP/s. These abstract values for demand are
mapped to actual cellular ATP demands in Section B.3.8.
The parameter R denotes the maximum rate at which resource can be consumed by all of the
mitochondria together and represents a cellular resource availability. In normal resting state the
total resource that is consumed is wnrn, and the resource consumed when these mitochondria
respire as fast as they can is wnrmax. We then assume this maximal respiration rate is achieved
by using all of the available resources, i.e. R ≈ wnrmax. It may be, however, that a state of
maximum respiration can only be maintained for a short time, and in our cost function we want
to describe the ‘steady state cost’ for different states. We therefore use R < wnrmax (R now
denotes the maximal respiration rate that can be maintained for longer periods of time). We
chose to use R = 0.8wnrmax leading to R = 760 and R = 3800 for wn = 1000 and wn = 5000,
respectively.
B.3.5 Saturating model parameters: smax and k
We set the parameters of the saturating model described in equation (B.2) such that it matches
the linear model for low respiration. This lead to k = 3.0 and smax = 1.54.
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B.3.6 The cost of resource consumption α
The value of α, i.e. the scaling parameter that appears in the cost function given by
C(w,m) = |D − S(w,m)|+ α(wrw +mrm) (B.4)
is hard to determine. Its value describes the cost of a unit of resource consumption relative to
the cost of a unit of ‘energy deficiency’ (the cost of S(w,m) being one energy-unit below D). We
estimated that a penalty for resource consumption usage should be about an order-of-magnitude
less than the penalty for not-satisfying demand, and have therefore decided to assume α = 0.1.
We note that the value of α has no influence on the shape of the demand-satisfying region, it
only changes the relative costs within (and outside of) the region.
B.3.7 Mutant parameters: 1, 2
In Chapter 4 we vary the parameter 1, describing the resource uptake rate of mutants relative
to wildtypes. Additionaly, mutants can be less efficient than wildtypes, producing less energy
per resource consumed; we denote this lower mutant efficiency by 2 ∈ [0, 1]. Because the
number of protons that are pumped across the mitochondrial inner membrane by the electron
transport chain complexes for every unit of resource (NADH) that is consumed is fixed, a lower
2 would have to mean that either i) the mutation has increased proton leak (or other ways
of depolarising the membrane), or ii) the mutation has made the ATP synthase dysfunctional.
The value of 2 can be related to the P/O ratio of the mutants relative to that of the wildtypes.
Most mtDNA mutations, however, affect the electron transport chain complexes themselves
and are therefore likely to reduce the flow of resources through the chain (which would mean a
low value for 1). This is why we assume 2 = 1 in our main model and only vary the parameter
0 < 1 < 1. For completion, here in the SI we provide a heatmap showing the cost in (w,m)
space for various values of 2 (Figure B.3).
B.3.8 Parameter units
We can relate our parameter values to actual values, e.g. expressing our demand D in ATP/s.
As an example of an ATP demand we use the ATP production rate in unstressed human skin
fibroblasts. Assuming that these healthy cells satisfy their demand, their net ATP production
rate should equal their ATP demand. The rate of ATP production in skin fibroblasts was
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estimated to be about 109 ATP/s, the large majority of which is supplied by mitochondria
[451]. The number of mtDNAs in healthy human skin fibroblasts was measured to be roughly
in the range 2400-5200 [452] (the variation in copy number was partly due to variation in ages
of the individuals), and we will use the value 4000 as an estimation. Using wn = 4000 we obtain
109 = 4000(sn − ρ1 − λρ2 − µρ3)
≈ 4000(sn − ρ2(10−5 + λ+ 0.1µ)
≈ 4000
(
sn − 109
[
10−5 + 0.07/(24 · 3600) + 0.1 · 0.07/(24 · 3600)
])
(B.5)
Here we used an mtDNA half-life (T1/2) of 10 days, giving a degradation rate ln(2)/10 ≈ 0.07
day−1, and assumed that the cells are in steady state with λ = µ. This leads to sn ≈ 2.6× 105
ATP/s meaning that, considering we used sn ≈ 1.1, our parameters sn, D are expressed in units
of about 2.6×105 ATP/s. This means that, in our units, the parameter values we use for ρ1, ρ2
and ρ3 are ρ1 ≈ 0.04, ρ2 ≈ 3828, and ρ3 ≈ 383.
B.4 Cost function outputs
B.4.1 Output visualisations
Figure B.2A shows the behaviour of equations (B.1) - (B.2) for various parameter values. Note
that none of the lines in the figure crosses the origin, because even when no ATP is created,
respiration is required to maintain the gradient which would otherwise be lost due to proton
leak. Figure B.2B-E shows how resource consumption rate and cost change as the number
of mtDNAs changes. Three regimes can be distinguished: 1) there are too few mitochondria
present to satisfy demand and they use their maximum possible resource uptake to get their
energy production rate as close to D as possible; 2) demand can be satisfied and the cost
now only depends on the amount of resource that is used; 3) resource has become limiting
and demand cannot be satisfied any more. The main difference between the two models is
that in the linear model, when demand is satisfied, the cheapest state is the one with the
smallest mtDNA copy number possible whereas the saturating model is cheapest at a higher
copy number. This is because mitochondria in the saturating model becomes more efficient as
less resources are being consumed.
Figures B.3A,B show the cost function as a heatmap in (w,m) space. This figure is similar
to Figure 4.2 in Chapter 4 but here we have fixed 1 = 1 and varied 2. Mutants are now
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less tolerated because they consume just as many resources as wildtypes, but still produce less
output. It is now not the case that intermediate heteroplasmies are less efficient; intermediate
heteroplasmies are only less efficient when 1 < 1 (mutants consume less resource) and when a
saturating output model (Figure B.2) is used. When 1, 2 < 1, it is possible for intermediate
heteroplasmies to be less efficient but the smaller the value of 2, the smaller the range of values
of 1 for which this is true; therefore, the effect of intermediate heteroplasmies being less efficient
will be most easily observed when the mutant efficiency is close to that of the wildtypes.
1
2
A) B) C)
D) E)
Figure B.2: Relationship between resource consumption and energy output. A) The energy production rate
of a single wildtype mitochondrion as a function of its resource consumption rate is shown, as given by equations
(B.1) and (B.2). For the linear model (corresponding to the straight lines) the parameters φ and β are changed by
10%, for the saturating model we vary smax and k. The magenta line indicates rmax. B) As w increases, demand
is shared between more mitochondria and each individual one can afford to consume resources at a lower rate (the
same figure legend applies for figures C, D and E). C) The total resource consumption increases with w because
the mitochondria need to consume a non-zero amount of resources to produce a net energy output and each mito-
chondrion comes with a maintenance cost. D) The total energy produced by wildtypes increases when mutants
are present. E) When demand is satisfied, the cost increases with w in the linear model, resulting in minimal
costs when copy numbers attain the minimum number required to satisfy demand (1). In contrast, for the satu-
rating model the cost decreases at first because as individual resource consumption drops, the energy production
efficiency increases. Minimum cost now occurs when mitochondria are working most efficiently (2). Parameters
1 = 0.1 and 2 = 1.0 were used.
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A) B)
Figure B.3: Changing mutant efficiency (2) does not lead to expensive intermediate heteroplasmies.
A) + B) Similar to Figure 4.2 in Chapter 4, these figures show the cost values in (w,m) space, but now as a
function of 2 (mutant efficiency) instead of 1. This time we show the cost in the entire space. The white lines
show the region in which demand is satisfied for our default parameter values. Because mutants consume the same
amount of resource as wildtypes (1 = 1), resource becomes limiting at relatively low values of m compared to
when 1 < 1. Note that intermediate heteroplasmies are not less efficient here.
B.4.2 Expensive intermediate heteroplasmies - explanation and robustness
Here we attempt to provide an explanation for why, in certain cases, intermediate heteroplasmy
values are more expensive than high or low values. In these cases, in high heteroplasmy regions
it is more efficient to increase heteroplasmy even more, whereas in low h conditions it is more
efficient to decrease h; this automatically implies there exists some intermediate heteroplasmy
value that is least efficient. Figures B.4A, B show the amount of resource consumed by in-
dividual wildtype and mutant mitochondria in four different example states. All states have
identical total copy numbers (w+m = 104) and total outputs (equal to demand), but different
heteroplasmy values (h = 0.1, 0.3, 0.7 and 0.9). When heteroplasmy increases, the individual
resource consumption rates rw and rm both increase to compensate for the higher mutant copy
number; this is true both in a low-h region (h increases from 0.1 to 0.3, Figure B.4A) and
a high-h region (h increases from 0.7 to 0.9, Figure B.4B). However, the total resource con-
sumption rate does not necessarily increase because the increase in h has caused a number of
wildtype mitochondria to become mutants, thereby decreasing the combined wildtype resource
usage. Computing the values of the resource consumption rates for the states with h = 0.1 and
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0.3, while referring to Figure B.4A, gives:
w1rw1 = 9000 · rw1 ≈ 3227
m1rm1 = 1000 · rm1 ≈ 125
w2rw2 = 7000 · rw2 ≈ 2981
m2rm2 = 3000 · rm2 ≈ 447, (B.6)
while the states h = 0.7 and 0.9 (referring to Figure B.4B) give
w1rw1 = 3000 · rw1 ≈ 1982
m1rm1 = 7000 · rm1 ≈ 1618
w2rw2 = 1000 · rw2 ≈ 846
m2rm2 = 9000 · rm2 ≈ 2665. (B.7)
Comparing the states with h = 0.1 and h = 0.3, the total rates of resource usage are 3352 and
3428 respectively; the lower heteroplasmy state is more efficient. However, when heteroplasmies
are higher, the high heteroplasmy state (0.9 rather than 0.7, with total resource usage 3511 vs
3600) is most efficient. This effect is due to the nonlinearity of Equation B.2.
Next, we investigate how robust the existence of an expensive intermediate heteroplasmy value
is. Let hmax denote the value of h with maximum cost at fixed total copy number (w + m).
Figure B.5A shows hmax as a function of both total copy number and 1, setting all other
parameters to their default values. The range of total copy numbers was chosen to correspond
roughly to the range for which demand can be satisfied in a fully wildtype cell (with the objective
of considering ‘plausible’ copy number regions). We see that an intermediate value of hmax exists
for a wide range of parameter values, but only for large enough 1. This means we only expect
to see expensive intermediate h values when neither of the two mtDNA species are severely
dysfunctional. We further varied the parameters ρ1 and smax which play important roles in the
cost function overall (ρ1) and the specifics of the saturating output model (smax), examples of
which are shown in Figure B.5B,C,D which illustrates their values have little influence on hmax.
Similar results were obtained by varying the parameters ρ2 and ρ3 by an order of magnitude.
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A)
    = 9000  
    = 1000
    = 0.1 
    = 7000  
    = 3000
    = 0.3
B)
= 1000  
= 9000
= 0.9 
= 3000  
= 7000
= 0.7 
Figure B.4: Intermediate h values require more resources to satisfy demand, but only if mutants con-
sume less resources. A) The resource consumption rates and energy production rates of wildtypes and mutants
are shown for two states: (w1,m1, h1) = (9000, 1000, 0.1) and (w2,m2, h2) = (7000, 3000, 0.3). In both cases,
the total energy output is equal to the demand. When heteroplasmy is higher (h = 0.3), the individual resource
consumption rates are higher in order to maintain a constant total energy output. Overall, the state with h = 0.1
uses the least resources (Equations B.6). 1 = 0.35 was used. B) This figure is similar to Figure (D) but now the
two states (w1,m1, h1) = (3000, 7000, 0.7) and (w2,m2, h2) = (1000, 9000, 0.9) are compared. The state with
h = 0.9 uses the least resources (Equations (B.7)).
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A) B)
C) D)
Figure B.5: The existence of intermediate heteroplasmy values is a robust feature of the saturating out-
put model. We show the value of hmax, the most expensive heteroplasmy value at constant copy number, as a
function of total copy number and 1 (describing mutant pathology). White regions correspond to hmax = 1.
A) Using our default parameter values, an intermediate hmax exists for large enough mutant functionality 1. B)
The parameter smax is increased by 50% with minimal effect on the output. We kept the parameter k fixed as
it defines the amount of proton leak (the resource consumption rate at zero energy output) which agrees with
the amount of proton leak in the linear output model whose parameters are based on experimental data. C) The
parameter ρ1 is increased by an order of magnitude with minimal effect on the output. D) The parameter ρ1 is
increased by an order of magnitude and smax is decreased by 50%. Again, change in hmax are small.
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Label Control optimal parameters satisfying
our two constraints
I λ(w) = µ+ c1(wopt − w) c1 = αRµ/wopt
II λ(w +m) = µ+ c1(wopt − (w +m)) c1 = αRµ/wopt
III λ(w+δm) = µ+c1(wopt−(w+δm)) c1 = αRµ/wopt
δ is optimised
IV λ(w,m) =
µ(αR(wopt−w−ηm)+w+ηm)
(w+m) αR = 10.0
η is optimised
Table B.1: Parameter values for the four different control mechanisms we employ. Two parameters of each
control are set by the two constraints we impose. The parameter αR was proposed to lie in the range 5-17 [1] and
here we used αR = 10. The values for δ and η are found by optimizing our cost function over the steady states
corresponding to our initial conditions. We used 50 initial conditions equally spread over the range h0 ∈ [0, 0.2].
The two values used for wopt are 1524 and 7616 (Table 4.3). We further use µ = 0.07 day
−1.
B.4.3 Comparison of the cost of different control mechanisms
In Section 4.2.3 of Chapter 4 we introduced four different feedback controls and compared their
mean costs. Here, we additionally show the means and variances of the wildtypes, mutants and
cost up to ∼ 82 years resulting from stochastic simulations. The parameter values we used to
compare the four controls are summarised in Table B.1 for clarity. We observe that the increase
in cost for the linear control with δ = 0 is mainly caused by an increase in mean mutant copy
number, the cause of which is discussed in more detail in the next chapter.
Figure B.7 shows the optimal values for δ in the linear feedback control λ(w,m) = µ+ c1(Nss−
(w+ δm)) as a function of 1. Stochastic simulations starting in steady state at either h0 = 0.1
or h0 = 0.8 were performed for T = 10
4 days. The mean integrated cost over these 104 days
was evaluated for different values of δ, and the optimal δ values are shown. This was done for
both the linear and the saturating model. The general trend is, as was shown for T = 100 in
Chapter 4, that the lower 1 the lower the optimal δ.
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Figure B.6: Wildtype, mutant and cost dynamics for four different control strategies. Dynamics are shown
for the four controls I, II, III, and IV defined in Table B.1. Again, we see that the effects of the control are more
noticeable in low copy number cells. Parameter are set as given in Table B.1. Values for wopt are those for the
saturating output model at low and high copy number. The free parameters in control III and IV (δ and η) were
optimised over initial conditions in the range h ∈ [0, 0.2]. For the optimization the default cost function parameters
were used as well as 1 = 0.3.
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Figure B.7: At long times and high heteroplasmies, energy sensing control becomes suboptimal. Related
to Figure 4.3C; The optimal value of δ in a linear feedback control is shown as a function of 1. Here we used
T = 104 days (optimization time) and low copy numbers for both the linear and saturating model. The solid and
dashed lines correspond to trajectories starting at h0 = 0.1 and h0 = 0.8, respectively. The less resources the
mutants consume (and the less output they therefore produce) the lower their optimal contribution to the control.
B.5 Zinc Finger nuclease treatment model
B.5.1 Visualisation of Zinc Finger concentrations during treatment
As explained in the ‘Methods’ section of Chapter 4, we simulate the treatment of cells by
mitochondrially targeted Zinc Finger Nucleases (mtZFNs). The concentration of the mtZFNs
is modelled by the following equation:
[ZFN ](t) =
I0
µz − b
(
e−bt − e−µzt) (B.8)
where I0 is the treatment strength (e.g. the initially added mtZFN concentration), b indicates
the treatment duration and µz is the mtZFN degradation rate. Figure B.8A shows this equation
for different treatment durations. As we found in Chapter 4, the weaker and longer treatment
option leads to larger heteroplasmy shifts.
B.5.2 Heteroplasmy values can increase after nuclease treatments
As mentioned in Section 4.2.3.2 of Chapter 4, there is a possibility for cellular heteroplasmy
to increase after a treatment has been applied. This is true especially if the selectivity of the
treatment is low (i.e. ξ is close to 1) and the initial heteroplasmy of a cell is high; in this
case treating a cell may even eliminate all wildtype mitochondria, increasing heteroplasmy to
1. To model the extent of this effect we initialise a cell with a given heteroplasmy h0, and let
160
Pre-treatment 
heteroplasmy value
A) B)
C) D)
Figure B.8: Zinc Finger Nuclease concentrations for short and long treatments. A) Here we show the con-
centration of mitochondrially targeted Zinc Fingers as modelled by Equation (B.8). The parameter values for the
short and strong treatment (I0 = 36, b = 11) are similar to those found in fitting the model to the data. For the
mtZFN degradation rate we used µZ = log(2) day
−1 (corresponding to a mtZFN half-life of 1 day). There exists
a possibility of increasing heteroplasmy levels through treatment. B) The probability of increasing hetero-
plasmy above its initial pre-treatment value h0, after one round of treatment and recovery, is shown as a function
of h0 and ξ. Cells are initialised with a total copy number of 500. The cross indicates the parameters used in Fig-
ure (D). The parameter values for I0, b and c1 are set to their fitted values: (I0, b, c1) ≈ (39, 20, 3 × 10−4). We
used δ = 1. C) Similar to figure (B), but now cells are initialised with a total copy number of 5000; in these large
copy number cells stochastic fluctuations in copy number have less effect and the probabilities of exceeding ini-
tial heteroplasmy values are smaller compared to Figure (B). D) An example of a distribution of post-treatment
heteroplasmy values is shown using parameters h0 and ξ as indicated by the cross in Figure (B). The orange line
indicates the value of h0 (the heteroplasmy that was present before the treatment started).
it undergo one round of treatment and recovery after which the final heteroplasmy is recorded.
This process is repeated to obtain the probability that, given an initial heteroplasmy h0, the
final heteroplasmy after treatment exceeds h0 (P (hfinal > h0|h0)). Figures B.8B,C show these
probabilities as a function of h0 and selectivity parameter ξ, for initial mtDNA copy numbers
500 and 5000; the effect-size is larger for low copy number cells. Figure B.8D shows an example
of the distribution of post-treatment heteroplasmies. The recovery time used in the simulations
is 30 days which is long enough for the cells to recover their initial copy numbers and short
enough for the change in h to be almost completely due to treatment, rather than due to
naturally occurring random drifts in heteroplasmy values. Chances of increasing heteroplasmy
are highest when h0 is very high or very low (if h0 is low the low mutant copy numbers increase
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the effect of stochastic fluctuations). In the examples shown, when ξ <= 0.6 (i.e. for every
mutant that is cleaved, 0.6 wildtypes are cleaved) increases in heteroplasmy are very unlikely
to occur.
B.5.3 Bayesian inference model outputs
As explained in Section 4.2.3.2 of Chapter 4, we expect a high correlation between the nuclease
treatment strength parameters I
(N)
0 , I
(H)
0 and I
(L)
0 (referring to normal, high and low mtZFN
concentrations) and the treatment duration parameter b; this is confirmed in Figure B.9A.
The ratio I0/b is expected to be higher at high mtZFN concentration since the parameter I0
represents mtZFN concentrations directly after treatment (Section 4.4). We observe that this
is indeed the case (Figure B.9B).
A) B)
Figure B.9: High correlation between nuclease treatment strength and duration. A) We show the cor-
relation between posterior samples of the mtZFN nuclease treatment strength I
(N)
0 and the treatment duration
parameter b, using kernel density estimation (with Gaussian kernels whose bandwidth is set by Scott’s rule [453]).
Similar results are obtained for I
(H)
0 and I
(L)
0 . B) Distributions of the ratios I
(H)
0 /b and I
(L)
0 /b are shown (using
posterior samples). As expected, the high mtZFN concentration setting appears to show higher ratio values. Ratio
distributions using normal mtZFN concentrations very closely resemble the high concentration ratios.
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C
Supplemental information
complementing Chapter 5
This appendix complements Chapter 5, and is split into two sections:
1. The first section contains various analytical descriptions of mtDNA dynamics:
• We show that the asymmetry in fluxes into the absorbing boundaries h = 0 and h = 1
can be qualitatively reproduced by considering a model of diffusion in heteroplasmy
space with a heteroplasmy-dependent diffusion coefficient.
• We analytically approximate the exponential increase in mutant mean observed when
δ = 0 in our linear feedback model.
• The birth-death model we employ in Chapter 5 is an example of a stochastic Lotka
Volterra (LV) model, which can be solved and leads to set of ordinary differential
equations describing the evolution of the moments of wildtype and mutant copy
numbers.
• We use the van Kampen system size expansion [294] to approximate the master
equation describing our mtDNA dynamics.
2. The last section contains explanations and estimations concerning the system of intercel-
lular mtDNA exchange introduced in Sections 5.2.1.3 and 5.2.1.4.
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• We illustrate the derivation of an equation for the long-time mean cellular het-
eroplasmy value in a 2-cell mtDNA exchange system in the limit of slow mtDNA
exchange (Equation 5.4).
• We provide suggestions as to why the stochastic drive observed in Section 5.2.1.4
occurs, and how the various control parameters influence the effect-size of this drive.
• We provide intuition about the mechanisms involved in creating a drift in (w,m)-
space along the steady state line.
• We estimate the feedback control strength.
• We estimate the mtDNA exchange rate γ.
C.1 Analytical descriptions of mutant and wildtype dynamics under various
simplifying conditions
C.1.1 Heteroplasmy-dependent diffusion produces results qualitatively sim-
ilar to heteroplasmy dynamics in our birth-death dynamics
Here we show that the results given in Figure 5.1 can be qualitatively reproduced by a ran-
dom walk in heteroplasmy space with an h-dependent diffusion coefficient. The work in this
particular section was in collaboration with Juvid Aryaman. Consider a diffusion equation
dx
dt
=
√
2D(x)ξ(t) (C.1)
where D(x) denotes a position-dependent diffusion coefficient and ξ(t) represents white noise.
The Fokker-Planck equation for the probability density p(x, t) of x(t) is given by (see e.g. [454])
∂p(x, t)
∂t
=
∂2
∂x
(
D(x)p(x, t)
)
(C.2)
As an example, we takeD(x) = x2/2 (i.e. dx/dt = x(t)ξ(t)) and introduce absorbing boundaries
at x = 1 and x = 2 by setting p(1, t) = p(2, t) = 0. The reason for considering diffusion in the
range x ∈ [1, 2] rather than x ∈ [0, 1] (which may seem a more natural choice in relation to
heteroplasmy) is that in the latter case diffusion near the left boundary becomes vanishingly
small and consequently no flux is seen into the boundary (alternatively, we could have assumed
D(x) = x2/2 + c for some constant c). We assumed x(t = 0) = 1.5, i.e. the starting position
is equidistant to either absorbing boundary, as is the case in our simulations of heteroplasmy
dynamics discussed in Section 5.2.1.1. Due to conservation of probability, the probability flux
164
J(x) satisfies
∂p(x, t)
∂t
= − ∂
∂x
J(x, t) (C.3)
and the flux into the absorbing boundaries x = 1 and x = 2 is then given by
J(1, t) =
∂
∂x
(D(x)p(x, t)) |x=1
J(2, t) =
∂
∂x
(D(x)p(x, t)) |x=2 (C.4)
Numerical evaluations of these fluxes are shown in Figure C.1, yielding qualitatively similar
results to the ones provided in Figure 5.1C. Flux into the boundary at the high-diffusion end
of the range is initially larger, but is later surpassed by flux into the low-diffusion boundary.
This is consistent with the interpretation illustrated in Figure 5.2 which suggests that, for low
values of δ, diffusion in heteroplasmy space is faster at low h compared to high h values which
leads to the initial dominant flux into h = 0 (Figure 5.1C). When integrating the boundary
fluxes over time, we find equal total flux into both boundaries, consistent with a constant 〈h〉.
Hence, heteroplasmy dynamics in our birth-death system with distinct mutant and wildtype
carrying capacities is qualitatively similar to the dynamics obtained from random diffusion with
a heteroplasmy-dependent diffusion coefficient.
Figure C.1: Position-dependent diffusion yields asymmetric boundary fluxes. We show the probability fluxes
into the absorbing boundaries as defined in equations (C.4). Like in Figure 5.1C, the flux into the boundary at
high diffusion is initially dominant.
C.1.2 Exponential increase in mutant mean can be described analytically
We here consider δ = 0, in which case wildtype dynamics are completely independent of mu-
tant dynamics. However, the mutant replication rate still depends on wildtype copy numbers
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through the relation λ(w) = µ+ c1(wss−w). The wildtype population will fluctuate over time,
which is experienced by the mutant population as a fluctuating replication rate λ(t). Using
this time-varying rate, the mutant probability density function Pm(t) can be described by the
master equation
∂Pm
∂t
= λ(t)(m− 1)Pm−1 + µ(m+ 1)Pm+1 −mPm [λ(t) + µ] (C.5)
which can be solved analytically to give the following expression for the expected value of m:
〈m(t)〉 = m0e
∫ t
0 (λ(τ)−µ)dτ . (C.6)
An analytical expression for
∫ t
0
λ(τ)dτ cannot be obtained using the wildtype birth-death dy-
namics, but it can be obtained if the wildtype dynamics are approximated by an Ornstein-
Uhlenbeck (OU) process. An OU process is a continuous time random walk which is steered
towards a central location, just like the wildtype population is steered towards its steady state
value. We will therefore approximate the wildtype dynamics w(t) by an OU process X(t),
which means that λ(t) − µ is also an OU process. Both the OU process X(t) as well as its
time integral Y (t) =
∫ t
0
X(τ)dτ are Gaussian random variables (see e.g. [455]). The mutant
dynamics can then be described by
〈m(t)〉 = m0eN(µ˜(t),σ˜2(t)) (C.7)
where µ˜(t) and σ˜(t) are the mean and variance of the integrated OU process
∫ t
0
(λ(τ)− µ)dτ =∫ t
0
(c1(wss −X(t)))dτ , respectively. In this approximation, 〈m(t)〉 is described by a log-normal
distribution.
We will now proceed as follows: 1) we present equations for the means and variances of a
general OU process X(t) and its time integral Y (t), 2) we express these equations in terms of
our control parameters µ, c1 and wss, and 3) we evaluate Equation (C.7) and comment on the
results.
Analytical expressions can be obtained for the means and variances of X(t) and Y (t), by writing
the OU process in the form of a Stochastic Differential Equation: dX(t) = θ(µX −X(t))dt +
σdW (t) where W (t) is a Wiener process. The following equations can then be derived using
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standard methods [455]:
〈X(t)〉 = (x0 − µX)e−θ(t−t0) + µX (C.8)
var(X(t)) =
σ2
2θ
(
1− e−2θ(t−t0)
)
(C.9)
〈Y (t)〉 = x0 − µX
θ
(
1− e−θ(t−t0)
)
+ µX(t− t0) + y0 (C.10)
var(Y (t)) =
σ2
θ2
(
(t− t0)− 2
θ
[
1− e−θ(t−t0)
]
+
1
2θ
[
1− e−2θ(t−t0)
])
(C.11)
where X(t0) = x0 and Y (t0) = y0 denote initial conditions. For long times, the mean and
variance of the OU process X(t) can be written as 〈X(t)〉t→∞ = µX and var(X(t))t→∞ =
σ2/(2θ), meaning the process converges to the normal distribution N(µX ,
σ2
2θ
).
Because X(t) represents our wildtype dynamics, Equations (C.8) and (C.9) correspond to the
wildtype mean and variance, respectively. Expressions for wildtype mean and variance under
our linear control can be obtained (derived in Section C.1.4.1, Equations (C.27) and (C.28)),
meaning that we can write the parameter µX , θ and σ in terms of our control parameters µ, c1
and Nss
∗. However, equalizing the mean and variance of the OU process and our controlled
wildtype dynamics only provides us with two constraints. As a third constraint, we set 1
θ
=
c1Nss which approximately equalises the relaxation times of the OU process and the wildtype
birth-death process.These three constraints are now sufficient to express the parameters µX , θ, σ
in terms of the control parameters µ, c1 and Nss; results match well with stochastic simulations
(Figure C.2A, B).
To evaluate Equation (C.7) we write
d(λ(t)− µ) = dλ(t)
= −c1dX(t)
= θc1(wss − µX)dt− θη(t)dt− c1σdW (t) (C.12)
and then use Equation (C.10), to derive†〈∫
(λ(τ)− µ)dτ
〉
=
c1(µX − x0)
θ
(1− e−θ(t−t0)) + c1(wss − µX)(t− t0). (C.13)
∗We set µX = 34wss +
1
4
√
w2ss − 8µc1 (using Equation (C.27)) and σ
2
2θ =
wss
8
(
wss ∓
√
w2ss − 8µc1
)
+ µ2c1 (using
Equation (C.28)).
†Assuming y0 = 0.
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This last equation represents the mean of the normal distribution in Equation (C.7).
If we simulate our wildtype and mutant dynamics with δ = 0 and start the wildtype population
in steady state, then x0 = wss and µX represents the stochastic expected value of w. If
µX = wss, then Equation (C.13) is equal to zero and Equation (C.7) can be written as 〈m(t)〉 =
m0e
N(0, σ˜2(t)). However, we will find in Section (C.1.4.1) that the deterministic wildtype mean
is slightly higher than the stochastic wildtype mean. This means that the mean of the normal
distribution describing 〈m(t)〉 is increasing with time, leading to the exponential increase of
〈m(t)〉. We note that even if this normal distribution would have zero mean, there would still
be an exponential increase in 〈m(t)〉 but at a much slower rate (Figure C.2).
In conclusion, by approximating wildtype dynamics by an OU process, we were able to derive
the exponential increase in mean mutant dynamics observed under our linear feedback function
with δ = 0. We found that the main cause of this exponential increase is the disagreement
between the deterministic and stochastic mean values for the wildtype dynamics, as derived in
Section (C.1.4.1).
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A) B)
D)C)
Figure C.2: Exponential increases in mean mutant copy numbers can be approximated analytically. A)
Mean wildtype copy numbers are shown for our linear feedback function with δ = 0 and Nss = wss = 500).
Stochastic simulations (5 × 104 repeats) are compared with i) deterministic values, and approximations based on
ii) a Lotka-Volterra model (Section (C.1.4.1)), iii) an OU-process, and iv) a system size expansion (SSE) (Sec-
tion C.1.5.1). The mean and variance of the OU-process were set to be identical to those predicted by the Lotka-
Volterra model; their equivalence is therefore trivial. B) The wildtype variance is shown for the same models as
shown in figure (A). C) The exponential-like increase in mean mutant copy number 〈m(t)〉 is shown using stochas-
tic simulations and various approximations as indicated. We also show predictions based on the OU-process ap-
proximation, but using µ˜(t) = 0 in Equation (C.7). D) Here we have added a simulation in which total copy
numbers were capped at 104, providing a more biologically realistic situation.
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C.1.3 Approximating the wildtype steady state distribution
If wildtypes are uncoupled from mutants (δ = 0), their dynamics are less complicated and
though closed form solutions for the general dynamics do not exist, solutions for the equilibrium
state can be obtained. We first outline the derivation of this equilibrium solution for a more
general system and then apply this result to our specific model. Let piN denote the equilibrium
probability distribution of observing copy number N , with
∑∞
N=0 piN = 1. The master equation
reduces to the simpler form
0 = µN+1piN+1 − (λN + µN)piN + λN−1piN−1 (C.14)
for all N , due to the equality dpiN/dt = 0. Following the approach outlined in Ref. [100], the
equation can be rewritten as
µN+1piN+1 − λNpiN = µNpiN − λN−1piN−1 (C.15)
Because the left and right hand side of this equation are equal except for N (left) being replaced
by N−1 (right), both sides can be considered constant. Using µ0 = 0 and pi−1 = 0, the constant
is found to be 0 and one obtains the balance equation
µNpiN = λN−1piN−1 (C.16)
This equation shows that the probability flow from state N to N − 1 is equal to the flow from
state N − 1 to N , and can be applied repeatedly to find an expression for piN [100].
In the particular system we study, µw = µw and λw = w(µ + c1(Nss − w) (we denoted N by
w to specifically refer to wildtype copy numbers). Inserting w = 1 in equation (C.16) yields
µ1pi1 = λ0pi0 = 0 (because λ0 = 0). In order to satisfy µ1pi1 = 0, we impose the condition
µ1 = 0. This condition is not true in our system and it will alter the underlying process, but
it forms an accurate approximation provided that pi1 is small compared to the mode of the
distribution. Repeated application of equation (C.16) yields
piN =
λ1λ2 · · ·λN−1
µ2µ3 · · ·µN pi1 (C.17)
with pi1 chosen such that
∑∞
i=1 pii = 1. Application of equation (C.17) yields accurate approxi-
mation to the true equilibrium probability distribution, as shown in Figure C.3.
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The approximation we derived in this section is only valid when a single mtDNA species is
present and can therefore be applied to homoplasmic cells. Its usefulness stems from the fact
that it can be applied for any form of λN and µN provided that the fraction in Equation (C.17)
can be evaluated. This approach provides a way of quickly examining the long-time equilibrium
mtDNA distribution without the need of time-consuming stochastic simulations. We will use
these results in Section C.2.3 to estimate the control strength parameter c1.
171
Figure C.3: Wildtype steady state distributions are accurately approximated numerically. Here we show
the wildtype steady state distributions as obtained through stochastic simulations (histograms) and numerical ap-
proximations (Equation C.17).
C.1.4 Lotka Volterra model
The Lotka-Volterra model has been used to describe the dynamics of interacting species since
1910 and is part of a wider class of multivariate birth-death processes [456]. Because we only
consider systems with two species (wildtype and mutant mtDNA molecules) we will present
equations for a stochastic two-species generalised Lotka Volterra system. We use the notation
λi(N, t), µi(N, t) to describe the birth and death rates of species i, where i = 1, 2 refers to
wildtype and mutant, respectively. The vector N =
(
n1
n2
)
contains the species’ copy numbers.
The Lotka-Volterra interaction model involves a particular form of λi(N, t) and µi(N, t), namely
λi(N, t) = λi(t)ni +
2∑
j=1
λij(t)ninj (C.18)
µi(N, t) = µi(t)ni +
2∑
j=1
µij(t)ninj (C.19)
where the first terms describe the characteristics of each individual species and the last terms
specify inter-species interactions.
A master equation describing the trajectory of the probability density function P (N ; t) can be
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derived and is given by
∂P (N, t)
∂t
=
2∑
i=1
(
λi(N − ei, t)P (N − ei; t)
+ µi(N + ei, t)P (N + ei; t)
−
[
λi(N, t) + µi(N, t)
]
P (N ; t)
)
, (C.20)
where e1 =
(
1
0
)
and e2 =
(
0
1
)
denote unit vectors.
An exact solution to Equation (C.20) cannot be found for general forms of λi(N, t) and µi(N, t),
but useful statistics (e.g. means and variances) can be derived from the generating function
G(Z, t), defined as
G(Z, t) =
∞∑
n1=0
∞∑
n2=0
P (N ; t)zn11 z
n2
2 (C.21)
with Z = (z1, z2). Derivatives of G(Z, t) correspond to species’ means, variances and higher
order moments. Combining equations (C.20) and (C.21) leads to a set of ordinary differential
equations describing the time evolutions of these moments. This is a standard procedure (see,
for example, [457]) and we here only provide the final result for the Lotka-Volterra system
defined in Equations (C.18) and (C.19):
d〈ni〉
dt
=
(
λi(t)− µi(t)
)
〈ni〉
+
2∑
j=1
(
λij(t)− µij(t)
)
(〈ni〉〈nj〉+ σij) (C.22)
d〈σii〉
dt
=
(
λi(t) + µi(t)
)
〈ni〉+ 2
(
λi(t)− µi(t)
)
σii
+
2∑
j=1
(
2
[
λij(t)− µij(t)
][
〈ni〉σij + 〈nj〉σii + σiij
]
+
[
λij(t) + µij(t)
][
〈ni〉〈nj〉+ σij
])
(C.23)
d〈σik〉
dt
=
(
λi(t)− µi(t) + λk(t)− µk(t)
)
σik
+
2∑
j=1
([
λij(t)− µij(t)
][
〈ni〉σkj + 〈nj〉σik + σikj
]
+
[
λkj(t)− µkj(t)
][
〈nk〉σij + 〈nj〉σik + σikj
])
(C.24)
where 〈ni〉, 〈σii〉 and 〈σik〉 describe the mean, variance and covariance of the different species.
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The equation describing the evolution of the first moment depends on the second moment,
whose own evolution depends on the third moment, etc. Moment closure schemes need to be
applied to make progress.
C.1.4.1 Solution for the mean and variance of a single species
Here we apply the results derived above to our linear feedback model in the setting of only a
single species being present (here assumed to be wildtype). In this situation, the stationary
copy number distribution closely follows a normal distribution which means we can set the
third order moments σijk to zero without much loss of accuracy. Using λw = w(µ+c1(wss−w))
and µw = wµ, we find
d〈w〉
dt
= c1wss〈w〉+ c1
(
〈w〉2 + σ2
)
(C.25)
dσ2
dt
= (2µ+ c1wss)〈w〉+ 2c1wssσ2 − 4c1〈w〉σ2
− c1
(
〈w〉2 + σ2
)
(C.26)
with 〈w〉, σ2 and wss denoting wildtype expected value, variance and deterministic mean, re-
spectively. The above equations can be solved for steady state, giving w ∼ N(〈w〉ss, σ2ss) with
〈w〉ss = 3
4
wss ± 1
4
√
w2ss −
8µ
c1
(C.27)
σ2ss =
wss
8
(
wss ∓
√
w2ss −
8µ
c1
)
+
µ
2c1
. (C.28)
The upper sign solution agrees well with simulations. This equation breaks down for very small
c1 (in which case copy number extinction becomes significant). We note that the expected
value of the stochastic process does not coincide with the deterministic mean; this deviation is
larger when turnover is large (large µ) or when the negative feedback term is small (small c1).
Equations (C.27) and (C.28) are used in Section C.1.2 to represent the mean and variance of
the OU-process approximating wildtype dynamics.
We can use Equations (C.27) and (C.28) to calculate the Coefficient of Variation (CV) of the
wildtype population, giving
CV =
√
8µ
c1
+ 2wss(wss −
√
w2ss − 8µc1 )
3wss +
√
w2ss − 8µc1
(C.29)
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Finally, we can rewrite this equation to give
c1 = − (1 + CV
2)2µ
CV2(CV2 − 1)w2ss
(C.30)
These two relations are useful as they allow us to relate the control parameter c1 to the more
robust CV.
C.1.5 System Size Expansion
Stochastic birth-death processes can be described analytically by a master equation. For our
model, with birth rate λ(w,m) and constant death rate µ, we obtain:
∂Pi,j
∂t
= λ(i− 1, j)(i− 1)Pi−1,j + µ(i+ 1)Pi+1,j
+ λ(i, j − 1)(j − 1)Pi,j−1 + µ(j + 1)Pi,j+1
− (i+ j)
(
λ(i, j) + µ
)
Pi,j (C.31)
where Pi,j(t) gives the probability of being in state (i, j) = (w,m) (the time dependence is
dropped for convenience). In general, this equation will not be analytically solvable and suitable
approximation methods are required.
In this section, we use van Kampen’s system size expansion (SSE) [294] to approximate the
above equation. First, we derive the leading order solution of the expansion, known as the
linear noise approximation (LNA). As we will see, the LNA provides useful insights and can
accurately describe the dynamics of our system for short time-scales. However, for longer
time-scales higher order terms are required to maintain accuracy. We provide a solution to the
expansion one order higher than the LNA in Section C.1.5.1, following the method developed in
Ref. [458]. Other approximation techniques, such as the Kramers-Moyal expansion [459, 460],
are not considered in this thesis. It was previously noted that the Kramers-Moyal expansion
fails to accurately describe birth-death master equations [454].
Generally, a master equation can be written in the form
p˙~n(t) = Ω
R∑
j=1
(
N∏
i=1
E−Sij − 1
)
fj(~n,Ω)p~n(t) (C.32)
where Ω is the system volume, R is the number of reactions involved, N is the number of
species, (S)ij is the stoichiometry matrix, ~n = (n1, n2, · · · , nN) gives the number of particles
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of each species, E is a raising and lowering operator‡, and p~n(t) is the probability distribution
of states ~n at time t. The equations fj(~n,Ω) specify the reaction rates. The SSE provides an
expansion of this master equation in powers of the inverse square root of the system volume Ω.
The expansion starts by expressing the state of the system in terms of a deterministic and
stochastic component. Consider a single species whose concentration and copy number are
denoted by φ(t) and n, respectively. One expects the distribution of n to be centered around
Ωφ(t) and to have a width of order
√
n ∝ √Ω. This motivates the following equation
ni = Ωφi(t) + Ω
1/2ξi (C.33)
where ξi describe the fluctuations around the deterministic solution φi(t). All terms in the
master equation can now be expressed in the new fluctuation variables ξi according to the
following transformations§
p~n(t) = Π(~ξ, t)
Ei → 1 + Ω−1/2 ∂
∂ξi
+
1
2
Ω−1
∂2
∂ξ2i
+ · · ·
p˙~n =
∂Π(~ξ, t)
∂t
− Ω1/2
N∑
i=1
∂φi
∂t
∂Π(~ξ, t)
∂ξi
(chain rule)
f(
ni
Ω
) = f(φi + Ω
−1/2ξi). (C.34)
Substituting Equations (C.34) into Equation (C.32) gives
∂Π(~ξ, t)
∂t
− Ω1/2
N∑
i=1
dφi
dt
∂Π(~ξ, t)
∂ξi
= Ω
R∑
j=1
[
− Ω−1/2
N∑
i=1
Sij
∂
∂ξi
+
1
2
Ω−1
∑
i,k
SijSkj
∂2
∂ξi∂ξk
+O(Ω−3/2)
]
×
[
fj(~φ) + Ω
−1/2∑
i
∂fj(~φ)
∂φi
ξi +O(Ω
−1)
]
Π(~ξ, t) (C.35)
which can be solved by collecting powers of Ω−1/2. Terms proportional to Ω1/2 form the macro-
scopic rate equations. The terms of order Ω0 form a Fokker-Planck equation, the solution of
‡Its effect on an arbitrary function f(~n) is given by e.g. Eif(~n) = f(~n+ ei) and E−1i f(~n) = f(~n− ei) (where
ei is a column vector with all zeros and a 1 at entry i). Using a Taylor expansion, the operator can be written
as Ei = 1 +
∂
∂ni
+ 12!
∂2
∂n2i
+ · · · .
§Ei changes ni into ni + 1, which is equivalent to changing ξi into ξi + Ω−1/2.
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which is the LNA:
∂Π(~ξ, t)
∂t
= −
2∑
i,j=1
Aij
∂(ξjΠ(~ξ, t))
∂ξi
+
1
2
2∑
i,j=1
Bij
∂2Π(~ξ, t)
∂ξi∂ξj
(C.36)
The coefficients Aij and Bij can be found by expanding equation (C.35) and are defined as
Aij =
R∑
k=1
Sik
∂fk
∂φj
Bij =
R∑
k=1
SikSjkfk (C.37)
The system we consider has two species (N = 2), four rate equations (R = 4) given by
f1 = wλ(w,m)
f2 = mλ(w,m)
f3 = wµ
f4 = mµ, (C.38)
and a stoichiometry matrix by
S =
1 0 −1 0
0 1 0 −1
 (C.39)
where the two rows refer to the wildtype and mutant species, respectively, and the columns
represent the reactions fi.
In order to continue, it is useful to rewrite Equation (C.35) as an expansion in derivatives
with respect to ~ξ, namely ∂tΠ =
∑
i
(
− ∂
∂ξi
Ai +
1
2!
∂2
∂ξ2i
Bi − 13! ∂
3
∂ξ3i
Ci + · · ·
)
where Ai, Bi, . . . are
functions of ~ξ, Ω and ~f . Evolution equations for the moments 〈ξiξj . . . 〉 can be obtained by
multiplying this equation by ξiξj . . . and integrating over all ~ξ. Using integration by parts, the
following set of coupled ODEs can be obtained for our N = 2 system:
dt〈ξ21〉 = 2A11〈ξ21〉+ 2A12〈ξ1ξ2〉+B11
dt〈ξ22〉 = 2A22〈ξ22〉+ 2A21〈ξ1ξ2〉+B22
dt〈ξ1ξ2〉 = (A11 + A22)〈ξ1ξ2〉+ A12〈ξ22〉+ A21〈ξ21〉+B12 (C.40)
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which can be solved to give
〈ξ21〉 =
µw2ss
(∂mλmss + ∂wλwss)3
(
2mss(1 +
mss
wss
)(∂mλ)
2(∂mλmss + ∂wλwss)t
− 4(∂mλ)(∂wλ)mss − (∂wλ)2wss + 3(∂mλ)2mss
+ 4e(∂mλmss+∂wλwss)t
{
∂mλ∂wλmss − (∂mλ)2mss
}
+ e2(∂mλmss+∂wλwss)t
{
(∂wλ)
2wss + (∂mλ)
2mss
})
(C.41)
〈ξ22〉 =
µm2ss
(∂mλmss + ∂wλwss)3
(
2wss(1 +
wss
mss
)(∂wλ)
2(∂mλmss + ∂wλwss)t
− 4(∂mλ)(∂wλ)wss − (∂mλ)2mss + 3(∂wλ)2wss
+ 4e(∂mλmss+∂wλwss)t
{
∂mλ∂wλwss − (∂wλ)2wss
}
+ e2(∂mλmss+∂wλwss)t
{
(∂wλ)
2wss + (∂mλ)
2mss
})
(C.42)
〈ξ1ξ2〉 = µwssmss
(∂mλmss + ∂wλwss)3
(
− 2(wss +mss)(∂mλ)(∂wλ)(∂mλmss + ∂wλwss)t
+ (∂wλ)
2wss + (∂mλ)
2mss − 2(∂wλ)(∂mλ)(wss +mss)
+ 2e(∂mλmss+∂wλwss)t
{
(∂mλ)(∂wλ)(wss +mss)− (∂wλ)2wss − (∂mλ)2mss
}
+ e2(∂mλmss+∂wλwss)t
{
(∂wλ)
2wss + (∂mλ)
2mss
})
(C.43)
where 〈ξ21〉, 〈ξ22〉 and 〈ξ1ξ2〉 denote the wildtype and mutant variance and covariance, respec-
tively. This solution assumes trajectories starting in the deterministic steady state (wss,mss);
all partial derivatives are evaluated at this steady state. The means of w and m are calculated
from the macroscopic rate equations at order Ω1/2 and are identical to the deterministic means.
The intermediate-time forms of these expressions (when the exponentially decaying terms have
died out) are given in Table 4.2 of Chapter 4.
Heteroplasmy variance can be derived using a Taylor expansion which, keeping only the leading
order, gives: var(h) ≈ ( ∂h
∂w
)2σ2w + (
∂h
∂m
)2σ2m + 2(
∂h
∂w
)( ∂h
∂m
)cov(w,m) = 1
(w+m)4
(m2σ2w + w
2σ2m −
2wm cov(w,m)).
C.1.5.1 Higher order terms
In order to obtain expressions up to order Ω−1, we use the approach outlined in Ref. [458].
First, the probability distribution Π(~ξ, t) is written in powers of the inverse square root of the
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system volume, i.e. Π(~ξ, t) =
∑∞
j=0 Πj(
~ξ, t)Ω−j/2. The moments follow a similar expansion:
〈ξkξm . . . ξr〉 =
∞∑
j=0
[ξkξm . . . ξr]jΩ
−j/2 (C.44)
with
[ξkξm . . . ξr]j =
∫
ξkξm . . . ξrΠj(~ξ, t)d~ξ. (C.45)
The final equation describing the evolution of the means of mutant and wildtype molecules to
order Ω−1 for our birth-death process, is given by [458]
∂t〈φi〉 = Jwi (〈φw〉 − φw) +
1
2
Ω−1Jwpi [ξwξp]0 (C.46)
where φi refers to the concentration of species i, and
Js,t,...,zi,j,...,r =
∂
∂φs
∂
∂φt
· · · ∂
∂φz
Di,j,...,r (C.47)
Di,j,...,r =
R∑
k=1
SikSjk . . . Srkfk(~φ) (C.48)
are introduced for more convenient notation (summation over repeated indices is used). Evolu-
tion equations for the moments 〈ξkξm . . . ξr〉 can be obtained in a similar way as before, giving
[458]
∂
∂t
[ξwξp]0 = J
r
w[ξrξp]0 + J
r
p [ξrξw]0 +Dwp. (C.49)
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Inserting Equations (C.47) and (C.48) into the above equation, and using our linear feedback
model, gives
[ξ1ξ1]0(t) =
(λ+ µ)w2ss
2(mss∂mλ+ wss∂wλ)3
[
2(∂mλ)
2(wss +mss)mss
(
(∂mλ)
mss
wss
+ (∂wλ)
)
t
+ 3(∂mλ)
2mss − (∂wλ)2wss − 4(∂mλ)(∂wλ)mss
+ 4e(∂mλmss+∂wλwss)t
(
(∂wλ)(∂mλ)mss − (∂mλ)2mss
)
+ e2(∂mλmss+∂wλwss)t
(
(∂wλ)
2wss + (∂mλ)
2mss
) ]
(C.50)
[ξ2ξ2]0(t) =
(λ+ µ)m2ss
2(mss∂mλ+ wss∂wλ)3
[
2(∂wλ)
2(wss +mss)wss
(
(∂mλ) + (∂wλ)
wss
mss
)
t
+ 3(∂wλ)
2wss − (∂mλ)2mss − 4(∂mλ)(∂wλ)wss
+ 4e(∂mλmss+∂wλwss)t
(
(∂wλ)(∂mλ)wss − (∂wλ)2wss
)
+ e2(∂mλmss+∂wλwss)t
(
(∂wλ)
2wss + (∂mλ)
2mss
) ]
(C.51)
[ξ1ξ2]0(t) =
−(λ+ µ)wssmss
2(mss∂mλ+ wss∂wλ)3
[
2(∂wλ)(∂mλ)(wss +mss)
(
(∂mλ)mss + (∂wλ)wss
)
t
− wss(∂wλ)2 −mss(∂mλ)2 + 2(∂mλ)(∂wλ)(wss +mss)
+ 2e(∂mλmss+∂wλwss)t
(
(∂wλ)
2wss + (∂mλ)
2mss − 2(∂wλ)(∂mλ)(wss +mss)
)
+ e2(∂mλmss+∂wλwss)t
(
(∂wλ)
2wss + (∂mλ)
2mss
) ]
(C.52)
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where wss and mss denote the deterministic steady states, and all partial derivatives (as well
as λ itself) are evaluated at steady state. Finally, we can solve Equation (C.46) which gives
〈w(t)〉 = wss + Ω−1 wss(λ+ µ)
2(mss∂mλ+ wss∂wλ)3
[
2(∂mλ)mss
{
(∂mλ)
2mss − (∂wλ)2wss
+ (∂wλ)(∂mλ)(wss −mss)
}
t
+ 3(∂mλ)
2mss + (∂wλ)
2wss − 2(∂mλ)(∂wλ)mss
+ 2e(∂mλmss+∂wλwss)t
(
(∂wλ)(∂mλ)mss − (∂wλ)2wss − 2(∂mλ)2mss
)
+ e2(∂mλmss+∂wλwss)t((∂mλ)
2mss + (∂wλ)
2wss)
]
(C.53)
〈m〉(t) = mss + Ω−1 mss(λ+ µ)
2(mss∂mλ+ wss∂wλ)3
[
2(∂wλ)wss
{
(∂wλ)
2wss − (∂mλ)2mss
+ (∂wλ)(∂mλ)(mss − wss)
}
t
+ 3(∂wλ)
2wss + (∂mλ)
2mss − 2(∂mλ)(∂wλ)wss
+ 2e(∂mλmss+∂wλwss)t
(
(∂wλ)(∂mλ)wss − (∂mλ)2mss − 2(∂wλ)2wss
)
+ e2(∂mλmss+∂wλwss)t((∂mλ)
2mss + (∂wλ)
2wss)
]
(C.54)
Unlike the LNA, these higher order solutions predict time-varying means. In reality 〈w(t)〉 and
〈m(t)〉 will always saturate due to one species inevitably reaching extinction after long times,
meaning the above equations are not valid for all times.
When ∂mλ = 0, we know that 〈m(t)〉 increase in an exponential-like fashion and we can
therefore make the ansatz that the linear term given above represents the first term of a Taylor
expansion. This leads to 〈m(t)〉 = e2µ/wsst, which agrees well with simulations for short times
(Figure C.2C). We can also derive the long-time value for 〈w(t)〉 in the case that ∂mλ = 0,
giving
〈w〉t→∞ = wss − µ
c1wss
=
3
4
wss +
1
4
√
w2ss −
8µ
c1
+
16µ2
c21w
2
ss
(C.55)
This result is very similar to the prediction made by the Lotka-Volterra model (Equation
(C.27)), the only difference being an extra term (16µ2)/(c21w
2
ss) appearing under the square
root. Because an ‘average’ cell has ∼ 1000 mtDNA molecules, this additional term is likely
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to be small. Equation (C.55) shows that the larger the deterministic steady state wss, the
smaller the difference between this steady state and the stochastic expected value; this is why
the exponential increase in 〈m(t)〉 is relatively large in low copy number cells. We note that
the solutions provided above can be extended to more general settings involving e.g. quadratic
controls or controls on both replication and degradation rates. In the latter case, all occurrences
of ∂mλ and ∂wλ are simply replaced by ∂m(λ− µ) and ∂w(λ− µ), respectively.
C.2 Intercellular mtDNA exchange
C.2.1 Fixation probabilities in the limit of slow mtDNA exchange
Here we calculate long-time cellular heteroplasmy values in the limit of slow mtDNA exchange,
i.e. γ  µ. In this limit, each cell is expected to fixate on mutant or wildtype before a new
intercellular mtDNA exchange event occurs. This extreme setting allows us to calculate the
fixation probabilities of each species analytically. The two-cell system we described here is an
example of a Moran process and fixation probabilities follow from standard results [461]. We
illustrate the derivation of these probabilities for our particular system, and use the result to
derive other quantities of interest.
We initialise two cells at heteroplasmy values h1 and h2, and denote the wildtype and mutant
steady state copy numbers in homoplasmic cells by wss and mss, respectively. Before any
mtDNA exchange event occurs, both cells fixate on either h = 0 or h = 1. Three possible
scenarios exist after this initial fixation: i) both cells fixated on w (with probability (1 −
h1)(1−h2) ≡ ζ), ii) both cells fixated on m (with probability h1h2 ≡ ζ ′) , or iii) one cell fixated
on w and the other on m (with probability 1− ζ − ζ ′); an illustration of the system is provided
in Figure C.4A. In the first two scenarios, the cells will remain in their fixated state forever
(assuming no mutations can occur). In the latter scenario, however, a new exchange event will
eventually occur, again giving rise to three possible scenarios (Figure C.4A).
Consider the situation in which the two cells have heteroplasmy values h = 0 and h = 1; we
will refer to these cells as c0 and c1, respectively. Full wildtype fixation occurs when a wildtype
mtDNA hops from c0 to c1 (before a mutant mtDNA hops from c1 to c0) and subsequently
takes over the existing mutant population. The rate at which a wildtype mtDNA hops out of
c0 is given by γ wss. The probability that a wildtype molecule hops before a mutant does, is
simply given by wss/(wss + mss). Finally, the probability of subsequent wildtype fixation is
equal to the fraction of w in c1, i.e. 1/(1 +mss). Similar arguments hold for the probability of
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complete mutant fixation. We can now write down the following equations:
P(w hops before m and w fixates) = P(w hops before m) P(w fixates)
=
wss
wss +mss
1
1 +mss
≡ α (C.56)
P(m hops before w and m fixates) = P(m hops before w) P(m fixates)
=
mss
wss +mss
1
1 + wss
≡ β (C.57)
If the mtDNA (mutant or wildtype) that hopped is unsuccessful at invading the host cell, then
the two cells will remain in their original configuration (i.e. one having h = 0 and the other
having h = 1); this occurs with probability 1− α− β (Figure C.4A).
The process described above will repeat itself until full mutant or wildtype fixation has been
reached. We can now straightforwardly derive the following equation:
P
(
w fixation
∣∣∣ h1, h2, wss,mss) = ζ + (1− ζ − ζ ′)α + (1− ζ − ζ ′)(1− α− β)α + · · ·
= ζ + (1− ζ − ζ ′)α
∞∑
i=0
(1− α− β)i
= ζ + (1− ζ − ζ ′) α
α + β
≡ Pw (C.58)
where α, β, ζ and ζ ′ are defined above. When the first step in the diagram shown in Figure C.4
is omitted and cells are initialised at h1 = 0 and h2 = 1 (or vice versa), the above expression
reduces to Pw =
α
α+β
. This simplified system is part of a more general result of N interacting
cells, in which case Pw =
1−1/r
1−1/rN with r = α/β [328, 461]. We can now evaluate mean cellular
heteroplasmy at long times, which is given by
〈h〉t→∞ = P(w fixation) · 0 + P(m fixation) · 1
= 1− Pw (C.59)
where we have assumed that the mtDNA population does not reach extinction in either cell.
If the mutant species has a higher carrying capacity, i.e. mss > wss, then both fractions
appearing in the definition of β (Equation (C.57)) are larger than those appearing in the
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definition of α (Equation (C.56)). This means that every time the system is in a state with
h1 = 0 and h2 = 1, chances of mutant fixation are slightly higher than those of wildtype
fixation. This eventually leads to an increase in mean heteroplasmy and it can be shown that
the inequality 〈h〉t→∞ > 12(h1 + h2) holds when mss > wss. Similarly, if wss > mss we obtain
〈h〉t→∞ < 12(h1 + h2).
Implementing our linear control strategy gives mss = wss/δ, which means Equation (C.59) can
be rewritten as
〈h〉t→∞ = (δ + wss)(h1 + h2 − h1h2) + δ
2h1h2(1 + wss)
δ2(1 + wss) + δ + wss
. (C.60)
This equation is shown in Figure C.4B as a function of δ, for h1 = h2 = 0.1 (the qualitative
shape of the graph is identical for any non-trivial values h1 and h2). Solving ∂δ〈h〉t→∞ = 0 gives
δ = 0 or δ = −2wss, the latter solution (which forms a minimum) being unphysiological as it
corresponds to a highly unstable system. The maximum mean heteroplasmy value at δ = 0 is
given by 〈h〉t→∞,max = h1 + h2 − h1h2.
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Figure C.4: Fixation probabilities in the limit of slow hopping. A) This cartoon illustrates all possible scenar-
ios that can take place in the limit γ  µ, meaning that both cells reach fixation before an exchange of mtDNA
molecules takes place. The parameters ζ, ζ ′, α and β, denoting the probabilities of the indicated events, are de-
fined in the text. We have neglected the probability that both cells reach extinction. An infinite chain arises in
which two cells at h = 0 and h = 1 can either fully fixate on wildtype (both cells reaching h = 0), fully fixate on
mutant (both cells reaching h = 1) or remain in their original state. B) We show 〈h〉t→∞ as a function of δ for
h1 = h2 = 0.1 and wss = 200. The maximum value of 〈h〉t→∞ occurs at δ = 0 and is given by (1− h1)(1− h2).
C.2.2 Intuitions behind stochastic drive and copy number drift
How does the interplay between mtDNA exchange rate, turnover rate, and control strength
determine heteroplasmy dynamics? Though we do not provide an analytical formula predicting
changes in mean h (an interesting future challenge), we can provide some intuition as to how
the relative strengths of inter- and intracellular mtDNA dynamics determine copy number
dynamics that exists.
When stochastic fluctuations move wildtype and mutant copy numbers away from steady state,
both the feedback control as well as intercellular interactions force copy numbers towards a new
steady state. The type of fluctuations that are seen depends on the relative strength of these
two forces. Figure C.5 shows an example of a system which, for fixed turnover µ, has either
a strong control and a slow exchange rate or a weak control and a fast exchange rate. In the
former case copy number dynamics mostly occurs along the steady state line, whereas in the
latter case cells are highly coupled and together fluctuate through (w,m)-space.
In Figure 5.4 we observed that deterministically, copy number equilibration between different
cells results in a slight increase (when δ < 1) in mean heteroplasmy due to a higher copy
number in a high-heteroplasmy cell. This, combined with many stochastic fluctuations in h,
can lead to increases in 〈h(t)〉 (Figure 5.6). Intuitively, we may expect a faster change in
〈h(t)〉 if a new fluctuation in heteroplasmy (due to intracellular mtDNA dynamics) occurs
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after full equilibration of heteroplasmies between cells (as a response to previous heteroplasmy
fluctuations) has taken place. In this way, maximum advantage is being taken of the small
increases in mean heteroplasmy after each cellular equilibration. Therefore, the higher the
mtDNA exchange rate relative to the intracellular mtDNA dynamics, the faster the increase
in 〈h(t)〉. Because we based part of this argument on deterministic dynamics, the conclusion
only holds in the strong control setting (deterministically, the dynamics only ever approach the
steady state line, which can be considered a strong control). In conclusion, we have provided
an intuitive explanation of why 〈h(t)〉 increases faster at higher mtDNA exchange rates in the
strong control setting, as observed through stochastic simulations in Figure 5.5A.
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Figure C.5: The interplay between mtDNA turnover, feedback control and intercellular exchange deter-
mine the type of copy number dynamics seen. This cartoon shows two settings which are assumed to have
identical mtDNA turnover rates: i) a strong feedback control (large b) and slow mtDNA exchange (left), and iii) a
weak feedback control and fast mtDNA exchange (right). In the former setting, states of both cells remain close
to the slow manifold whereas in the latter setting the two states remain close together and fluctuate further away
from the manifold.
What is the cause of a drift in (w,m)-space along the steady state line? Imagine a cell in
a deterministic steady state (wss,mss). As birth and death rates are balanced, fluctuations
increasing or decreasing w, to reach states (wss + ∆w,mss) or (wss − ∆w,mss), are equally
likely (similarly for m). When the new state, after a fluctuation occurred, is mapped back
towards the steady state line along a line of constant heteroplasmy¶, the position on the steady
state line has changed (Figure C.6). When δ < 1, a downwards wildtype fluctuation leads
to a shift up the line towards mutant fixation (after having mapped back towards the steady
state line) whereas an upwards fluctuation leads to a net shift down the line towards wildtype
¶This is the case for deterministic dynamics, and is also true on average in a stochastic setting.
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fixation. However, the size of these shifts is not symmetric, the upwards shift being larger than
the downwards shift (Figure C.6). This argument was made previously in Ref. [328] to explain
the existence of drift towards the species of higher carrying capacity. However, the situation is
more subtle because fluctuations in mutant species lead to exactly the opposite behaviour (i.e.
the downwards shift is larger than the upwards shift along the steady state line, Figure C.6).
To add to the complexity, wildtype fluctuations are more likely to occur than mutant ones if
h < 0.5 whereas mutant fluctuations are more frequent when h > 0.5 (Figure C.6). We thus
stress that the explanation for the drift provided by the authors in Ref. [328] is incomplete.
How can we make progress in providing an analytical approximation to the rate of increase of
cellular mean heteroplasmy 〈h(t)〉? As observed in Section 5.2.1.4, heteroplasmy variance is
indicative of this rate of increase, and thus providing an equation for e.g. the initial rate of
increase of var(h) may give some new insights.
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Figure C.6: The emergence of drift along the steady state line. Here we show a cartoon (not drawn to scale)
of the effect mutant and wildtype fluctuations around their steady states have on movement along the determin-
istic steady state line. The yellow and pink lines highlight shifts that are produced by fluctuations in mutant and
wildtype species, the yellow line indicating the larger shift. After a fluctuation, states are mapped back towards
the steady state line along lines of constant heteroplasmy (dashed lines). The green dots represent the initial state
from which up or down fluctuations in w or m (illustrated by the red dots) can occur with equal probability. The
shift towards mutant fixation caused by downward fluctuations of w is larger than the shift towards wildtype fix-
ation caused by upwards fluctuations of w (observed in (1) and (3)). The opposite is true for mutants, in which
case a net shift towards wildtype fixation is seen. When h < 0.5 ((3) and (4)) wildtype copy numbers are higher
than mutant numbers and therefore fluctuations in w are more likely to occur, which is illustrated through asym-
metric fluctuation sizes. The relatively frequency of all the fluctuations occurring, as well as the size and direction
of the shifts they induce along the steady state line, together give rise to the existence of a drift term.
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C.2.3 Estimation of control strength parameter c1
In order to estimate the control strength parameter c1, we focus on estimating the coefficient
of variation (CV) of wildtype copy numbers across cells homoplasmic in wildtype; we can then
obtain c1 using Equation (C.30). The CV is a measure of the width of the copy number
distribution across cells (or over time in a single cell), and therefore an indication of control
strength, and has the advantage of not depending on mean copy numbers.
We explored different methods of estimating the CV, one of which involves determining the
variation in wildtype copy number along skeletal muscle fibres. Because we assume a single
fibre consists of many ‘cells’, a copy number distribution along a fibre can be interpreted as
a distribution across cells. We collected data from two studies (Refs. [21, 85]), and only use
data from fibre regions homoplasmic in wildtype or from fibre regions in which w show little
correlation with heteroplasmy (in which case δ ≈ 0 and the control strength is not affected by
the presence of mutants). The resulting copy number distributions from three fibres are shown
in Figure C.7A,B, and lead to the following estimations for the CV: 0.69, 0.55 and 0.49. Such
high values for the CV, however, would lead to high chances of mtDNA extinction in single
cells (see below) which seems unrealistic. We thus conclude that it is likely these CV’s do not
solely reflect the actual control feedback strength, but mostly reflect changes in in fibre volume
or mitochondrial density (mitochondria are more concentrated near neuromuscular junctions,
nuclei and capillaries [462]). Therefore, despite the high copy number variance observed along
the fibres, it may still be that copy numbers within local fibre regions are strongly controlled.
To obtain a better intuition about how the CV affects mtDNA distributions, we plotted example
wildtype distributions for several CV values (Figure C.7A). These distributions are obtained
by i) using Equation (C.17) to obtain the steady state wildtype distribution for a given value
of c1 (assuming a linear control λ(w) = µ + c1(Nss − w)) and ii) using Equation (C.29) to
obtain a value for the CV. We observe that when CV & 0.3, an appreciable rate of fixation
occurs. This means that in a population of cells, each containing a linear feedback control
steering copy number towards some fixed value‖, some mtDNA-less cells exist which experience
a large stochastic fluctuation driving their copy numbers towards extinction. Figure C.7B
shows the probability of mtDNA extinction as a function of CV, obtained through stochastic
simulations. Because it seems unlikely that a feedback control is so loose as to allow for copy
number extinction, we use CV = 0.25 as an upper bound (Figure C.7B); at this value extinction
probability is very low. As a lower bound we pick the value CV = 0.02 because it seems unlikely
‖The probability of a cell reaching copy number extinction does not depend on the value of Nss.
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mtDNA populations are controlled more tightly than as indicated by the magenta distribution
in Figure C.7C.
We appreciate the our upper and low bound choices for the CV are somewhat arbitrary, but
we would argue they provide a plausible biological parameter range. We do not use this range
to make quantitative statements, we only use it to speculate about whether cellular mtDNA
exchange could plausibly lead to significant changes in mean cellular heteroplasmy (Section
5.2.2.3).
To conclude, we estimate that the CV of a (wildtype) mtDNA population across identical cells
lies in the range CV ∼ [0.02, 0.25]. Using Nss = 500 and µ = 0.07, as assumed in Figures 5.5
- 5.8, this corresponds to c1 ∼ [5.5 × 10−6, 7 × 10−4]. We note that the unrealistically high
values for the CV obtained by using skeletal muscle data suggest that most of this variation
is due to external factors (e.g. volume changes along the fibres). As such, measuring wildtype
copy number distributions across a population of cells (which will always show heterogeneity
in volume) may not provide a good estimate of the CV. Instead, non-destructive copy number
measurements in single quiescent cells over time can be used (as suggested in Table 5.5 of
Chapter 5).
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Figure C.7: Estimating the feedback control strength. A) Wildtype copy number values measured along sin-
gle fibres are shown for two fibres defined as ‘fibre 1’ and ‘fibre 4’ in Figure 7 of Ref. [21]. Copy numbers were
measured in 10µm thick slices of 36-month old rat quadriceps. B) Data from ‘fibre 19’ was taken from Figure 3
of Ref. [85]. These copy numbers were measured in 10µm thick vastus lateralis muscle slices from a 76-year old
male human subject. C) Steady state wildtype copy number distributions, with their corresponding coefficient of
variations, are shown at h = 0 for different control strengths using Nss = 500 and µ = 0.07. Distributions were
obtained by using the analytical approximation derived in Section C.1.3. These approximations show good agree-
ment with stochastic simulations. D) Here we show the probability of copy number extinction, when using a linear
feedback function λ(w) = µ + c1(Nss − w), as a function of the CV. We used µ = 0.07 and Nss = 500, which
then fixes c1 given a value for the CV (Equation (C.29)). The fixation probability is defined at 2000 days and ob-
tained through stochastic Gillespie simulations (5 × 104 repeats). The vertical line denotes the upper bound of our
CV estimations, namely CV = 0.25; at this value, extinction is still very low. We note that any nonzero fixation
probabilities shown here will continue to increase over time until all trajectories have gone extinct.
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C.2.4 Estimation of mtDNA exchange rate
Here we estimate the intercellular mtDNA exchange rate γ in two different ways: 1) using
experimentally measured diffusion coefficients of mtDNA and mitochondrial proteins, and 2)
using the rate at which high-heteroplasmy regions spread out over time along muscle fibres.
C.2.4.1 Estimating γ using mtDNA and protein diffusion coefficients
For our first estimation, we use diffusion coefficients of both mtDNA nucleoids as well as
mitochondrial inner membrane proteins (as nucleoids are closely associated with the inner
membrane [355]). Assuming 1D random diffusion of an mtDNA molecule along the length of a
fibre, the position of the molecule is described by a Gaussian centered at the initial position of
the mtDNA. The variance of the Gaussian increases with time. As discussed in Section 5.2.2.2,
we assume a single fibre can partitioned into ‘cells’ whose length we denote by Lc. To estimate
the rate of mtDNA exchange between cells, we want to know the average time it takes for the
mtDNA to diffuse along the length of a cell. We use two different ways to estimate this time,
as outlined below.
First, we use the first passage time, i.e. the first time at which the mtDNA molecule reaches a
neighbouring cell (given that it just entered the current cell). Though the expected first passage
time for 1D random diffusion diverges, the most likely first passage time, i.e. the ‘typical’ first
passage time ttyp, can be calculated analytically using standard methods (Equation (C.61)).
Due to the diverging expected value, however, the first passage time distribution is heavy-
tailed and ttyp may therefore not be representative of first hitting times in general; hence the
reason for considering an alternative estimation.
Second, we use the root-mean-square displacement LRMS, which represents the standard devi-
ation of the probability distribution centered at the initial point and is a measure of the spatial
extent of random diffusion. The time it takes for LRMS to be equal to Lc, tRMS, is provided in
Equation (C.62). We see that these two estimates estimates we provided only differ by a factor
of 3.
ttyp =
L2c
6D
(C.61)
tRMS =
L2c
2D
(C.62)
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We can now estimate the mtDNA exchange rate between cells γ, which is modelled as a Poisson
process. The waiting times in between hopping events (tw) are exponentially distributed: tw ∼
Exp(γ), meaning that 〈tw〉 = 1/γ. We want this waiting time to be equal to the time it takes
to diffuse across a cell. Using the estimates derived above, we obtain
γ =
2D
L2c
(using tRMS) (C.63)
γ =
6D
L2c
(using ttyp) (C.64)
Table A.3 in Section A.3 shows experimentally measured diffusion coefficients of various mito-
chondrial components. From this table, we find that the values for D corresponding to mtDNA
nucleoids and complex II and V of the respiratory chain (which are large inner membrane com-
plexes and may be indicative of nucleoid diffusion) lie in the range D ∼ [0.001, 0.1]µm2/s. We
can now calculate the corresponding range of γ by assuming Lc = 30µm (as discussed in Sec-
tion 5.2.2.2) and using Equations (C.63), giving γ ∼ [0.2, 60] day−1. We note that the diffusion
coefficients of order 0.1µm2/s correspond to mobile subpopulations of complex II and V; less
mobile populations and mtDNA nucleoids mostly fall into the range ∼ [0.001, 0.01]µm2/s; we
therefore argue that γ is most likely to lie in the range γ ∼ [0.2, 6.0] day−1.
C.2.4.2 Estimating γ using the spread of abnormal fibre regions
For our second method we use the rate of spreading of high-heteroplasmy regions along muscle
fibres. Measurements of the length of these COX-negative regions (L) in humans, rhesus
monkeys and rats are summarised in Table 5.3 of Chapter 5. We only use the upper bound of
these measurements because shorter regions are likely to have originated from a mutation event
later in life∗∗. Though even the longest regions may have started to form years after birth, we
believe the data will be sufficient to provide us with another order-of-magnitude estimation.
Figure C.8 shows the measured values of L plotted against the age of the organism in which
they were measured.
Given a value for D, the predicted length of an abnormal region at time Ti is given by
√
2DTi
††.
We denote the experimentally measured values of L corresponding to time Ti by yi (~y consists
∗∗We assume that if a COX-negative region of length L was measured in e.g. a 40-year old subject, the
mutant took 40 years to spread over the distance L. As it is likely that the mutation expanded in less time, the
actual mtDNA diffusion coefficient is likely to be higher than our estimate.
††Here we use the root-mean-square distance travelled. We take it as a given that the mutation has successfully
expanded.
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of N different experimental measurements). Assuming a Gaussian error model, we can write
yi =
√
2DTi +N(0, σ
2) (C.65)
Because it is easier to work with a linear model, we write y2i = 2DTi + N(0, σ˜
2) where σ˜ is a
re-scaled noise variance. The log-likelihood of the model is given by
L = −N
2
log(2piσ˜2)− 1
2σ˜2
N∑
i=1
(y2i − 2DTi)2 (C.66)
The maximum likelihood estimate of D, DMLE, is the value of D that minimises the quantity∑N
i=1(y
2
i −2DTi)2. Using the experimental data we find DMLE ≈ 4.6×10−4µm2/s, which leads
to γ ≈ 0.09 day−1 (using Equation (C.63)). The predicted values of L using this MLE are
shown in Figure C.8. Additionally, we show predictions based D = 0.001 and D = 0.01.
As noted before, experimentally observed COX-negative regions can be the result of a mutation
that occurred years after birth; our maximum likelihood estimator can therefore be considered
a lower bound. The predicted values for L when using D = 10−2µm2/s are much higher than
the observed data (Figure C.8), though we do expect most data to lie below our predictions and
it could be that mtDNA molecules reach a neighbouring cell relatively quickly but other factors
(e.g. extinction of the mutant in some cells, or fission of mitochondria which blocks further
diffusion) slow down its rate of spreading along the fibre. We therefore consider D = 10−2µm2/s
an upper bound on the mtDNA diffusion coefficient (using D = 0.1µm2/s leads to unrealistically
high predictions of L, confirming speculations in the previous section that such high coefficients
(observed for mobile subpopulations of complex II and V) are not applicable to mtDNA).
In conclusion, based on both our estimation methods we estimate the mtDNA (i.e. nucleoid)
diffusion coefficient to lie in the range D ∈ [4.6× 10−4, 0.01]µm2/s, giving γ ∈ [0.09, 6] day−1.
We believe γ is most likely to lie in the lower region of this range. We note that it is difficult
to provide accurate estimates for γ as e.g. the rate of mtDNA diffusion may not be constant
along fibres and may also change with age.
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Figure C.8: Estimating mtDNA diffusion coefficients using the spread of abnormal fibre regions. We plot
the relation between age and the length of a COX-negative region (L) along a muscle fibre. The data we used
is summarised in Table 5.3 (only upper bounds were used), extra data was taken from Ref. [341] (not shown in
the table). Predictions arising from our maximum-likelihood estimate DMLE , as well as D = 10
−3µm2/s and
D = 10−2µm2/s are shown (using L =
√
2DT with T denoting time in seconds).
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